University of Nebraska - Lincoln

DigitalCommons@University of Nebraska - Lincoln
Biological Systems Engineering--Dissertations,
Theses, and Student Research

Biological Systems Engineering

Summer 7-27-2016

Alginate Hydrogels as Three-Dimensional Scaffolds
for in Vitro Culture Models of Growth Plate
Cartilage Development and Porcine Embryo
Elongation
Taylor D. Laughlin
University of Nebraska - Lincoln, tdlaughlin@huskers.unl.edu

Follow this and additional works at: http://digitalcommons.unl.edu/biosysengdiss
Part of the Biochemical and Biomolecular Engineering Commons, Biological Engineering
Commons, Biology and Biomimetic Materials Commons, Biomaterials Commons, and the
Molecular, Cellular, and Tissue Engineering Commons
Laughlin, Taylor D., "Alginate Hydrogels as Three-Dimensional Scaffolds for in Vitro Culture Models of Growth Plate Cartilage
Development and Porcine Embryo Elongation" (2016). Biological Systems Engineering--Dissertations, Theses, and Student Research. 62.
http://digitalcommons.unl.edu/biosysengdiss/62

This Article is brought to you for free and open access by the Biological Systems Engineering at DigitalCommons@University of Nebraska - Lincoln. It
has been accepted for inclusion in Biological Systems Engineering--Dissertations, Theses, and Student Research by an authorized administrator of
DigitalCommons@University of Nebraska - Lincoln.

ALGINATE HYDROGELS AS THREE-DIMENSIONAL SCAFFOLDS FOR IN
VITRO CULTURE MODELS OF GROWTH PLATE CARTILAGE DEVELOPMENT
AND PORCINE EMBRYO ELONGATION
by
Taylor D. Laughlin

A THESIS

Presented to the Faculty of
The Graduate College at University of Nebraska
In Partial Fulfillment of Requirements
For the Degree of Master of Science

Major: Agricultural and Biological Systems Engineering

Under the supervision of Professor Angela K. Pannier

Lincoln, Nebraska

July 2016

ALGINATE HYDROGELS AS THREE-DIMENSIONAL SCAFFOLDS FOR IN
VITRO CULTURE MODELS OF GROWTH PLATE CARTILAGE DEVELOPMENT
AND PORCINE EMBRYO ELONGATION
Taylor D. Laughlin, M.S.
University of Nebraska, 2016
Advisor: Angela K. Pannier
The establishment of in vitro culture models utilizes tissue engineering principles
to design functional mimics of in vivo environments in vitro. Advantages for the use of in
vitro culture models include ethical alleviation of animal models for therapeutic testing,
cost efficiency, and a greater ability to study specific mechanisms via a systematic,
ground-up approach to development. In this thesis, alginate hydrogels are utilized in the
development of in vitro culture models of porcine embryo elongation and growth plate
cartilage development. First, the effect of scaffold and modifications to the scaffold were
explored in both projects. In order to modulate cell-scaffold interactions, the alginate
molecule was covalently modified with the arginine-glycine-aspartic acid (RGD) peptide,
which has been extensively used to promote cell adhesion in vitro. In the porcine embryo
elongation studies, a previously established culture system was used as a tool to
encapsulate embryos and explore the effect of soluble factors on embryo survivability,
rate of morphological changes, gene expression and hormone production by using RGDmodified alginate and alginate mixed with osteopontin (SPP1), a glycoprotein known to
be secreted in the uterus. RGD-alginate encapsulation led to significant increases in
embryo survivability and morphological changes along with corresponding cellular
outputs. In the growth plate cartilage development model, chondrocytes were

encapsulated in alginate and RGD-alginate to elucidate effects of cell adhesion,
mimicking cell-matrix interactions within the growth plate, on chondrocyte phenotype.
Additionally, alginate encapsulation was utilized to culture chondrocytes in media
supplemented with parathyroid hormone (PTH) or Indian hedgehog (IHH) to begin to
study the mechanisms behind these two molecules on the establishment of the zonal
architecture and column formation that is unique to the growth plate. Cell cycle
distribution, gene expression immunofluorescence and fluorescent in situ hybridization
techniques together indicated our ability to suppress hypertrophy using alginate hydrogel
scaffolds and/or signaling molecules. Overall, utilization of these in vitro culture models
as tools to study developmental mechanisms can be used to advance both the fields of
porcine embryology and cartilage developmental biology to improve pregnancy
outcomes in pigs and to engineer therapies for the treatment of growth plate injuries and
diseases.
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CHAPTER 1- Thesis Introduction and Background

1.1. Introduction
The development of in vitro culture models using tissue engineering techniques is
a promising approach to answer biological questions about a given tissue system. Tissue
engineering is classically defined by Langer and Vacanti as applying “the principles of
biology and engineering to the development of functional substitutes for damaged tissue”
with the main objective being the development of whole organs for transplantation to
circumvent the overwhelming scarcity of donated organs [1]. While this task remains
daunting to this day, tissue engineering has evolved from this strict definition and has
taken on many roles, such as becoming an invaluable tool for the study of biological
development.
Currently, there are two well-established representations of tissue systems- twodimensional (2-D) cell culture and animal models. While a wealth of knowledge has thus
far been gained through cell culture and animal models, it is recognized that 2-D cell
cultures are not representative of the physiology of real tissues and animals are not
completely representative of human tissue [2]. A reduction in the gap between cell
culture and animal studies can be facilitated via 3-D cell cultures and tissue culture
models [2]. By utilizing tissue engineering techniques- the combination of scaffolds,
factors and cells- models of development can be established to answer crucial questions
necessary to advance our understanding of biological systems. These models, or in vitro
culture models, are representations of in vivo biological systems but are independent of
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any living organism. In vitro culture models allows for the isolated study of whole tissues
or organs without the necessity of animal models, thus bridging the gap between 2-D cell
culture and animal model experimentation. This thesis focuses on the development of in
vitro culture models with the use of alginate hydrogels.
Hydrogels, or polymeric materials that exhibit the ability to swell and retain water
within their structure without degrading in water, are ideal scaffold systems to use in the
engineering of tissues or in vitro culture models due to their close resemblance to the
extracellular matrix (ECM) of many native tissues [3]. In particular, alginate, a
polysaccharide derived from brown algae, is one such material that forms hydrogels
when crosslinked in the presence of divalent cations (i.e. Ca2+, Ba2+, etc.). These threedimensional (3-D) hydrogel structures can be molded or crosslinked into many shapes
and sizes [4]. After crosslinking, the mechanical properties of alginate hydrogels can
exhibit a range of Young’s moduli, but can be tailored toward a specific stiffness that
correlates to many different tissues within the body and can even be modulated to mimic
a particular tissue type [5]. Alginate is inherently biocompatible, which is a desirable
property of a biomaterial when working with biological entities such as cells or whole
tissues [6]. Not only are alginate hydrogels biocompatible, but also alginate in its basic
chemical structure is non-fouling, or it allows for little to no protein adsorption, which
leads to the inability for cells to adhere to the structure [7]. Thus alginate acts as a “blankslate” scaffold in this respect and allows for the study of specific effects that 3-D culture
has on cell and tissue cultures. Finally, because of the simple active groups found on the
alginate molecule, it can be easily chemically modified to present factors in a controlled
manner to study interactions between cells and the surrounding scaffolding [8]. All of
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these properties allow researchers to ask basic, developmental biological questions by
first encapsulating cells or tissues within an alginate hydrogel matrix to strictly study the
change from 2-D culture to 3-D culture. Questions can then be asked about the role that
mechanical and/or molecular factors play in cellular maturation by introducing changes
to these aspects within the hydrogel in a controlled manner. For this thesis, alginate was
utilized to design 3-D scaffold for two objectives.
For the first objective of the thesis, previously developed alginate scaffolds [9]
were utilized as a tool to probe questions about the role of ECM ligands in porcine
embryo elongation in vitro. Elongation is the period of porcine gestation where drastic
embryonic morphological changes occur within a very short time period. Preimplantation elongation is characterized by a change in embryonic shape from a spherical
morphology, with a radius from 0.5- to 1.5-mm in diameter, to a filamentous
morphology, with a length of up to 100-mm, within a time frame of hours at any point
between days 10 and 12 of gestation [10]. It is estimated that 40% of embryos are lost
during the pre- and peri-implantation period of gestation, with approximately 20% due to
deficiencies in the elongation process described above. However, the mechanisms behind
the success or failure of elongation remain largely unclear [11]. Therefore, the first
objective of this thesis was to improve upon the existing in vitro model by introducing
known factors into the scaffold itself, including factors such as Osteopontin (SPP1) and
the specific integrin binding motif found in SSP1, Arginine-Glycine-Aspartic acid
(RGD), in order to understand their specific role in elongation.
For the second objective of the thesis, alginate hydrogel scaffolds were designed
to mimic an ECM for growth plate chondrocytes to establish an in vitro model of growth
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plate cartilage. Growth plate cartilage, found at the ends of long bones during
prepubescent development, is the cartilaginous structure responsible for the longitudinal
growth of bones [12]. During development, distinct zones of the growth plate emerge
with each zone containing chondrocytes with a specific phenotype. From the ends of the
long bones to the beginning of ossification, the zones have distinct characteristics. The
resting zone is made up of immature, quiescent chondrocytes that have low instances of
proliferation and are round in morphology [13]. As the chondrocytes begin to mature,
they flatten into coin-like shapes and initiate an increase in proliferation [14]. Flattened,
highly proliferative cells that form columns make up the proliferative zone, and this zone
is of particular interest because of the manner by which proliferation takes place:
chondrocytes divide perpendicular to the axis of growth, rearrange themselves into stacks
and repeat, leading to longitudinal growth [15]. Once the chondrocytes mature further,
the process of hypertrophy begins. In the prehypertrophic and hypertrophic zones,
chondrocytes take on an enlarged morphology and initiate apoptosis leading to bone
formation [16]. Growth plate cartilage is not capable of repairing or regeneration once
injured or diseased. In prepubescent long bones, growth plate cartilage is the softest part
of the bone during development and is therefore the most susceptible part of the bone to
injury. An injury to this fragile cartilage, particularly within the proliferative zone, results
in severe deformities and long-term pain in the worst cases. In addition to the inability of
growth plate cartilage to heal itself, there are currently few therapeutic options for
patients with these injuries. By developing an in vitro culture model for growth plate
cartilage, the specific mechanisms behind zonal arrangement and the resulting
architecture can be elucidated, leading to a better understanding of the developmental
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process of the growth plate and in turn leading to the investigation and identification of
therapeutic techniques to treat injuries. Therefore, the second objective of this thesis is to
use an alginate hydrogel scaffold system to develop an in vitro culture system to
determine the basic signaling factors necessary for the development of the zonal
architecture seen in vivo within growth plate cartilage.
By designing and optimizing these two in vitro culture systems, the knowledge
and understanding of physiological processes will be advanced, and the scientific
community will gain a useful tool to study reproduction in a controlled setting and to
study degenerative cartilage diseases leading to the availability of better therapeutic
treatments. The remainder of this introduction is arranged as follows- the basic principles
and advances in tissue engineering are covered, then the significance of alginate to this
thesis is described, followed by a more thorough explanation of in vitro culture models,
and finally, the development of the two in vitro culture models covered in this thesis, a
model of porcine embryo elongation and growth plate cartilage development, are
introduced.

1.1.1. Tissue Engineering
The main goal when tissue engineering was emerging as a prevalent field of study
within biology and engineering was to build new organs for patients relying on scarce
donors for whole organ transplantation. The field of whole organ engineering must
advance further before the necessity of organ donors is no longer, however tissue
engineering has made great strides in advancing the field’s knowledge of the intricacies
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of tissue development and viability in order to keep working toward this overall goal.
Since Langer and Vacanti first defined tissue engineering, it has been further described as
the combination of its fundamental aspects: cells or tissue, scaffolding and bioactive
signals [17]. The first necessity, cells, can be collected from many sources including from
animal sources, patient’s own tissues, and the cells may be fully differentiated or be
derived from or be stem cells [1]. Second, the scaffolding can be used to mimic the native
ECM or environment surrounding the cell. Since the emergence of tissue engineering,
research groups have taken many different approaches in designing the scaffolds for a
specific tissue type. For example, some choose to decellularize an existing donated organ
before introducing the patient’s own cells to the ECM [18]. By using this method, the risk
of negative immune responses is lessened due to the fact that the patient is receiving their
own cells. However, the risk is not completely mitigated since the surrounding ECM is
still foreign. Others have utilized naturally- or artificially-derived biomaterials to design a
base ECM scaffold within which cells can be cultured [7]. Many types of biomaterials,
including ceramics (e.g hydroxyapatite (HA) or tri-calcium phosphate (TCP)), synthetic
polymers (e.g. poly-l-lactic acid (PLA) or polyethylene glycol), and natural polymers
(e.g. collagen or alginate), are used in tissue engineering approaches [19]. Rigid materials
like HA or TCP are utilized in bone tissue engineering due to their chemical and
mechanical similarity to the targeted tissue [20]. Other biomaterials such as polyurethane,
collagen or alginate have been used in models because of their mechanical similarity to
soft tissues [21-23]. Alginate has been used in many tissue engineering applications to
date including as an injectable cell delivery vehicles [24] as well as wound dressings
[25], dental impressions [26], and immobilization matrices because of its
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biocompatibility, tunable mechanical properties and easy modification, which will be
discussed further below [7]. Finally, bioactive signals are vital to the success of the
development of engineered tissues. Signals such as proteins like fibronectin (FN) or
osteopontin (SPP1) allow for scaffold-cell interaction that mimics the in vivo cell-matrix
interaction within a tissue system that drive cellular growth and differentiation to guide
the cells toward a specific function [27]. It has been shown that without bioactive signals,
the loss of cellular phenotype and differentiation into unintended phenotypes occurs in
vitro [28]. All three of these aspects, scaffold, cells and bioactive signals are explored
and optimized in this thesis in two different models to study growth plate cartilage
development and embryo elongation in vitro.
By utilizing tissue engineering techniques to develop in vitro culture models from
the ground up, researchers have been able to better understand the basic environment
necessary for tissue development in order to eventually repair, maintain or enhance tissue
function for regenerative and replacement therapies [29]. Additionally, by building these
tissue systems to function in an in vitro environment, the possibility emerges of using
these engineered tissues for drug discovery, therapeutic testing, or injury investigations in
place of 2-D cell culture systems or animal models [2]. In this thesis, alginate hydrogels
were utilized as the natural polymer for the scaffold to support embryo elongation and
growth plate cartilage development in vitro.
1.1.2. Alginate
Alginate is a biocompatible, naturally-derived, linear polysaccharide that was
originally thought to be produced strictly by algae such as M. pyrifera and A. nodosum,
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but it has since been proven to be isolated from bacterial sources such as P. Aeruginosa
as well [30, 31]. Currently, alginate is used in a wide range of applications including the
commercial food industry, cosmetics production industry, and medical and
pharmaceutical materials, further supporting the FDA’s claim of safety (GRAS) [31-33].
More relevant to this thesis, alginate has been used in biomedical applications as wound
dressings, dental implants and tissue engineering [34].

Fig. 1-1. Chemical structure and ionic crosslinking of alginate. Alginate is made of M
and G blocks and it ionically crosslinks with divalent cations such as Ca 2+ to form
hydrogels (Reprinted from Andersen et al., Carbohydr. Chem, 2012)

1.1.2.1. Properties of Alginate
Alginate is a block copolymer that is comprised of varying ratios of L-guluronate
(G) and D-mannuronate (M) residues depending on the natural source (Fig. 1-1) [35].
The crosslinking of sodium alginate in the presence of divalent cations such as calcium
(Ca2+) or barium (Ba2+) produces hydrogels, or water-swollen and crosslinked networks
of hydrophilic polymer chains produced by a simple reaction between two chains that
will not dissolve in water [36]. It is believed that only the G-blocks of alginate participate
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in intermolecular crosslinking to form hydrogels, as shown in Fig. 1-1, indicating the
M:G ratio has a significant impact on the mechanics of crosslinking [32, 35]. The most
critical advantages of using alginate to develop in vitro culture models are perhaps its
biocompatibility and non-immunogenicity, however other advantages such as mild
gelation conditions, tunable mechanical properties and ease of functionalization also add
to its appeal as a biomaterial scaffold [6].
Among many other synthetic or naturally occurring biomaterials, alginate is
widely used in tissue engineering as a scaffolding material. Because it is known to be
biologically inactive, in the sense that protein adsorption and cell attachment to
unmodified alginates are low due to hydrophilcity and charge, this polymer is well suited
to be implanted into or even merely in contact with the human body [37]. It has even
been shown that alginates with a G-content of 50% or above are recognized as not
eliciting an immune response [37]. Without modifications, this nonfouling characteristic
allows alginate to serve as a “blank slate”, acting only as a mechanical support system to
study the effects 3-D culture has without any other interference. Additionally, the
mechanical properties and adhesion potential of the alginate hydrogels can be easily
modulated to fit specific needs of the target system.
1.1.2.2. Modulation of Alginate Mechanical Properties
Tissues of the body have a wide range of stiffness, making the ease of the control
of the mechanical properties of biomaterials used for in vitro culture models essential.
The Young’s moduli of alginate hydrogels can be modulated by changing the
concentration of alginate in solution, the chemical makeup of the alginate molecule, the
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solvent used to dissolve the alginate, the gelation temperature and also by changing the
divalent cation used for crosslinking [5, 29, 35, 38]. For example, alginate has been
modified with sodium periodate to induce degradability of the hydrogel by oxidation for
better control of changes in mechanical properties in alginate [39]. Another way to
change alginate mechanical properties and to obtain an alginate hydrogel with a lower
Young’s modulus (< 10 kPa), one could choose to dissolve the alginate at lower
percentage (w/v) and/or a use an alginate with a lower G content, dissolve the alginate in
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Fig. 1-2. Mechanical properties of alginate are modulated
by changing percentage in solution. The stiffness of the
alginate hydrogels used in this thesis range from 5- to 20kPa.

PBS, and/or gel the solution at a higher temperature [23, 40]. On the other hand, if the
goal is to employ an alginate hydrogel with higher Young’s modulus (>40 kPa), a higher
percentage of alginate and/or a higher concentration of G blocks should be used, the
solution should be made with Ca2+ free DMEM with a low phosphate concentration
and/or should be gelled at a lower temperature [39, 40]. With all of these control
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mechanisms, the compressive modulus for alginate hydrogels can range from less than 1kPa to over 1000-kPa, with lower moduli being used as an ECM mimic for tissues like
smooth muscle, while the higher moduli being used in bone tissue engineering
applications [5]. For the purposes of this thesis, alginate hydrogels with a Young’s
modulus ranging from 5- to 20-kPa were used, prepared by varying the density (w/v) of
medium viscosity (>200 mPa) alginate (Fig. 1-2). Although the mechanical properties of
alginate can be varied with relative ease, there are a few disadvantages of using alginate
in its unmodified form. For instance, alginate does not degrade in a controllable fashion,
and because of the inability of proteins to adsorb to the surface of alginate, cell adhesion
is not promoted in unmodified alginate gels. In order to address these concerns, many
modifications to the alginate molecule and hydrogel have been explored, as described
next.
1.1.2.3. Alginate Modifications
To modulate aspects such as bioactivity, degradation rate and mechanical
properties, chemical modifications can be made to the alginate molecule, allowing for
greater control over the design of the hydrogel, specifically for tissue engineering uses.
Calcium crosslinked alginate hydrogels slowly and uncontrollably degrade in
physiological conditions due to ion exchange, and it has been proven that covalent
crosslinking yields hydrogels with much higher stability over time [40]. By introducing
oxidation points into the alginate molecule by using γ-radiation and/or periodate
oxidation in combination with molecular weight modulation, it has been shown that the
degradation rate of the alginate hydrogels can be strictly regulated without changing the
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initial physical properties of the gel [39-41].
While controlling degradation rate is an important aspect of scaffold design, the
ability of the encapsulated cells to interact with the surrounding matrix is also crucial.
Mammalian cells do not have receptors for alginate polymers, which makes alginate
relatively inert, however, cell adhesion is a basic requirement for cell survival [6, 42].
Cell adhesion molecules such as fibronectin (FN), collagens, laminin, and osteopontin
(SSP1) bind cell surface receptors such as integrins and syndecans [43] and can be easily
blended within the alginate solution prior to crosslinking to incorporate them within the
gel. However, the covalent modification of alginate with any of these full proteins poses
many problems: proteins must be isolated and purified to not induce an immune response,
the length of time these proteins are active is very short making replacement necessary,
the position of the whole molecule to present the active portion is difficult, and it is very
difficult to control the kinetics of functionalization with whole proteins and alginate [44].
One of the most ubiquitous integrin binding motifs found in these proteins is the peptide
sequence RGD [44, 45]. It has been shown that the use of only this short sequence can
stimulate different cell responses not only by modulating the average concentrations of
ligands, but also by presenting the ligands in a way that allows or even triggers integrin
aggregation and mechanotransduction from the surrounding matrix [46]. The conjugation
of RGD to alginate has been utilized extensively in tissue engineering [28, 47, 48]. For
example, RGD modification to alginate at varying densities showed that the inclusion of
the adhesion peptide at specific densities enhanced the functionality of baby hamster
kidney fibroblasts; fibroblasts demonstrated higher rates of proliferation and secreted
more VEGF over time when encapsulated in RGD-alginate than in unmodified alginate,
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indicating cell adhesion was crucial to the functionality of these fibroblasts [49].
Additionally, RGD modification to alginate aided in the guidance of adipose-derived
adult stem cells down a chondrogenic line and has even been used to pattern cellular
growth on alginate surfaces and within alginate scaffolding [50-52]. Tissues such as
cardiac muscle, cartilage, and bone have all been engineered with the use of the RGD
peptide conjugated with alginate [47, 52]. The utilization of such a small sequence
negates the aforementioned disadvantages that come with whole protein conjugation,
allowing for controlled, reproducible conjugation densities while still presenting cell
adhesion moieties. In this thesis, the RGD peptide was conjugated to the alginate using
carbodiimide chemistry to explore the effects of cell adhesion on both of the two culture
systems.
Alginate has proven to be a suitable biomaterial for tissue engineering; the
material is biocompatible and inert, the mechanical properties can be modulated for both
of our applications, and the cell-scaffold interactions can be easily tuned for our models.
For these reasons, alginate hydrogel scaffold systems were designed and optimized for
the purposes of developing in vitro culture models of both porcine embryo elongation and
growth plate cartilage development. An introduction on in vitro culture models follows.
1.1.3. In Vitro Culture Models
The development of in vitro culture models utilizes the techniques of tissue
engineering (i.e. scaffolds, cells and provision of bioactive signals) to produce
biologically suitable substitutes for organ systems or tissues, which can in turn be utilized
for pharmaceutical, diagnostic or research purposes [53]. Until recently, most early-stage
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Fig. 1-3. The principles of in vitro culture models. Tissue engineering techniques,
or the combination of cells, scaffolds and signals, are utilized in the development
of in vitro culture models. These models act as the bridge between cell culture
models and animal models, giving researchers another tool for studying
pharmaceutical, diagnostic or developmental mechanisms.

experiments that ranged from exploring fundamental biological mechanisms to highthroughput drug screenings were conducted using immortalized, mono-layered cell lines.
While the use of cell lines in 2-D culture remains an important tool in many research
endeavors, it is generally accepted that this mode of culture is highly divergent from
native tissue physiology [2]. Culturing in two dimensions (2-D) leads to the loss of cell
polarity, a lack of cell-cell and cell-matrix interactions, a change in gene expression, and
a tendency to induce dedifferentiation that would not be experienced in 3-D culture
models [54, 55]. Animal models have also been used to study biological development as
well as the efficacy and safety of drugs and drug delivery methods. However, while
animal models have been integral in studying many in vivo mechanisms, this approach
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too can have shortcomings. The disadvantages of using animal models include the
inability to model drug therapeutic responses accurately or induce stem-cell
differentiation, the incompetence in accurately mimicking human responses, as well as
the ethical concerns with using live animals for research [2, 54].
In order to bridge the gap between cell culture and animal studies (Fig. 1-3), in
vitro culture models have been developed using tissue engineering techniques, which
uses cells, scaffolds and bioactive molecules to develop simulations of tissues in vitro.
Models have been developed using cells of many different types, scaffolds made of
varying materials and a wide range of bioactive signals to design the construct for a
specific purpose. Applications for in vitro culture models include the exploration of
various aspects of disease dynamics, drug discovery, diagnostics, and developmental
biology. Recently developed 3-D culture models have already proven to be more
physiologically relevant than either cell culture or animal models and have showed
improvement in the response of the developed model to controlled stimuli [56]. For
example, 3-D in vitro culture models have been extensively utilized in the study of cancer
and metastasis, as well as other diseases, and have probed for the response of tissues to
therapeutic and pharmacological agents [57-60]. Models of cancers in the bladder,
breasts, kidneys, lungs, ovaries, pancreas and prostate have utilized 3-D in vitro cultures
to better understand the development, metastasis, vascularization and response to
therapeutic drugs of these cancers [61, 62]. For instance, Bissell et al. used 3-D cultures
within reconstituted basement membrane, or Matrigel, and bioactive signals to show the
significant role of the extracellular context in tumorigenesis [2]. Additionally,
osteoarthritis has been studied in vitro to understand the degradation and calcification of
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articular chondrocytes for example, by treating with factors known to be involved in the
disruption of articular cartilage [63]. Tissue engineered 3-D models of gastrointestinal
inflammatory disease, rheumatoid arthritis, heart disease, and of many more organ system
disorders have proven to demonstrate markers such as gene expression and protein
excretion reminiscent of the tissue disease, which their monolayer counterparts were
unable to do [21, 63-65]. All of these culture models have utilized a variety of different
scaffold materials that were chosen carefully for their functions. In order to develop in
vitro culture models to study both porcine embryo elongation and growth plate cartilage
development, alginate was extensively utilized in this thesis because of the many
desirable characteristics of the biomaterial, as described previously. First, alginate was
employed to encapsulate and culture porcine embryos for the study of RGD and SPP1 in
elongation in vitro.

1.2. In Vitro Model of Porcine Embryo Elongation
In swine bred for food production, the average number of eggs released from the
ovaries per estrus cycle is 19-20,with around 18-19 being fertilized [66]. The amount of
oocytes released during estrus is >20 and the fertilization rate is greater than 90%,
however after 114 days of gestation the average litter size is only 10.5 piglets [67]. It is
estimated that of the almost 50% embryonic loss, 20% is due to deficiencies in or
asynchronous elongation [68]. Elongation is the rapid and dramatic change in
morphology after the blastocyst hatches from the zona pellucida and begins to prepare for
implantation (see Fig. 1-4) [67]. It has been shown that between days 10 and 12 of
gestation, the embryo rapidly (3-4 hours) elongates from a sphere of around 1.5 mm in
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Fig. 1-4. Schematic of the timeline of porcine embryo elongation. Embryo elongation begins at any
point between days 9 and 10. By day 12, the embryo has elongated and is now filamentous with a
length of over a centimeter. Additionally, the secretion of estrogen and the secretion of
steroidogenic transcripts increase as the embryo elongates while the total protein and rate of
proliferation remains constant throughout the process.

diameter to a 100 to 150 mm filamentous form and it has been shown to be associated
with cellular reorganization and remodeling in the pig, rather than hyperplasia like in
ruminants [69]. During elongation, estrogen production by the embryo increases in order
to modulate the production and secretion of other proteins downstream and to signal for
the recognition of pregnancy [69]. It is hypothesized that an upregulation of the immune
responsive cytokine, interlekin-1β (IL1B) contributes to rapid trophoblast elongation and
pregnancy establishment in pigs [70, 71]. Also throughout elongation and along with
estrogen production by the embryo, changes in the expression of steroidogenic gene
transcripts such as steroidogenic acute regulatory protein (STAR), cytochrome P450 side
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chain cleavage (CYP11A1), and aromatase (CYP19A1), have been observed [72-74].
Many molecular signaling factors are known to play a role in the initiation of this
elongation process, both from the uterine wall and from the embryo itself. Fibroblast
growth factor 7 (FGF7), transforming growth factor-betas (TGFβ), osteopontin (SPP1),
fibronectin (FN), and laminin (LN) are all present in the uterine milieu and have been
implicated in maternal interactions during elongation and implantation [75, 76]. More
specifically, the glycoprotein SPP1 has been shown to be upregulated within the uterine
milieu as the embryo initiates elongation [75]. Evidence also suggests that the activation
of alpha 5 and beta 3 integrins on the embryonic trophectoderm by the specific integrin
binding sequence RGD found in SPP1, FN and LN induces cytoplasmic reorganization
during embryo development and elongation by stimulating cell-cell adhesion and
promoting cell migration [77-79]. Furthermore, it has been shown in vitro that SPP1
added exogenously to the culture media enhances the development of early porcine
embryos to the blastocyst stage [80]. Porcine blastomeres were cultured on dishes that
were coated with FN and an enhancement of the development to the blastocyst stage over
the non-coated control was observed [81]. These studies suggest a role of cell adhesion
proteins on early embryonic development.
Several factors have been associated with embryonic mortality in porcine
gestation that include the proper timing of the secretion of hormones like estrogen and the
subsequent induction of the production and secretion of signaling molecules like FN and
LN that are involved in elongation and implantation [82]. Any disruptions in the
presentation of these signaling factors can lead to deficiencies in elongation and crosstalk between the mother and the embryo, as well as asynchronies in elongation between
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litter-mates [83]. Complete failure of the blastocyst to undergo elongation results in
embryonic loss [73]. Because of the potential for asynchronies in elongation, along with
the wide span of time rapid elongation could take place, it is difficult to study the
initiation of elongation in vivo.
Many attempts to culture and promote the elongation of porcine embryos in vitro
have been unsuccessful; however, some success has been achieved in other species. For
example, the culture of bovine embryos in vitro has been demonstrated using a gel tube
made of agar [84]. While evidence of elongation was observed in this study, the
embryonic disc failed to develop and the morphological changes observed were more
likely due to the incomplete encapsulation of the embryo [85, 86]. Moreover, porcine
embryo elongation had not yet been witnessed in vitro until an alginate hydrogel culture
system was developed in our lab [9]. Using a double layer alginate encapsulation
technique, porcine embryos were encapsulated in alginate and were cultured in basal
media for up to 96 hours. Elongation was observed only in encapsulated embryos,
demonstrating the initiation of elongation in vitro for the first time [9]. However, the
occurrence of a morphological change was not the only evidence of successful
elongation. The expression of pertinent transcripts such as STAR, CYP11A1, CYP19A1
and IL1B was elevated only in the embryos that elongated in vitro, demonstrating a
pattern in gene expression that resembled the pattern seen in in vivo produced embryos
[9]. Additionally, the increase of the secretion of estrogen, which is necessary for the
recognition of pregnancy, was observed only in the in vitro produced embryos that
showed morphological changes [9]. Furthermore, the protein levels of all encapsulated
embryos as well as the controls remained constant throughout culture, regardless of the
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state of morphological change, validating the idea that the elongation process is of
rearrangement and remodeling and not that of proliferation [87]. All of these data
combine to suggest that porcine embryo elongation is possible in vitro with the utilization
of the aforementioned alginate hydrogel system and it could then be used as a valuable
tool to study mechanisms behind the initiation and maintenance of elongation in Chapter
2 of this thesis. In order to explore the effects of cell adhesion on elongation and survival
in vitro, the ECM protein SPP1 was mechanically mixed into the scaffold prior to
crosslinking, exposing the embryo to the protein during culture. Additionally, the RGD
peptide was conjugated to alginate using previously described methods to explore the
differences between whole protein interactions and small peptide sequence interactions
and effect on elongation and survival. The information gained from these studies will
shed light on the impact of SPP1 and RGD on elongation. Understanding the role of these
molecules will lead to further improvements of this system in order to continue to study
embryo elongation in vitro. This alginate culture system, while ideal for the study of
porcine embryo elongation, was also employed in the development of an in vitro culture
model for growth plate development, which is introduced in the following section.

1.3. In Vitro Model of Growth Plate Cartilage
Many bones in the human body, particularly long bones, grow longitudinally via
endochondral ossification of growth plate cartilage. This hyaline, or growth plate,
cartilage is responsible for controlling the rate of growth of these bones from the
beginning of development until puberty. The growth plate is arranged into zones, each
with its own specific phenotype (Fig. 1-5). The resting zone contains slowly proliferating,
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Fig. 1-5. A) Schematic of growth plate showing zonal arrangement. B) Depiction of an overview of the
signaling pathways between PTHrP and IHH. (Recreatd from Deckelbaum et al., 2002)

rounded, stem-like cells randomly distributed throughout the zone and chondrocytes in
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this zone are responsible for renewing the pool of proliferative chondrocytes [88]. These
chondrocytes produce parathyroid hormone-related protein (PTHrP) [89]. As they
mature, resting zone chondrocytes begin to flatten into a coin-like shape and proliferate at
a high rate where daughter cells arrange themselves into columns, giving rise to the
architecture of the proliferative zone [89]. This zone is characterized by an increase in
collagen type 2 (Col2) expression and after many mitotic cycles, chondrocytes begin to
hypertrophy [16]. In the hypertrophic zone, chondrocytes increase in size, an increase in
Indian hedgehog (IHH) expression is observed, and cells produce a calcified matrix rich
in collagen type X (ColX), indicating the initiation of ossification [88, 90]. The
chondrocytes are terminally differentiated at this point and begin to secrete specific
proteins like VEGF to attract osteoblasts, initiate programmed cell death and osteoblasts
invade the matrix, leading to bone formation [12, 89]. A wide range of signaling factors
and matrix proteins are responsible for the zonal arrangement of the growth plate and for
the columnar arrangement of the proliferative zone, however the specific mechanisms by
which this architecture is formed have remained unclear [12].
Generally, however, it is known that systemic factors such as growth hormone,
parathyroid hormone, thyroxine, oestrogen, androgen, vitamin D and glucocorticoids in
conjunction with locally produced factors such as bone morphogenetic proteins (BMPs),
Wnts, fibroblast growth factors (FGFs), hedgehog proteins, insulin-like growth factors,
and retinoids play a role in growth plate development [12]. Precise combinations of many
of these factors tightly regulate the entry into and exit from each stage of chondrocyte
differentiation, which correspond to the well-defined resting, proliferative,
prehypertrophic and hypertrophic zones [91]. Any disruptions in this exact coordination
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of signaling factors can lead to bone deformities ranging from slight to severe and
crippling in nature. It has been identified that the interplay between PTHrP expression
and IHH signaling takes on a significant role in maturation and ultimately zonal
arrangement (Fig. 1-5) [91]. PTHrP synthesized by immature chondrocytes acts as a
signaling ligand on the PTH/PTHrP receptors located on the surface of more matured
chondrocytes aiding in the delay of further differentiation into hypertrophic chondrocytes
[92]. IHH is synthesized by chondrocytes that have just stopped proliferating, but also
induces the expression of PTHrP in periarticular perichondrium [93]. This feedback loop
between PTHrP and IHH serves to regulate the pace of chondrocyte differentiation and
the hypothesis is that a tight regulation of spatial and temporal presentation of these two
signaling factors aids also in the formation of the columnar architecture of the
proliferative zone. A depiction of the potential mechanism of PTHrP and IHH signalling
is shown in Fig. 1-5.
Attempts have been made to engineer many types of cartilage in vitro including
fibrocartilage, found in the intervertebral discs, hyaline, which includes articular
cartilage, and epiphyseal cartilage, also known as the growth plate by using many
different approaches and scaffolds. For example, articular cartilage cultures have been
designed free of scaffolds (seeded in a monolayer on osteogenic calcium phosphate), in
cell pellets, in natural scaffolds like agarose gels, gelatin or hyaluronic acid sponges, as
well in synthetic scaffolds like PGA/PLA [94-98]. More pertinent to this thesis, articular
cartilage has been cultured extensively in alginate hydrogels. For example, alginate has
been utilized to culture articular chondrocytes and to present factors to promote cell
viability, cell proliferation and matrix synthesis, demonstrating that the addition of
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factors to the culture induced specific changes in survivability and proof of differentiation
and maintenance of chondrocytic phenotypes [99, 100]. Furthermore, cultured
chondrocytes have even been implanted into osteoarthritic model animals after first being
cultured in vitro in either pellets or in alginate hydrogels, showing an improvement in
osteoarthritic healing in alginate cultures over that of both control models and implants
from pellet cultured chondrocytes [101]. Although the goal of this thesis is to culture
growth plate chondrocytes, strategies such as the culture using alginate encapsulation can
be taken from the culture models developed for articular cartilage development and
applied to the culture of growth plate chondrocytes.
While there are much fewer examples of in vitro culture models for growth plate
cartilage development as compared to those of articular cartilage in the literature, key
studies have been conducted that hint at the underlying mechanisms of zonal arrangement
and columnar formation. For instance, pellet cultures, which are chondrocytes that have
been centrifuged at high speeds to form a densely packed aggregation of cells and are
cultured in that form, have been used to study the effects of serum factors on columnar
architecture development in growth plate chondrocytes [102, 103]. While the apparent
alignment of the chondrocytes in the pellet was noted, other forms of characterization
such as fate mapping or fluorescent in situ hybridization (FISH) to visualize gene
expression distribution was not utilized to confirm the true lineage of the chondrocytes or
the zonal arrangement characteristic of growth plate cartilage [102, 103]. Furthermore,
distinct zones of maturation were not observed in pellet cultures [102, 103]. These studies
have suggested that specific factors such as thyroxine can effect developmental or
morphogenic processes within the growth plate and groups have claimed to recapitulate
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the in vivo formation columnar structures, but thyroxine alone was not sufficient to
produce zonal architecture [102, 103]. Much like organoid cultures of epithelial cells,
pellet cultures tend to self-organize regardless of the experimental manipulations, and
these results have not since been reproduced in the literature. Furthermore, unlike
controlled tissue engineering studies described in this thesis, pellet cultures are unable to
present crucial factors in a controlled and precise manner, nor in a way that allows for
spatial distribution of the presentation of these factors. The results seen in these studies
could be the result of the indirect effects of the exposure of strictly outer cells to media
factors. In addition to pellet cultures, alginate hydrogels have been utilized to influence
the directionality of proliferation in chondrocytes. Aydelotte, et al. used sodium alginate
crosslinked in a calcium chloride (CaCl2) solution with no sodium chloride (NaCl)
included, which formed small radial channels within the bead [104]. While chondrocytes
appeared to align within the channels, no other characterization was performed on the
chondrocytes to explore proliferation rates or gene expression that may be indicative of
the proliferative phenotype. There is a necessity both for better design of in vitro model
systems and for improved techniques to characterize the system to elucidate mechanisms
behind zonal and columnar formation in the growth plate. In this thesis (Chapter 3), an in
vitro culture model of growth plate cartilage was developed using alginate hydrogels in
order to explore the effects of interaction with both scaffold ligands like RGD and factors
such as PTH and IHH on growth plate phenotype.

1.4. Thesis Objectives
In this thesis, the natural biomaterial alginate is utilized in the design of scaffolds
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for the development of in vitro culture models of both porcine embryo elongation and
growth plate development. The approaches taken here have led to advancements in the
knowledge of both of these systems. The remainder of this thesis is laid out in the
following manner: the background, methods, results and conclusions for the development
of an in vitro porcine embryo elongation models are presented in Chapter 2, the
background, methods, results and conclusions for the development of an in vitro growth
plate model are described in Chapter 3, and finally the overall conclusions of this thesis,
along with ideas for future improvements of both of these systems can be found in
Chapter 4.
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CHAPTER 2- Using 3-D Alginate In Vitro Culture System to Explore the Role of
SPP1 and RGD on the Initiation of Preimplantation Porcine Embryo Elongation

2.1. Introduction
During the pre-implantation period of pregnancy, the pig embryo undergoes a
dramatic transformation from spherical (~1-2 mm) through the transitional ovoid (~4-5
mm) and tubular (<10 mm) morphologies and finally to a long thin, filament (<100 mm)
between day 9 and 12 of gestation [10, 69, 82, 105]. Once initiated, the process of
embryo elongation is very rapid, with remodeling of the trophoblast and changes in
conceptus length occurring at a rate of 35-40 mm per hour on day 11-12 [106]. As a
result, the morphological transition between a tubular and filamentous embryo typically
occurs within 2-3 hours and has been shown to be associated with cellular reorganization
and remodeling in the pig, rather than hyperplasia like in ruminants [69, 87]. The
majority of early embryonic mortality in the pig occurs during this period, and is
characterized by deficiencies in embryo elongation [66, 82, 107].
Proper timing of the presentation and secretion of critical molecular factors in the
embryo, as well as within the uterine environment, is vitally important to the initiation of
the elongation process (day 9-12 of gestation), as well as the developmental competence
of embryos during the pre-implantation period of pregnancy [10, 68, 69]. The secretion of
many uterine-specific factors like osteopontin (SPP1) have been shown to be upregulated within the uterine milieu as the embryo initiates elongation and has been
suggested to play a role in conceptus-maternal interactions during elongation and
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implantation [75, 76, 108]. SPP1, a glycoprotein produced by the uterine lumen as early
as day 9 of gestation, has been shown to stimulate cell adhesion both within the embryo
and between the embryo and the epithelial cells of the uterus [109]. The ligand binding
affinity is modulated within the embryonic cells via cytoplasmic domain transduction of
intracellular signals [109]. Cell adhesion within the embryo and between the conceptus
and the uterus leads to cytoplasmic reorganization and focal adhesions, which are
necessary for elongation [109]. Disruptions or delays in the presentation of uterine
specific factors can lead to asynchronies or deficiencies in the initiation of elongation,
which can be detrimental to the survival of pig embryos and can influence within-litter
birth weight variability [83].
Prior research has identified many specific signaling factors in addition to SPP1
that may affect elongation and implantation [75, 110, 111]. However, elucidating the
exact mechanisms by which these factors affect the initiation of the elongation process
has remained a challenge. This deficiency in knowledge is attributed primarily to the
inability to study porcine embryo elongation in vitro, due to both the short amount of
time this dramatic transformation takes to complete, and also the lack of adequate in vitro
culture systems capable of replicating the uterine environment that could allow for
continuous real-time evaluation of this process. Previous attempts to culture porcine
embryos have been unsuccessful in facilitating the crucial elongation process, mainly due
to the disruption of normal maturation by two-dimensional (2-D) culture [84]. Recently,
our group has developed a novel embryo culture system, using an alginate hydrogel
network that creates a three-dimensional (3-D) system that encapsulates embryos,
maintains viability and embryo architecture, and facilitates morphological changes with
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corresponding increases in expression of steroidogenic transcripts and estrogen
production, consistent with the initiation of elongation in vitro [9].
The objective of the present study was to expand our alginate culture system and
incorporate a key uterine factor, SPP1, thought to play a role on elongation, such that we
can begin to investigate the role of SPP1 on the initiation of elongation in the pig. In
addition to presenting the complete SPP1 protein within our alginate system, we also
investigated the presentation of the integrin receptor binding amino acid sequence, ArgGly-Asp (RGD), the specific active ligand of SPP1.

2.2. Materials and Methods
2.2.1. Production and Collection of Embryos
All animal protocols were approved by the U.S. Meat Animal Research Center
(USMARC) Animal Care and Use Committee and met the Federation of Animal
Societies [112] guidelines for the care and use of agricultural animals in research. White
crossbred gilts consisting of Landrace, Yorkshire, and Duroc genetics were checked daily
for estrus. Following first detection of estrus (designated as d 0), gilts were artificially
inseminated with semen from pooled terminal Duroc sires collected from a commercial
boar stud and again 24 h later with the same pool of semen. In 11 independent replicate
collections, 39 pregnant gilts were slaughtered at the USMARC abattoir at d 9 of
gestation. Following slaughter, reproductive tracts were removed immediately and each
uterine horn was flushed with 20 mL (~37° C) of 25 mM Hepes-buffered RPMI-1640
media (Invitrogen, Carlsbad, CA) containing 1x antibiotics/antimycotics (Sigma-Aldrich,
St Louis, MO). Embryos (n = 340) were recovered and classified according to size and
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morphology using a standard stereomicroscope (Nikon Instruments, Inc., Melville, NY).
Embryos were then washed with Hepes-buffered RPMI-1640 media containing 1x
antibiotics/antimycotics and 10% heat-inactivated fetal bovine serum (FBS; Invitrogen).
Embryos from litters containing consistently spherical embryos (~1 mm in diameter with
a range of 0.5 to 1.5 mm) were recovered and were randomly assigned to the in vitro
culture treatments for encapsulation, as described next.
2.2.2. Alginate Solution and Modification
Sodium alginate (Pronova UP MVG, >60% guluronic acid, 200,000 – 300,000
g/mol, NovaMatrix, Sandvika, Norway) was dissolved in sterile 1X phosphate buffered
saline (PBS; Sigma Aldrich, St. Louis, MO) at a concentration of 0.7% w/v. Embryos
encapsulated in unmodified alginate solution, as described below, were labeled ALG.
For some conditions, whole molecule SPP1 (R&D Systems, Minneapolis, MN) was
mechanically mixed into the 0.7% alginate solution prior to cross-linking at a
concentration of 0.1 µg/mL alginate solution. Embryos encapsulated in this alginate
solution were labeled SPP1. As a second type of modification, alginate was covalently
modified with a glycine-arginine-glycine-aspartic acid-serine-proline (GRGDSP) peptide
(Anaspec, Fremont, CA) to a concentration of 4 µmol/g alginate using carbodiimide
chemistry, as previously described [42]. Embryos encapsulated in this alginate solution
were labeled RGD. Briefly, two grams of sodium alginate were added to 200 mL of MES
buffer (0.1M MES, 0.3M NaCl, pH 6.5) and the alginate was allowed to dissolve for 7-8
hours on a stir plate. 1-ethyl-(dimethylaminopropyl) carbodiimide (EDC; Sigma Aldrich)
was added to activate 5% of the uronic acids of the alginate polymer backbone in order to
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form amide linkages with the peptide. To stabilize the reactive EDC intermediate against
a competing hydrolysis reaction, N-hydroxy-sulfosuccinimide (sulfo-NHS; Pierce,
Rockford, IL) was also added to the solution at a 2:1 EDC to NHS ratio. Lastly, the
GRGDSP peptide was incorporated into the solution, conjugating to the alginate
backbone via the terminal amine of the peptide. After 20 hours of reacting, the
conjugation reaction was quenched through the addition of hydroxylamine hydrochloride
(Sigma Aldrich). The alginate solution was then dialyzed (3.5 kD MWCO, 45 mm flatwidth dialysis tubing; Spectrum Laboratories, Rancho Dominguez, CA) in a salt solution
(NaCl in ddH2O) with stirring over the course of 3 days. The dialysis salt solution was
replaced with decreasing salt solutions, starting with a concentration of 6.75-g/L followed
by 5.25-, 3.75-, 2.25-, 0.75-, and 4 washes of 0-g/L NaCl in ddH2O every 8 hours. The
resulting alginate solution was frozen to -80°C, lyophilized to dryness and was dissolved
in PBS as described above prior to encapsulation. To verify successful conjugation of the
GRGDSP peptide to the alginate polymer backbone, NMR spectroscopy was used to
characterize the samples. Unmodified alginate and GRGDSP-alginate were dissolved in
deuterium oxide (D2O; Sigma Aldrich) and placed in separate NMR tubes. The 1H-NMR
spectra of the samples were recorded on a Bruker DRX-500 500 MHz NMR spectrometer
at an operating frequency of 500.13 MHz. Embryos encapsulated in this modified
alginate were labeled RGD.
2.2.3. Embryo Encapsulation and Culture
After collecting and washing embryos as described above, all embryos were
placed into a petri dish containing Hepes-buffered RPMI-1640 media containing 1x
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antibiotics/antimycotics and 10% FBS, and were randomly assigned to 4 groups:
encapsulated in unmodified alginate hydrogels (ALG), encapsulated in RGD-modified
alginate hydrogels (RGD), embryos encapsulated in alginate hydrogels supplemented
with SPP1 (SPP1) or non-encapsulated, 2-D cultured controls (CONT). Embryos
assigned to all groups besides CONT were encapsulated within their respective alginate
hydrogel using a double encapsulation method described previously and described below
[9]. Briefly, unmodified or modified (see above) sodium alginate was dissolved in sterile
PBS to a final concentration of 0.7% (w/v). 30-µL droplets of warmed, sterile alginate
solutions were placed onto polystyrene culture dishes. A single embryo was pipetted into
each droplet of alginate in a minimal amount of the media in which they were held prior
to encapsulation as to not dilute the alginate solution. Each droplet was then pipetted into
a warmed, sterile cross-linking solution (50 mM CaCl2, 140 mM NaCl) and allowed to
gel for 3 minutes.
The resulting alginate beads with encapsulated embryos were then rinsed twice in
Hepes-buffered RPMI-1640 media containing 1x antibiotics/antimycotics and 10% FBS.
Following the rinse, each bead was encapsulated in a second layer of alginate, using
identical methods as described above with the exception of 45-µL of alginate was used as
the base droplet to completely submerge the initial bead, to ensure thorough
encapsulation of each embryo. The final resulting double-layered beads, along with the
CONT embryos, were then washed once with pre-gassed culture media containing
Hepes-buffered RPMI-1640, 1x antibiotics/antimycotics and 10% FBS. ALG, RGD,
SPP1 and CONT embryos were cultured in individual wells of 4-well NUNC plates
(Thermo-Scientific, Rochester, NY) with 1-mL of culture media for 96 h at 38.5°C and
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5% CO2 in air with 100% humidity. Every 24 hours, 500 µL of media was removed for
estradiol quantification and 500-µL of fresh media was added to each well at that time.
2.2.4. Characterization of Embryo Viability and Morphology
Every 24 h, an image was recorded of each embryo by photographing with a SMZ1500
stereomicroscope (Nikon Instruments, Inc.). Embryo survival was determined by
assessment of blastocyst fragmentation [9], in which surviving embryos were
characterized with no apparent sign of cellular degeneration, whereas dying embryos had
significant cellular degeneration resulting in blastocyst compaction and darkening of the
embryo. Embryos undergoing morphological changes were characterized by a tubular
formation of the embryo within the gel and subsequent flattening of this tube, with many
of these embryos migrating out of the gel forming a secondary spherical structure once
freely in the culture media. Based on visual appraisal of these images, surviving embryos
were classified into the following treatment groups: CONT (non-encapsulated control
embryos, none of which exhibited any morphological change and thus did not warrant
further classification), ALG+ (embryos encapsulated in alginate with observable
morphological changes), ALG- (embryos encapsulated in alginate with no observable
morphological change), RGD+ (embryos encapsulated in RGD modified alginate with
observable morphological changes), RGD- (embryos encapsulated in RGD modified
alginate with no observable morphological change), SPP1+ (embryos encapsulated in
alginate supplemented with SPP1 with observable morphological changes), or SPP1(embryos encapsulated in alginate supplemented with SPP1 with no observable
morphological change). Morphometric evaluations (i.e., diameter and area) were
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measured using the Bioquant Nova image analysis software (Bioquant, Nashville, TN) on
surviving embryos from CONT embryos and those that underwent observable
morphological changes within the encapsulated treatments.
2.2.5. Cellular Proliferation
At the termination of the 96 h culture period, a subset of surviving embryos from
each of the treatment groups (n = 3 per treatment) were snap frozen in liquid nitrogen to
be used to assess cellular proliferation. Cellular proliferation was assessed by measuring
the total DNA content from each embryo using the CyQUANT Cell Proliferation Assay
Kit, according to manufacturer protocol (Molecular Probes, Inc., Eugene, OR). An
additional subset of surviving embryos from each condition (i.e., CONT, ALG-, ALG+,
RGD+, n=2; RGD-, SPP1-, SPP1+, n=1) were used for confocal microscopy
confirmation of proliferation. For that analysis embryos were fixed in 4%
paraformaldehyde (EMSDiasum, Hatfield, PA) at 4°C overnight, then were stored in
70% Ethanol in ddH2O. At the time of processing, embryos were rehydrated in 1X PBS
and ddH2O.The embryos were then washed twice in a wash buffer (WB) consisting of
0.05% Tween-20 (Thermo Fisher Scientific, Waltham, MA) in 1X PBS. The embryos
were permeabilized in 0.1% Triton X-100 (Thermo Fisher Scientific) in 1X PBS for 30
minutes at room temperature and were again washed twice in the aforementioned WB. A
blocking solution consisting of 1% BSA (Sigma-Aldrich) in 1X PBS was applied to the
embryos for 30 minutes at room temperature, and then the embryos were incubated in the
primary antibody buffer consisting of 1% BSA, 0.01% Triton X-100, 0.01% Tween-20
and the Ki67 polyclonal primary antibody (Life Technologies, Santa Cruz, CA) at a
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1:250 dilution in 1X PBS for 2 hours at room temperature. After the primary antibody
incubation, the embryos were washed 3 times in WB for 10 minutes. In order to
incorporate the secondary antibody, the embryos were incubated in a solution containing
1% BSA with 0.01% Tween-20 and AlexaFluor 488 goat anti-rabbit secondary antibody
(Life Technologies) in 1X PBS at a 1:100 dilution for 2 hours at 37°C. After the
secondary antibody incubation, a solution of DAPI at 1:2,000 and rhodamine-phalloidin
(EMD Millipore, Billerica, MA) at 1:500 and 0.01% Tween-20 in 1X PBS was applied
for 30 minutes. The embryos were finally washed with 1X PBS for 30 minutes, mounted
individually on slides and imaged using an Olympus FV500 Inverted confocal
microscope. Images were used to qualitatively observe the extent of cellular proliferation
to confirm the extent of cellular proliferation measured by the CyQUANT Cellular
Proliferation Assay.
2.2.6. Transcript Expression Analysis
At the termination of the 96-h culture period, an additional subset of surviving
embryos from each of the treatment group (n = 3 per treatment group) were snap frozen
in liquid nitrogen to be used to assess transcript expression levels. Whole-cell RNA
(wcRNA) was extracted from individual embryos using the RNeasy Microkit (Qiagen,
Valencia, CA) with on-column DNase-I treatment as described by the manufacturer.
Quantification of the wcRNA was performed with RiboGreen as indicated by the
manufacturer (Molecular Probes, Inc).
Using porcine-specific primers previously validated to amplify mRNA specific
for the long form variant of steroidogenic acute regulatory protein (STAR) [113],
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aromatase (CYP19A1), interleukin-1β (IL1B) [72, 82], and glyceraldehyde 3-phosphate
dehydrogenase (GAPDH) [114], transcript expression levels were assessed using a twostep, real-time quantitative PCR (qPCR) method with a Chromo4 real-time PCR
detection system (Bio-Rad, Hercules, CA). Briefly, reverse transcription was performed
with 1 ng of wcRNA from embryos in the corresponding treatment groups using the
iScript cDNA Synthesis kit (Bio-Rad) according to the protocol of the manufacturer.
Each qPCR was assayed in duplicate and consisted of 50 pg equivalents of cDNA, 0.25
µM of the appropriate forward and reverse primers, and 12.5 µL of 1x iTaq SYBR Green
Supermix with ROX (Bio-Rad) in a 25 µL reaction. All PCR conditions included
denaturation (95°C for 2 min) followed by amplification (95°C for 15 sec, 60°C for 15
sec and 70°C for 45 sec) for 40 cycles. Melt-curve analysis and gel electrophoresis were
used to confirm amplification of a single product of the predicted size.
Expression levels for each transcript were based on the threshold cycle (CT)
values determined using the Opticon Monitor 3 software (Bio-Rad). For each transcript,
one assay was performed containing equal representation of all embryo treatment groups.
After converting the exponential CT to the linear CT using the formula 2-CT [115], the
intraassay CV for each transcript was determined by averaging all samples from the
assay. The intra- assay CVs for STAR was 14.4%; ; CYP19A1 was 14.8%; IL1B was
16.8%; and GAPDH was 17.0%. Preliminary analysis of the relative expression level (2C

T)

for GAPDH indicated constitutive expression between the treatments (data not

shown); therefore, GAPDH was used as the reference control transcript. Calculation of
the relative quantity (RQ) value was determined using the comparative CT method [115].
RQ values are expressed as arbitrary units.
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2.2.7. Estradiol-17β and Protein Assays
Analyses of Estradiol-17β (E2) and protein content in the culture medium were
performed in samples obtained after 96 h from basal media and cultures containing
embryos represented in the cellular proliferation assays and qPCR analysis (i.e., CONT, n
= 8; ALG+, n = 7; ALG-, n = 11; SPP1+, n = 9; SPP1-, n = 11; RGD+, n = 15; RDG-, n =
7). Culture media were measured for E2 using a radioimmunoassay procedure described
previously and validated in swine [82, 116]. Culture media were measured for E2 in
duplicate in five assays with inter- and intra-assay CVs of 11.97% and 3.73%,
respectively. In addition, culture media were measured for total protein content using a
bicinchoninic acid protein assay (Pierce). The protein content in the culture media was
measured in duplicate in five assays with inter- and intra-assay CVs of 16.9% and 7.24%,
respectively
2.2.8. Statistical Analyses
Proportional data for embryo survival and morphological changes following
culture were analyzed using the Chi-square test and were reported as least-squares means
± standard error of the mean (LSM ± SEM) after calculating with GLIMMIX model
procedures [117, 118]. Morphometric analysis, cellular proliferation, transcript
expression data, and culture media E2 and protein levels were analyzed using MIXED
model procedures and results are reported as LSM ± SEM [117, 118]. When a significant
F- statistic was generated, means were separated using Dunnett’s multiple comparison
test [117, 118]. Means were considered statistically different at P ≤ 0.05 and tendencies
between P = 0.051 and P = 0.10. Morphometric analysis, cellular proliferation, and
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transcript expression data were categorized into treatment groups corresponding to
CONT, ALG+, ALG-, RGD+, RGD-, SPP1+, and SPP1- embryos and the model
included the fixed effects of treatment, the covariate of initial embryo size, and the
random effect of gilt within treatment. Culture E2 and protein data were categorized into
treatment groups (i.e., MEDIA, CONT, ALG+, ALG-, RGD+, RGD-, SPP1+, and SPP1-)
and the model included the fixed effects of treatment, replicate, the covariate of initial
embryo size, and the random effect of gilt within treatment by culture time interaction.
To remove skewness and normally distribute the data, all transcript expression and E2

Fig. 2-1. (1) After flushing from the uterus, embryos are placed in RPMI media. A single embryo is pipetted
up and (2and 3) is pipetted into an alginate droplet. (4) The droplet is pipetted into calcium solution to
crosslink. (5) The formed bead is washed twice in RPMI before (6) being placed into another droplet of
alginate solution. (7) The droplet including the bead is pipetted up and into calcium solution for crosslinking.
(8) The entire layered construct is washed in RPMI before (9) being placed into one of the four wells of the
plate for culture. (Recreated from Sargus-Patino et al.)
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data were log-transformed prior to statistical analysis and back- transformed to report
observed means.

2.3. Results
2.3.1. Confirmation of RGD Modification
To explore the effect of cell adhesion molecules and specifically the effect of integrin
activation via RGD on elongation, embryos were encapsulated in either alginate (ALG),
SPP1 supplemented alginate or RGD-conjugated double-layered beads and cultured in
vitro over 96 hours (Fig. 2-2). To accomplish this project objective, the RGD peptide had
to be covalently conjugated to the alginate molecule. To confirm the successful
conjugation of the RGD peptide to alginate prior to use in encapsulation studies, 1H-

ALG
P
S D R G
β

RGD

Fig. 2-2. 1H-NMR spectra to confirm conjugation of RGD peptide to ALG molecule. ALG (top) and RGD
(bottom) with peaks noted for possible corresponding amino acids: glycine (G), arginine (R), aspartic acid
(D), serine (S), proline (P) and potential β–hydrogens (β).
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1

NMR was utilized. Fig. 2-2 shows the H-NMR spectra of unmodified alginate (top
spectrum) and GRGDSP-conjugated alginate (bottom spectrum). New peaks between
δ2.5 and δ3.5 were distinctly detected in the spectrum of RDG-alginate compared to
unmodified alginate. Additional peaks were specifically detected in the RGD-conjugated
alginate compared to the unmodified alginate between δ0.8 and δ1.2 and may be
representative of β-hydrogens of the peptide. Based on previous 1H-NMR studies
involving RGD peptide, these peaks have been labeled as the predicted amino acid (Fig.
2-2) [119].
2.3.2. Evaluation of Embryo Viability, Morphology and Morphometry
Fig. 2-3 shows representative phase images of embryos from all treatment groups at all
time points as examples of images used to evaluate viability, assess morphological
changes and perform morphometric analyses. Statistical analysis of the survivability and
percent of embryos showing morphological changes at the termination of culture within
all treatment groups is shown in Fig. 2-4 and further detailed in Table 2-1.
After 96h of culture, the blastocysts were examined for degeneration and it was
determined that while there was a tendency for differences in survivability between
treatment groups (P= 0.0667), the addition of SPP1 to the hydrogel network prior to
encapsulation yielded a tendency to increase survivability (37.43% ± 5.48%) when
compared to CONT (23.2% ± 4.79%; P< 0.10). Furthermore, the presentation of RGD
via the hydrogel scaffold also revealed a tendency to increase survivability (42.99% ±
5.72%) when compared to the control (P< 0.10) (Fig. 2-4A and Table 2-1).
Embryos were also classified for morphological changes, which are characterized as
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24h

48h

72h

96h

RGD

SPP1

ALG

CONT

0h

Fig. 2-3. Representative images of embryo morphological changes in culture. Embryos were cultured without
encapsulation (CONT) or within double-layered, 0.7% alginate hydrogels: unmodified alginate hydrogel
(ALG), alginate with SPP1 (SPP1), or RGD-modified alginate (RGD). Images are taken of each embryo every
24 hours for 96 hours. Scale bar is 1-mm in length.

when a spherical embryo changes into a more tubular shape followed by the elongation
and flattening of this tube over time. All encapsulated treatment groups contained
embryos that showed morphological changes in vitro (bottom 3 panels of Fig. 2-3), while
none of the CONT embryos exhibited morphological changes (top panel of Fig. 2-3).
Differences in the percentage of embryos showing morphological changes by 96h in
culture are illustrated in Fig. 2-4B and C and more detailed data can be found in Table
2-1. Significant differences in the percentage of embryos that showed morphological
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A

B

Percent Survival

Percent Morphological Change

75

*

30
15

60

**

Percent (%)

Percent (%)

Percent (%)

45

45
30

ALG

SPP1

Treatment

RGD

0

45
30
15

15

Ctrl

Percent Morphological Change
(of surviving)
*

**

60

60

0

C

75

75

Ctrl

ALG

SPP

RGD

0

Treatment

Ctrl

ALG

SPP

RGD

Treatment

Fig. 2-4. Survival rates and percent of embryos showing morphological changes in culture for all treatment
groups. A) Survival rates for all treatment groups. Encapsulation in RGD facilitates significantly higher
survivability than non-encapsulation, as does encapsulation in SPP1. B) Percent of all embryos that
underwent morphological changes. No CONT embryos showed morphological changes. Encapsulation in
RGD demonstrated a significant increase in the percentage of embryos showing morphological changes over
ALG while it only tended to be increased over SPP1. C) Percent of surviving embryos that underwent
morphological changes. Encapsulation in RGD tended to lead to an increase in morphological changes over
ALG. (*indicates a tendency with p< 0.10, ** indicates significance with p< 0.05)

changes by 96h were observed (P< 0.0001) when considering all embryos within the
treatment groups (Fig. 2-4B). The percentage of embryos that underwent morphological
changes was significantly higher when encapsulated in RGD (23.81% ± 4.65%) than in
either ALG or SPP1 (10.71% ± 3.38% and 13.64% ± 3.66%, respectively; P< 0.05).
Significant differences between treatment groups (P< 0.0005) were observed when only
considering the percent of morphologically changing embryos out of those that survived.
Of only the surviving embryos (Fig. 2-4C), RGD had the highest percentage of
morphologically changing embryos at nearly 60% (55.56% ± 8.28%), which tended to be
greater than ALG (31.03% ± 8.59%; P< 0.10).
In order to explore differences in gene expression, proliferation, and E2 and protein
production between embryos that survived and showed morphological changes and those
that did not have morphological changes, each surviving embryo within encapsulated
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Table 2-1. Survivability and morphological change data for all treatment types. Values are reported as the
least-squares mean ± SEM as determined using GLIMMIX analysis for the main effect of treatment.
Significance for the effect of treatment was determined using Chi-squared analysis. († indicates the
comparison between the described condition and CONT, ‡ indicates the comparison between the described
condition and ALG and ✳ indicates the comparison between the described condition and SPP1).

Number of
Embryos
Embryo Survival
(%)

CONT

ALG

64

64

23.2 ± 4.79

34.35 ± 5.47

P-value

SPP1

P-value

64

0.1202

†

37.43 ± 5.48

RGD

P-value

64
0.0495

†

0.6819

‡

0.0088†
42.99 ± 5.72

0.2643 ‡
0.4698 ✳

No
morphological
Change from all
embryos (%)
Morphological
change from all
embryos (%)
Morphological
change from
surviving
embryos (%)

0.9728†
100

89.29 ± 3.38

0.9733†

86.36 ± 3.66

0.5597‡

0.9716†
76.19 ± 4.65

0.0288‡
0.0909✳

0.9728†
0

10.71 ± 3.38

0.9733

†

13.64 ± 3.66

0.5597

‡

0.9657

†

0.6593

‡

0.9716†
23.81 ± 4.65

0.0288‡
0.0909✳

0

31.03 ± 8.59

0.9663

†

36.36 ± 8.37

0.9638†
55.56 ± 8.28

0.0533‡
0.1154 ✳

treatment groups was partitioned into those that had changes (+) and those that did not (-)
and morphometric data were measured (Table 2-2) regarding initial and final diameters as
well as initial and final areas of each surviving embryo. The diameter and the area of all
embryos at 0h averaged to be 0.79 mm and 38 mm2 were not significantly different
across the treatment groups or between embryos that showed morphological changes and
those that did not by 96h. However, by the end of culture those embryos that had changes
observed in both diameter and area (P< 0.0001) were statistically different across
treatment groups. For example, the final average diameter of embryos cultured in ALG
that showed morphological changes (ALG+) was 1.887 mm, and given that the average
diameters of those embryos at 0h was 0.839 mm, this morphological change represents an
increase in diameter of over 150% (155.66% ± 26.25%). Conversely, the final average

44
Table 2-2. Summary of morphometric analysis along with proliferation data of all embryo treatments divided
into subsets of morphometrically changing embryos (+) and non-changing embryos (-). Values are reported as
the least-squares mean ± SEM as determined using Mixed procedure analysis.

Number of
Embryos
Initial Diameter
(mm)

CONT

ALG+

ALG-

SSP1+

SSP1-

RGD+

RGD-

14

7

16

9

18

14

13

0.934

0.839

0.778

0.611

0.908

0.711

0.785

SEM (upper)

0.098

0.125

0.088

0.09

0.096

0.088

0.086

SEM (lower)

0.089

0.109

0.079

0.078

0.087

0.078

0.078

Final Diameter
(mm)

0.957

1.887

0.891

1.234

0.922

1.64

0.929

SEM (upper)

0.113

0.32

0.113

0.206

0.111

0.228

0.116

SEM (lower)

0.101

0.274

0.1

0.176

0.099

0.2

0.103

Δ Diameter (mm)

0.039

1.449

0.11

0.737

0.008

1.154

0.127

SEM

0.151

0.227

0.161

0.214

0.16

0.172

0.166

Δ Diameter (%)

4.26

155.66

15.59

113.76

5.05

173.57

20.33

SEM

17.5

26.25

18.56

24.75

18.56

19.84

19.17

Initial Area
(mm2 )

48.417

39.939

31.55

24.417

52.979

29.704

38.539

SEM (upper)

12.508

14.939

8.824

9.071

13.779

8.945

10.416

SEM (lower)

9.94

10.872

6.895

6.614

10.935

6.841

8.2

Final Area (mm 2 )

47.764

104.208

40.43

75.84

48.495

78.415

43.351

SEM (upper)

12.077

38.386

11.046

27.602

12.402

23.585

11.527

SEM (lower)

9.604

8.052

8.676

20.237

9.876

18.131

9.106

Δ Area (mm 2 )

12.27

70.29

14.87

69.09

-88.45

57.15

12.47

11

15.61

11.76

15.26

11.26

12.78

11.65

Δ Area (%)

7.71

218.33

32.46

248.92

1.37

224.72

36.61

SEM

29.11

43.67

30.88

41.17

20.88

33.01

31.89

Proliferation (µg
DNA)

0.454

0.331

0.137

0.51

0.653

0.979

0.413

SEM (upper)

0.646

0.351

0.145

0.54

0.929

1.037

0.437

SEM (lower)

0.267

0.17

0.07

0.262

0.384

0.503

0.212

SEM

diameter of embryos cultured in ALG that did not show morphological changes (ALG-)
was 0.891 mm, which compared to an initial average diameter of 0.778 mm, only
represents an increase in diameter of about 15% (15.59% ± 18.56%). Thus, the change in
diameter of ALG+ embryos was significantly different (P< 0.05) than the change in
diameter observed in ALG-. Holding the same trend as change in diameter, the final
average area of ALG+ embryos was 104.208 mm2, while this same population of
embryos began the culture with an average area of 39.939 mm2, which is an increase in
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area of almost 220% (218.33% ± 43.67%). Conversely, the final average area of embryos
cultured in ALG that did not show morphological changes (ALG-) was 40.430 mm2
while that same population began culturing with an average area of 31.550 mm2, which is
an increase in area of only just over 30% (32.46% ± 30.88%). Therefore, the change in
area of ALG+ embryos was significantly different (P< 0.05) than the change in diameter
observed in ALG- embryos. The trend of drastic increases in the average diameters and
areas for encapsulated embryos that showed morphological changes after 96h holds true
across all treatment groups (Table 2-2): the diameter of SPP1+ embryos increased by
113.76% ± 24.75% and the area increased 249.92% ± 41.17% during the culture period,
and the diameter of RGD+ embryos increased 173.57% ± 19.84% while the area
increased 224.72% ± 33.01% throughout the culture period. Conversely, the lack of
appreciable change in average diameter or area in encapsulated embryos that did not
show morphological changes by 96h is also observed across all treatment groups: the
diameter of SPP1- embryos increased by only 5.05% ± 18.56%, while the area increased
by only 1.37% ± 20.88% during the culture period, and the diameter of RGD- embryos
increased by 20.33% ±19.17% while the area increased by 36.61% ± 31.89% throughout
the culture. The average change in diameter and area was significantly different (P< 0.05)
for morphologically changing groups (i.e., ALG+, SPP1+, RGD+) when compared to
their non-changing counterparts (i.e., ALG-, SPP1-, RGD-) and when compared to
CONT. However, there were no statistical differences observed between any of the
treatment groups with morphologically changing embryos (i.e., ALG+, SPP1+, RGD+).
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2.3.3. Cellular Proliferation
Cellular proliferation was first assessed by the total amount of DNA in each
embryo at the end of culture. As shown in Fig. 2-5C and in Table 2-2, there were no
significant differences (P= 0.655) in DNA content across treatment groups or between
non-changing and morphologically changing embryos. The average DNA content per
embryo in every treatment group remained low, or below 1 µg in total, with the lowest
group, ALG-, having on average only 0.137 µg of DNA per embryo, while the group
with the highest amount, RGD-, had 0.979 µg of DNA per embryo on average. CONT
embryos averaged 0.454 µg of DNA each, which was close to the overall average of all
treatments. These data suggest that any morphological change observed in embryos was
not due to an increase in proliferation. To qualitatively examine the distribution of
proliferation within embryos cultured in vitro, confocal microscopy probing for the
nuclear proliferation marker Ki-67 was performed (Fig. 2-5A and B). A low abundance
of nuclei (estimated to be 5% for all treatment groups) were positive for Ki-67,
supporting the quantitative proliferation results (Fig. 2-5C). Representative confocal
images taken at 60X magnification of embryos stained to visualize total nuclei (blue),
proliferating cells (green), and cytoskeletal structure (red) are shown in Fig. 2-5A. Blue
arrows point to nuclei of cells that are not proliferating, while green arrows indicated
proliferating cells. Interestingly, in all of the treatment groups besides CONT, the
resemblance of an intact embryonic disc can be observed at a lower magnification. A
representative image of an embryo at 10X magnification is shown in Fig. 2-5B, with a
green arrow pointing to a small portion of the embryo with cells abundantly proliferating,
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as would be observed in an embryonic disc.

CTRL

ALG

SPP1

RGD

(+)

(-)

A

N/A

DAPI

ACTIN

Ki-67

C

B

Cellular Proliferation

2.5

2.0

Total DNA (µg / embryo)
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embryonic
disc

1.5

1.0

0.5

0.0

CONT
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ALG-
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SPP1-

RGD+

RGD-
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Fig. 2-5. Representative images and quantitative data for proliferation. A) Representative images of embryos
at 60x magnification stained for DAPI to visualize nuclei, rhodamine-phalloidin to visualize F-actin and Ki-67
to visualize proliferating cells. Images are shown for embryos that underwent morphological changes (+) an
those that did not (-) for all treatment groups. Blue arrows point to examples of Ki-67 negative nuclei while
green arrows point to examples of Ki-67 positive nuclei. Scale bar is 20 µm. B) Representative image at 10x
magnification of potential embryonic disc on an embryo encapsulated in ALG that underwent morphological
changes by 96h. Scale bar is 100 µm. C) Quantitative cellular proliferation data indicating total µg of DNA
per embryo in each treatment group.
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2.3.4. Transcript Expression Analysis
To explore the gene expression profile of embryos encapsulated in ALG, SPP1,
RGD or non-encapsulated CONT, qPCR was used. The relative level of expression of
transcripts of STAR, CYP19 and ILB were quantified. The expression of STAR mRNA
shown in Fig. 2-6A and described further in Table 2-3 revealed a tendency in differences
between treatment groups (P= 0.0875). The highest expression of STAR was observed in
ALG+ embryos with an RQ of 17.50 and only tended to be different (P< 0.10) than the
lowest expression seen in SPP1- embryos, with an RQ of 1.52. The expression of CYP19
mRNA as shown in Fig. 2-6B and Table 2-3 revealed significant differences between
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Fig. 2-6. Transcript expression of A) STAR, B) CYP19 and C) IL1B determined by qPCR from in vitro
produced embryos encapsulated in modified or unmodified ALG hydrogels. (n=3)
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treatment groups (P< 0.01). More specifically, the expression of CYP19 was significantly
increased in ALG+ and RGD+ embryos over both of their respective (-) counterparts and
over CONT (P< 0.05), while the CYP19 expression level in SPP1+ embryos only tended
to be higher (P< 0.10) than SPP1-, but was not significant when compared to CONT. The
highest RQ for CYP19 expression was seen in ALG+ embryos at 11.05, and then RGD+
with 10.86 and the lowest level of expression was SPP1- with an RQ of 0.24.
Additionally, IL1B mRNA expression levels shown in Fig. 2-6C and Table 2-3 revealed
significant differences (P< 0.001) between treatment groups. While the expression only
tended to be higher (P< 0.10) in RGD+ embryos than in RGD-, with the highest RQ
value of 215.38, the expression of IL1B in RGD+ embryos was significantly higher (P<
0.05) than SPP1+, ALG+, and CONT embryos. There were no statistical differences
between either SPP1+ or ALG+ and CONT.

Table 2-3. Detailed gene expression data with RQ and upper and lower SEM given for all treatment groups.

Pr> F
STAR
RQ

0.0875

CONT

ALG+

ALG-

SPP1+

SPP1-

RGD+

RGD-

13.646

17.498

6.59

4.898

1.524

10.94

4.325

SEM (upper)

10.013

11.143

5.438

3.792

1.192

8.027

3.226

SEM (lower)

5.775

6.808

3.051

2.137

0.8669

4.63

1.848

CYP19
RQ

0.0111

0.952

11.054

0.262

2.82

0.244

10.864

0.406

SEM (upper)

0.968

11.504

0.279

3.898

0.259

11.064

0.561

SEM (lower)

0.48

5.637

0.135

1.636

0.125

5.482

0.235

IL1β
RQ

0.0004

0.093

0.082

0.099

0.198

19.143

215.278

11.376

SEM (upper)

0.173

0.127

0.275

0.391

38.667

401.317

21.509

SEM (lower)

0.06

0.05

0.073

0.131

12.804

140.116

7.441
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2.3.5. Analysis of E2 and Protein Content
Media was collected every 24h of culture and was analyzed for E2 production of
the embryos as well as the total protein production. Samples from 0h-72h were not
analyzed in this study. For samples taken at the termination of culture, significant
differences (P< 0.05) were observed in the level of E2 in the culture media between
treatment groups (Fig. 2-7A). The amount of E2 produced was significantly higher (P<
0.05) in the subsets of treatment groups of embryos that exhibited morphological changes
(i.e., ALG+, SPP1+, RGD+) than media gathered from wells containing CONT. RGD+
embryos produced the most E2 in culture, and this level of secretion only tended (P<
0.10) to be higher than that of RGD- embryos. No significance was found between either
ALG+ or SPP1+ and their (-) counterparts, although the mean values of E2 were higher
for morphologically changing embryos. Conversely, the total protein content (Fig. 2-7B)
in the media gathered from culturing embryos was not statistically different (P= 0.7555)
between any treatment groups nor between control media, suggesting an increase in the
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Fig. 2-7. A) Estradiol secretion by 96h in all treatment groups as determined by RIA assay. B) Total protein
production by 96h in all treatment groups, as well as an additional culture media control.
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secretion of E2 by morphologically changing embryos is not due to an overall increase in
protein secretion.
Table 2-4. Estrogen and total protein concentration in the media of embryos cultured for all treatment groups
reported with means and SEM.

E2
Concentration
(pg/mL)
SEM (upper)
SEM (lower)
Total Protein
(mg)
SEM

Media

CONT

ALG+

ALG -

SPP1+

SPP1-

RGD+

RGD-

0

12.12

82.89

32.33

81.621

28.366

118.413

30.74

0

9.428

67.183

21.771

56.291

17.185

63.138

24.57

0

5.303

37.107

33.315

10.702

41.655

41.181

13.655

14.719

15.692

15

16.238

12.716

15.732

14.78

14.843

1.113

1.569

1.372

1.326

1.681

1.247

1.482

0.297

2.4. Discussion
In this study, alginate hydrogels were used both to present factors known to play
a role in embryo elongation, and as a 3-D scaffold to support the culture of and observe
the successful initiation of elongation of pre-implantation porcine embryos. Alginate
hydrogels have been used in the development of in vitro culture systems for reproduction
studies in multiple species. For example, alginate has been developed for use as a 3-D
scaffold to support ovarian follicle culture, both from mice and non-human primates [29,
120-124], to promote development of the zona pellucida in mouse morulae [125] and to
aid in development of early bovine blastocysts [126, 127]. Recently our lab has used
alginate to encapsulate porcine embryos in order to facilitate and study the natural
progression of development (i.e. elongation) in vitro. The double encapsulation method
was developed in our lab and utilizes a 3-D alginate scaffold to fully encapsulate the
developing blastocyst, showing elongation of the porcine embryo for the first time in
vitro [9]. With this tool, researchers are able to move past the once unsurpassable barrier
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of in vitro development onto further investigations into the mechanisms behind the
initiation of elongation. In this present study, we aimed to utilize and build upon this base
scaffold system to ask what role preimplantation embryonic and uterine specific factors
like SPP1 and the integrin binding initiated by the RGD sequence in SPP1 play in
elongation.
SPP1 is a glycoprotein secreted by the endothelial cells of the uterus, and its
secretion is signaled by the E2 production from the embryo during elongation [109].
SPP1 is reported to stimulate cell-cell adhesion, increase ECM interactions and promote
cell migration, which are all important to the successful initiation of elongation [78, 108,
109]. Evidence also suggests that the activation of integrins on the embryonic
trophectoderm by the specific integrin binding sequence in SPP1, RGD, induces
cytoplasmic reorganization during embryo development and elongation by stimulating
cell-cell adhesion and promoting cell migration [77-79]. Additionally, it was
demonstrated that both SPP1 and RGD stimulated migration of porcine trophectoderm
cells specifically via haptotaxis, further supporting the idea that SPP1 mediates cell
migration during elongation [77, 78].
Given the evidence of the involvement of SPP1 and particularly the RGD
sequence in embryo development, the whole protein as well as the peptide sequence was
integrated into an alginate scaffold system to encapsulate embryos, and the effect of the
presentation of these factors on survival, morphological changes, cellular proliferation,
gene expression, and E2 and protein production was explored. When encapsulating
embryos in ALG, RGD and alginate mixed with whole molecule SPP1, a tendency of
increased survivability emerged between embryos cultured in RGD over those cultured in
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2-D (CONT). The survivability of embryos encapsulated in RGD is significantly greater
than the CONT group, while those embryos in ALG or SPP1 were not significant over
CONT, suggesting that the presumably higher density presentation of the RGD peptide
(compared to SPP1) to the culturing embryos may provide the embryos with the
necessary physical and biological stimuli for survival [42]. However, given that
survivability in RGD was nearly 43%, which is much lower than the survival rate of
embryos in vivo in the preimplantation period of pregnancy (up to 80%), integrin binding
and cell adhesion cannot be the only mechanism that is involved in survival [66].
While incorporation of RGD into the alginate hydrogel showed some
improvements in embryo survivability, its effect on embryonic morphological changes
was also greater. In this study, we observed a significant increase in the percentage of
embryos undergoing morphological changes if they were encapsulated within RGD
modified alginate scaffolds when compared to embryos encapsulated in either ALG or
ALG supplemented with SPP1. The increase in morphologically changing embryos
supports previous evidence that suggest SPP1, or more likely the RGD sequence in SPP1,
interacts with receptors (i.e. integrins) on the conceptus to promote embryonic
development, as well as migration and signaling within the uterus, supporting the
initiation of elongation [79, 109]. We demonstrated that 23% of embryos in RGDmodified ALG hydrogels elongated, but when only considering the percentage of those
that elongated in RGD as a percentage of only those embryos that survived, 55% of
embryos showed morphological changes. The elongation rate of embryos in ALG in our
previous study out of those that survived was only 38%, indicating the addition of RGD
to the scaffold improves upon the previous studies. To compare to other studies, it has
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been shown that bovine embryos cultured in vitro have shown the initiation of elongation
of anywhere between 50-88% of cultured embryos [84]. However, in that study, a
cylinder hydrogel was used, which could force directional growth of the embryos, and no
other endpoints demonstrated signs of elongation by the same mechanisms seen in vivo
[84]. In our current study, success in elongation was observed in spherical hydrogels with
no particular directional mechanical influence, indicating the initiation and continuation
of elongation within this system are truly driven by the embryo’s ability to elongate.
Each treatment group (i.e. ALG, SPP1 and RGD) was further divided by whether
the embryo within that group did or did not show morphological changes by 96h and was
denoted by (+) or (-), respectively. To better quantify morphological changes,
morphometric data such as initial and final diameter and area of all surviving embryos
were measured. As expected, by the end of the culture period, the difference in
morphological changes (both diameter and area measurements) was significantly greater
in the (+) treatment groups (i.e. ALG+, SPP1+, and RGD+) than the (-) subsets of
individual treatment groups (i.e. ALG-, SPP1-, and RGD-). We used this partitioning
method to observe the differences in gene expression, proliferation and E2 and protein
production between (+) and (-) subgroups moving forward.
In the pig, the elongation process is known to be characterized by rapid cellular
remodeling and differentiation in contrast to hyperplasia, that is, the trophoblast does not
undergo proliferation while the embryonic disc is still undergoing development, but
rather cells of the trophoblast remodel and migrate in a way that leads to morphological
changes. [128]. The synthesis of DNA is highly regulated within the cells of the embryo
and an increase in total DNA within the embryo is indicative of an increase in cell
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number, or proliferation. When examining the total DNA content of individual embryos,
no statistical differences were observed between any of the treatments or any of the
subgroups, indicating that although the morphologically changing subgroups showed
increased diameters and areas (i.e. RGD+, SPP1+, ALG+), there was no increase in total
DNA as compared to non-changing subgroups, meaning the morphological changes were
not due to proliferation, confirming previous findings [66, 128]. Another utilized method
of assessing the proliferation status of the embryos involves the use of confocal
microscopy and a Ki-67 antibody[128]. The expression of Ki-67, a protein ubiquitously
expressed during the G1, S and G2 phases of the cell cycle, but not during the G0 phase,
would indicate an increase in proliferation, and the presence of Ki-67 within the embryo
was compared to the total number of nuclei via DAPI staining [87]. Qualitative
assessment of proliferation via Ki-67 staining [129] confirmed that there were no notable
increases in proliferation across treatments. Additionally, only about 5% of the total
nuclei were also positive for Ki-67, which further supports studies that show that low
levels of proliferation are observed in elongating embryos [128]. Interestingly, evidence
of a potential embryonic disc was observed in embryos of all treatments and subgroups
except for CONT, and the maintenance of this cluster of proliferating cells suggests that
the potential to become a viable organism is maintained in encapsulated embryos [87].
Along with morphological changes, pig embryo elongation is characterized by
changes in transcriptional markers such as steroidogenic transcripts (STAR, CYP19) and
immune response related transcripts (IL1B) [72-74]. It has been previously reported that
transcription levels of STAR, a major initiator of steriodogenesis [130] are increased in
tubular embryos when compared to levels in spherical and ovoid embryos [72, 73]. In this
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study, the expression of STAR tended to be higher in ALG+ embryos than in the SPP1embryos, which were encapsulated embryos with the poorest elongation outcomes,
suggesting the increase in STAR mRNA expression in ALG+ embryos are more similar to
in vivo produced ovoid embryos than SPP1- are [9]. However, unlike the results shown in
our previous study [9], there were no statistical differences between any of the treatment
groups in the expression of STAR, which could indicate the embryos in our system
showed gene expression levels that are more similar to ovoid embryos [72, 73]. CYP19 is
a gene that encodes for the enzyme aromatase cytochrome P450, which catalyzes
estrogen synthesis [131] and a significant increase in the expression of CYP19 was
observed in morphologically changing subgroups (i.e. ALG+, SPP1+, RGD+) when
compared to their corresponding, non-changing counterparts (i.e. ALG-, SPP1-, RGD-).
It has also been shown that an upregulation of this gene is seen in tubular conceptuses
compared to spherical and ovoid conceptuses, suggesting that the expression of CYP19 in
the in vitro produced morphologically changing embryos is similar to that of in vivo
elongating embryos, and aligns with the slight increase in CYP19 expression in
morphologically changing embryos that was shown in our previous study [9, 72, 132].
IL1B a gene that is also related to maternal-conceptus communication and it is
hypothesized that an upregulation of IL1B contributes to rapid trophoblast elongation and
pregnancy establishment in pigs [70]. The production of this inflammatory mediator by
the conceptus is hypothesized to activate inflammatory pathways in the uterine
endometrium, allowing the uterine endometrium to become further receptive to
implantation by mediating the maternal immune response [133]. The increase in mRNA
expression for IL1B was only observed to be upregulated in embryos from the RGD+
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group. The significant increase in the expression of IL1B in embryos encapsulated within
RGD-alginate further supports the idea that those embryos that are elongating within
RGD-alginate are developing similar to later stage in vivo produced embryos (i.e.,
tubular) [9]. Additionally the RGD+ embryos are generating the appropriate signaling
cascade, thereby allowing for proper communication with the uterus, which is essential
for survival and progression through the elongation process [128]. The upregulation in
the IL1B mRNA expression was not observed in any other treatment group or subgroup,
which may suggest that the presumably high concentration of RGD peptide presented to
the embryos is capable of activating the signal cascade involved in IL1B transcript
production.
Not only is the preimplantation elongation process characterized by notable
changes in transcript expression and dramatic morphological changes, but also it is also
associated with increased E2 synthesis [69, 134]. During this period of gestation, the
conceptus secrets E2, which is responsible for maternal recognition, the establishment of
pregnancy and for the preparation of the uterine lining for superficial implantation by the
stimulating the production and secretion of many endometrial secretory proteins [10, 128,
135]. The significant increase in the secretion of E2 from embryos showing
morphological changes (i.e. ALG+, SPP1+, RGD+) over CONT embryos demonstrates
the similarities between those embryos and in vivo elongating embryos. In addition, this
upregulation of E2 in the in vitro culture media of ALG+, SPP1+, and RGD+ over the
CONT embryos was independent of production of total protein within the culture
medium. Sargus-Patino et al demonstrated that increases in total protein were observed in
uterine flushings but were not observed in culture media, suggesting an upregulation of
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steroidogenesis and estrogen production may be independent of maternal-embryo crosstalk [9]. Similarly, the independence of E2 production and changes in protein production
(or lack thereof) support the hypothesis that E2 is produced by elongating embryos
regardless of total uterine protein secretion [9]. Additionally, these results correspond
with the increased expression of the steroidogenic transcript CYP19 in the ALG+, SPP1+,
and RGD+ embryos, which supports previous findings of a direct relationship between
that transcript and E2 synthesis in the embryo [72, 131].
In conclusion, this study demonstrated that a encapsulation within a supportive
alginate matrix modified with the integrin binding sequence RGD found in adhesion
molecules like SPP1 leads to changes in survivability, morphology, gene expression, and
protein secretion within encapsulated embryos that emulates those changes observed in in
vivo elongating embryos. Our study validated the use of alginate hydrogels for the in
vitro culture of porcine embryos, as well as demonstrated that this culture system can be
used to probe mechanisms behind elongation by systematically presenting factors known
to play a role in elongation. Greater understanding of what is necessary for the success of
elongation could lead to strategies to reduce embryonic loss due to disruptions in the
initiation and maintenance of elongation. An improvement in survival of preimplantation
embryos will lead to overall increases in litter size, significantly impacting the
profitability of swine production. Furthermore, this culture system could even be utilized
in other time points of gestation or in other species to elucidate the mechanisms behind
the intricacies of animal gestation.
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CHAPTER 3- 3-D In Vitro Culture Model of Growth Plate Cartilage using Alginate
Hydrogel Scaffolds

3.1. Introduction
During embryonic and adult skeletal development, the shape and length of bones
is determined by the activities of the growth plate cartilage, a spongy tissue capping the
ends of every long bone [136]. The growth plate controls elongation of long bones
through endochondral ossification, a maturation process that results in chondrocytes
being partitioned into functionally and morphologically distinct zones (Fig. 3-1) [137].
The most immature resting zone is a reservoir of quiescent progenitor cells that are
collectively responsible for the proliferative potential (and thereby total growth potential)
of cartilage by restraining terminal differentiation and maintaining the cell cycle of
chondrocytes residing in neighboring zones [89]. Resting zone chondrocytes eventually
mature into a zone of high proliferation, where cell shape changes and acquisition of
planar cell polarity results in the formation of a unique cytoarchitecture, where discoid
cells become arranged into columns that resemble stacks of pennies [15]. The extent of
column formation in the proliferative zone specifically potentiates the ability of cartilage
to elongate as compared to thickening oppositional growth, promoting the long and
slender morphology of the endochondral bones with high length/width ratios. Once
columnar architecture is established and as the lengthening of the proliferative zone
pushes chondrocytes further from the resting zone, cells begin to become less
proliferative and start to swell, making up the small pre-hypertrophic zone [138] Finally,
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Fig. 3-1. Schematic of zonal architecture during growth plate development. The name of the
zone is to the left of the schematic and major markers of each zone are shown to the right, with
a depiction of the PTHrP/IHH feedback loop overlaid on the proliferative zone.

chondrocytes undergo terminal differentiation into a hypertrophic zone featuring
complete cell cycle withdrawal, massive cell swelling, and the construction of a
specialized extracellular matrix that serves as a template to be remodeled into bone [12].
The hypertrophic zone is the effector of bone elongation, as the rate of hypertrophy is
directly related to the extent of bone growth [16].
One of the major responsibilities of these growth plate chondrocytes is to produce
an extracellular matrix (ECM) of defined shape and size that is characteristic of each
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particular zone of the growth plate [139]. The ECM of the growth plate is made up of
several cell matrix proteins that promote cell adhesion [139, 140]. It is known that cell
shape, proliferation, and differentiation are all affected by cell adhesion, and
chondrocytes in different zones of the growth plate secrete different amounts and types of
adhesion proteins, leading to the hypothesis that the type of ECM surrounding
chondrocytes in the growth plate affects chondrocyte behavior [48, 141]. For example,
collagen type II (Col2) is expressed everywhere in the growth plate as the most abundant
protein in the cartilage, while collagen type X (ColX) is only expressed in the early
hypertrophic and hypertrophic zones [89]. Interestingly, there are many other proteins
within the growth plate, including fibronectin (FN) and laminin (LN), which activate
integrin binding via their arginine-glycine-aspartic acid (RGD) peptide sequence. It has
been previously shown that cell adhesion and integrin binding are essential not only to
survival and morphology, but also to the function of chondrocytes specifically within the
resting and proliferative zones of the growth plate [142, 143].
Along with the aforementioned cell-matrix interactions, paracrine interactions
between chondrocytes within the growth plate help to determine chondrocyte behavior.
While it is known that many vectors are involved in growth plate development and
maturation, a complex paracrine signaling network seems to be fundamentally rooted in
reciprocal interactions between two major pathways, Indian hedgehog (IHH) and
Parathyroid-related protein (PTHrP) [89, 92, 136]. Periarticular resting zone cells secrete
PTHrP, which diffuses through the growth plate to produce a gradient of signaling
activity, which is crucial to maintain the proliferative potential and columnar organization
of the proliferative zone, as demonstrated by severe growth defects and aberrant tissue
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architecture phenotypes exhibited by PTHrP null cartilage in mouse [144]. Additionally,
PTHrP signaling suppresses the rate of cartilage hypertrophy by promoting the
phosphorylation of Sox9 to restrain maturation of proliferative zone cells, and is thought
to be the major signaling effector of resting zone chondrocytes [145]. The crosstalk
between PTHrP and IHH signaling is important for the establishment and maintenance of
zonal arrangement of chondrocytes in cartilage, and remains to be fully elucidated. IHH
is secreted by prehypertrophic chondrocytes between proliferative and hypertrophic
zones and is thought to promote PTHrP expression, although IHH has never been directly
observed to diffuse into the zone of maximal PTHrP expression [144]. Nevertheless, loss
of IHH signaling results in a loss of PTHrP expression and premature hypertrophy,
associated with a complete loss of the proliferative zone and related column formation as
shown by the chondrodysplasia-like phenotype of IHH knockout mutant mice and
cyclopamine inhibitor treatment in organotypic culture of growth plate explants [146,
147].
While in vivo knockout models have elucidated many factors that are involved in
the development of functional growth plate cartilage, there are questions to be answered
that cannot rely on such studies, and in vitro culture studies have been attempted. It has
been well established that two-dimensional (2-D) culture of chondrocytes leads to a loss
of chondrocytic phenotype and dedifferentiation over time [148, 149]. More recently,
attempts have been made to avoid the characteristic 2-D dedifferentiation by culturing
growth plate chondrocytes in 3-D in vitro by using suspension cultures, pellet cultures or
biomaterial scaffolds [103, 150, 151]. Perhaps most significant of in vitro growth plate
chondrocyte culture to-date, Randall et al. demonstrated the use of a pellet culture
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technique to induce what resembled columnar alignment (mimicking the proliferative
zone) in vitro by transiently transfecting chondrocytes to upregulate or down regulate the
response to factors within the growth plate prior to pelleting and culturing cells with or
without that specific factor treatment [103]. While the daughter cells could be traced from
the origin in semi columnar formations, downfalls still exist in this model. Most notable,
the ability to modulate growth, and more specifically zonal arrangement, in pellet and
suspension cultures is limited as a result of difficulties in inducing bioactive gradients
that can promote cell polarity and/or regions of localized signal transduction, and so it
follows that advancing in vitro culture models of coordinated tissue growth using tissue
engineering principles is critical to further growth plate cartilage research [152].
Tissue engineering involves the use of tissues or cells, scaffold materials and
bioactive signals to develop functional organ tissues in vitro and has become a tool for
engineers and developmental biologists to develop and model tissue development [1, 56].
Tissue engineering has been employed to extensively study and regenerate articular
cartilage, and groups have attempted to culture articular chondrocytes in protein-,
polysaccharide-, and synthetic-based biomaterials in vitro and most relevant to this thesis,
alginate has been extensively studied for this use [153]. Alginate is a linear
polysaccharide that forms hydrogels when crosslinked in the presence of divalent cations.
It is widely used in tissue engineering applications because of its inherent non-fouling
nature and ease of functionalization of the alginate molecule, and because the pore size of
alginate hydrogels allows for the diffusion of waste out and nutrients and growth factors
into the tissue engineered construct [7, 47, 154]. Tissue engineers have also utilized
alginate when encapsulating growth plate chondrocytes. For example, growth plate
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chondrocytes have been encapsulated in “semi-solid” alginate beads and when cultured in
vitro it was found that the cells maintained their rounded phenotype, indicating that the
chondrocytes were not entering into the proliferative zone nor entering hypertrophy,
showing a maintenance of phenotype over time [155]. More recently, groups have
utilized alginate to inject growth plate chondrocytes into mice for long-term culture, and
have even observed zonal arrangement and column formation [28]. However, no specific
questions concerning the effects of any particular growth factor within the system were
able to be identified, as the induction of zonal arrangement was most likely caused by
factors present in vivo. Therefore, a method to culture growth plate chondrocytes that
allows for the presentation of specific factors in a controllable manner to investigate the
necessary factors to induce zonal arrangement of chondrocytes in vitro is still needed.
In the present study alginate hydrogels were used to develop a 3-D in vitro culture
system to study the development and zonal arrangement of growth plate cartilage. The
objectives were two-fold: 1) To explore the effect of culturing growth plate chondrocytes
in alginate hydrogels (ALG) and RGD-modified ALG scaffolds (RGD) on viability,
matrix formation (Col4, Col6 and F-actin), cell cycle distribution, differentiation status
(Col2/Col1 ratio), changes in ColX, PTHrP, PTH1r and IHH transcript expression, as
well as the Col2/ColX ratio via fluorescent in situ hybridization (FISH); and 2) To better
understand the role of the PTHrP/IHH feedback loop in zonal arrangement by introducing
soluble factors such as PTH or IHH to the culture media and studying changes in cell
cycle distribution, differentiation status (Col2/Col1 ratio), changes in ColX, PTHrP,
PTH1r and IHH transcript expression, as well as the distribution of the expression of
Col2 and ColX via FISH.
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3.2. Materials and Methods
3.2.1. Alginate Formulation
Alginate solutions were prepared by dissolving sodium alginate power (Pronova
UP MVG, >60% guluronic acid, 200,000 – 300,000 g/mol; NovaMatrix, Sandvika,
Norway) or RGD-modified alginate (see below) in sterile 1X phosphate buffered saline
(PBS; Thermo Fisher, Waltham, MS) to a concentration of 1.5% (w/v). After alginate
was allowed to dissolve for up to 8 hours, the solution was filtered using disposable
Rapid-Flow PES filters with a pore size of 0.20-µm (Thermo Fisher) to ensure sterility.
To conjugate RGD to the alginate molecule, previously described carbodiimide
chemistry was utilized [42]. Briefly, 2 grams of sodium alginate were added to 200-mL
of MES buffer (0.1M MES, 0.3M NaCl, pH 6.5) and the alginate was allowed to dissolve
for up to 8 hours on a stir plate. 1-ethyl-(dimethylaminopropyl) carbodiimide (EDC;
Sigma Aldrich, St. Louis, MO) was added to activate an estimated 5% of the uronic acids
of the alginate polymer backbone in order to form amide linkages with the peptide. To
stabilize the reactive EDC intermediate against a competing hydrolysis reaction, Nhydroxy-sulfosuccinimide (sulfo-NHS; Pierce, Rockford, IL) was also added to the
solution at a 2:1 EDC to sulfo-NHS ratio. Finally, the glycine-arginine-glycine-aspartic
acid-serine-proline (GRGDSP) peptide (Anaspec, Fremont, CA) was added to the
solution at a concentration of 4-µmol/g alginate, conjugating the peptide to the alginate
backbone via the terminal amine of the peptide. After 20 hours of reacting, the
conjugation reaction was quenched via the addition of hydroxylamine hydrochloride
(Sigma Aldrich). The alginate solution was then dialyzed (3.5 kD MWCO, 45 mm flat-
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width dialysis tubing; Spectrum Laboratories, Rancho Dominguez, CA) in a salt solution
(NaCl in ddH2O) with stirring over the course of 3 days. The salt solution was replaced
with decreasing salt solutions with a starting concentration of 6.75-g/L followed by 5.25-,
3.75-, 2.25-, 0.75-, and four washes of 0-g/L NaCl in ddH2O every 8 hours. The resulting
alginate solution was frozen to -80°C, lyophilized to dryness and was dissolved in PBS as
described above. To verify successful conjugation of the GRGDSP peptide to the alginate
polymer backbone, 1H-NMR spectroscopy was used to characterize the samples.
Unmodified alginate and GRGDSP-alginate were dissolved in deuterium oxide (D2O;
Sigma Aldrich) and placed in separate NMR tubes. The 1H-NMR spectra of the samples
were recorded on a Bruker Avance III-HD 700 MHz NMR spectrometer.
3.2.2. Chondrocyte Isolation
Neonatal Swiss Webster mice (Jackson Laboratories, Sacramento, CA) at
postnatal day (P) 4, (P0 being the day of birth), were used for the collection of growth
plate chondrocytes. All procedures performed on animals were consistent with regulatory
agency policies and were approved by the Institutional Care and Use Committee at the
University of Nebraska Medical Center (UNMC). Pups were euthanized and the growth
plate cartilage from the two hind limbs was rapidly harvested into 1X Hank’s Balanced
Salt Solution (HBSS; Thermo Fisher), and then transferred into Dulbecco’s Modified
Eagle Medium (DMEM, Invitrogen, Carlsbad, CA) with 10% fetal bovine serum (FBS;
Atlanta Biologicals, Flowery Branch, GA) and 1% glutamine/penicillin/streptomycin
(GPS; Invitrogen); collagenase (Sigma Aldrich) was added to the media at a
concentration of 0.25%. The growth plates in the collagenase solution were maintained in
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a passively humidified incubator at 37°C and 8% CO2 for 4 hours to dissolve the existing
extracellular matrix (ECM). After incubation the solution containing the growth plates
was pipetted against a petri dish to further break up the tissue, releasing the chondrocytes.
The chondrocytes were pelleted by centrifugation at 125 x g using a Sorvall Legend RT
centrifuge (Kendro Laboratories, Newtown CT) for 5 minutes and resuspended in
DMEM with FBS and GPS to relieve the cells of collagenase. The extracellular debris
was allowed to settle by gravity for one minute and the remaining cells in the supernatant
were moved to another tube and were counted using a hemacytometer prior to moving on
to encapsulation. The isolated primary chondrocytes were centrifuged at 125 x g for 5
minutes, counted using a hemacytometer, and divided into aliquots depending on the
number of different scaffold types used (described further below). All cells were
maintained in the incubator until time for alginate encapsulation.
3.2.3. Alginate Encapsulation
Chondrocytes were encapsulated in alginate (ALG) or RGD modified alginate
(RGD) beads prior to culturing. Homogenous alginate beads were formed using the basic
“drop” method previously described by other investigators [9, 120]. The concentration of
chondrocytes in alginate solution was 8,000,000-cells/mL of alginate. Therefore, each 10µL bead was made to contain 80,000 primary growth plate chondrocytes. Collected
growth plate chondrocytes were counted, the appropriate amount of cells was pelleted by
centrifugation at 125 x g for 5 minutes, and the remaining media was aspirated. The
calculated amount of either ALG or RGD was mechanically mixed into the cell pellet,
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pipetting up and down only once. The entire solution was gently vortexed to ensure
complete mixing.
Prior to chondrocyte-alginate hydrogel formation, a crosslinking solution was
prepared with ddH2O, calcium chloride, and sodium chloride (50-mM CaCl2/140-mM
NaCl; Sigma Aldrich) and was used to gel the cell-alginate mixture. In a 24-well plate, 2mL of crosslinking solution was pipetted into each well, and the entire plate was placed
into the incubator to warm before being used for bead fabrication. To create the alginate
beads, 10-µL of alginate-cell solution was drawn up into a pipette tip. The tip was wiped
with a Kimwipe to ensure the alginate could drop freely from the tip. Hovering 2-3 inches
over one well containing crosslinking solution, the plunger was rapidly depressed,
allowing the alginate to fall from the tip and into the solution. If the alginate bead did not
break the surface of the crosslinking solution, the crosslinking solution was pipetted
gently on top of the bead until it became submerged, and the alginate-cell solution was
allowed to crosslink forming a hydrogel bead. While each bead was crosslinking, the
procedure was repeated, dropping alginate-cell solution into individual wells. After 2
minutes, the remaining crosslinking solution was removed from the well and the resulting
bead was moved to a different well plate containing wells with 2-mL of DMEM with
FBS and GPS for up to 10 minutes to wash away any remaining free calcium ions. The
bead was washed again in a serum free MEM-alpha medium without Phenol Red (αMEM; Invitrogen) for up to 10 minutes to rid the bead of any remaining wash media and
serum. After both washes, the bead was placed into cartilage culture media (described
below) for long-term culture.
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3.2.4. Culture Conditions
Cartilage culture media was prepared using previously described methods [15]: αMEM supplemented with 50-µL/mL GPS, β-glycerophosphate (10-mM; Sigma Aldrich),
and L(+) ascorbic acid (50-µg/ml; EMD, Darmstadt, Germany). In addition,
dexamethasone (1-nM; Sigma Aldrich), proline (1-mg/mL; Sigma Aldrich), antioxidant
(1:100; Sigma Aldrich), sodium pyruvate (1-mM; Gibco Lifetech, Grand Island, NY),
nonessential amino acids (1:100; Thermo Fisher), and Insulin-Transferrin-Selenium+3
media supplement that includes linoleic and oleic acids, and bovine serum albumin (ITS
+3; 1:100; Sigma Aldrich) were added to the media. For treatment conditions,
parathyroid hormone (PTH; Sigma Aldrich) or Indian hedgehog (IHH; R&D,
Minneapolis, Minnesota) were added to the culture media in the concentrations described
in the experimental design. Beads were cultured in a 48-well plate within a humidified
incubator at 37°C and 8% CO2 for up to 7 days.
3.2.5. Evaluation of Viability
The viability of cells encapsulated in alginate and RGD-alginate was evaluated
using a Live/Dead Cell Viability kit (Invitrogen). After culture for 0 to 7 days, beads
were removed from media and then incubated in a solution of 2 µM Calcein AM/4 µM
ethidium homodimer-1 in PBS for 30 minutes in the dark. After the incubation, the
solution was replaced with PBS and beads were imaged with fluorescence on a Leica
DMI6000B inverted microscope to visualize live and dead cells. The overall level of
viability was qualitatively assessed for any excessive cell death. Images are
representative of 3 replicates.
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3.2.6. Immunofluorescent Imaging
For immunofluorescence (IF) analysis of beads containing chondrocytes, all
reagent and wash solutions contained 2mM CaCl2 to maintain the cross-linked alginate.
After 0 to 7 days of culture, beads were fixed with 4% paraformaldehyde (PFA, Sigma
Aldrich) for 20 minutes, permeabilized with 1×Tris-Buffered Saline (TBS) made with
15-mM Tris-HCl (Fisher Scientific) and 136-mM NaCl (JT Baker, Center Valley, PA)
plus 0.1% Triton X-100 (1×TBST, Triton from EMD, Darmstadt Germany), and blocked
for 2 hours with 10% heat-inactivated sheep serum (HISS, Sigma Aldrich). The beads
were incubated with gentle rocking at 4º C in either rabbit-anti-Collagen VI (1:500;
Abcam, Cambridge, UK) or rabbit-anti-Collagen IV (1:500; Abcam) primary antibody in
2% HISS/TBST overnight. The beads were then incubated in a secondary anti-mouse
AlexaFluor 647 antibody (1:1000; Jackson Laboratories) and phalloidin-labeled
AlexaFluor 488 (1:100; Invitrogen) for 2 hours in 2% HISS/TBST. After washing in
TBST 3 times for 5 minutes, the coverslips were mounted with gelvatol or with Prolong
Gold antifade reagent with DAPI (Invitrogen).
For the IF analysis of cell cultures, the data are representative of n=3 beads. All
factors within the alginate gel were visualized using a Zeiss 710 laser scanning confocal
microscope. Optical sections (line averaging of 2, scan speed of 4 or 5, and typical
resolution of 1024×1024) were collected at 1.8-µm intervals for between 15 and 25
sections (total depth of 30-40-µm).
3.2.7. Transcript Expression Analysis
Immediately after crosslinking (D0) or after 1 (D1), 4 (D4) or 7 (D7) days of culture, 4
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beads were harvested and were immediately placed in 50-µL of 50-mM
ethylenediaminetetraacetic acid disodium salt dihydrate (EDTA; Fisher Chemical, Fair
Lawn, New Jersey) in ddH2O to dissociate the chondrocytes from the alginate matrix.
RNA was isolated using the NucleoSpin® RNA Plus kit (Thermo Fisher) according to
the manufacturer’s instructions. Quantification of RNA was performed using a Thermo
Fisher Scientific NanoDropOne spectrophotometer. RNA was converted to cDNA using
Superscript IV (Thermo Fisher) according to the manufacturer’s instructions and
resulting cDNA was quantified again after the reaction using the spectrophotometer.
ddPCR was performed according to the manufacturer’s protocol (Bio-Rad Laboratories,
Inc., Pleasenton CA). Using mouse-specific primers (Table 3-1) (IDT, Coralville, IA),
transcript expression levels for Actin, RPL13a-2, and HPRT were used as
housekeepering genes. Transcript expression levels of collagen 1 (Col1), collagen 2
(Col2), collagen X (ColX), parathyroid hormone related protein (PTHrP), parathyroid
hormone receptor (PTH1R), and Indian hedgehog (IHH) were assessed. Thermal cycling
conditions were 95°C for 10 min; 40 cycles of 94 °C for 30 seconds, 60°C for 60
seconds, 98°C for 10 minutes, and a 4°C hold. The transcript count of each gene of
interest was normalized with a geometric average of the transcript count of the
housekeepers. Data from this analysis are reported as fold change in the geometric mean
± SEM over the transcript count of the non-treated control and significance was
calculated using two-way ANOVA analysis using Prism software (GraphPad Software,
Inc, La Jolla, CA). The number of replicates for each treatment group is reported in the
tables corresponding to the figure.
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Table 3-1. Sequence of primers used for ddPCR amplification.

Forward Sequence
Gene
5’ à 3’
Housekeeping
Actin

CCCATCTACGAAGGTTACGCC

HPRT

CTGGTGAAAAGGACCTCTCG

RPL13-a

ATCCCTCCACCCTATGACAA

Target
Col1

CACTGGTGATGCTGGTCCTG

Col2

AATGGGCAGAGGTATAAAGATAAGGA

ColX

TTCTGCTGCTAATGTTCTTGACC

PTHrP

AGTTAGAGGCGCTGATTCCTACA

PTH1r

AGGTGGTTCCAGGGCACAA

IHH

CCCCAACTACAATCCCGACA

3.2.8. Flow Cytometry
Fluorescence-activated cell sorting (FACS) was used to analyze cell cycle
distribution in cultured chondrocytes. Alginate beads were dissociated using 200-µL of
50-mM EDTA in polypropylene tubes (Becton Dickinson Labware, Cedex, France) for 5
minutes. Using a sterile transfer pipette (VWR, West Chester, PA), the tubes were filled
completely with 0.1-µm sterile filtered PBS (Hyclone, Logan, Utah) and centrifuged at
125 x g for 5 minutes. The supernatant was removed using the same transfer pipette
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making sure to keep 200-µL of volume left in the bottom of the tube to ensure the cell
pellet was not disrupted during pipetting, and the pellet was resuspended by vortexing
using a Vortex Genie 2 (Thermo Fisher). As cells vortexed they were fixed by adding icecold 90% ethanol using a transfer pipette dropwise, one drop per second, to
approximately 3-mL total volume. Fixed cells were maintained at -20°C for anywhere
from 24 hours to 7 days, and subsequently stained with propidium iodide (Molecular
Probes, Eugene OR) (0.05 mg/mL) in Telford’s reagent for 1 hour at 4°C in the dark to
label DNA. Labeled cells were filtered through 5-mL Filter-cap polypropylene Falcon
tubes (Corning Labs, Tamaulipas, Mexico) and were immediately analyzed on a BD
FACSCaliber 2 flow cytometer (BD, Franklin Lakes, NJ). Resulting cell cycle
distribution was analyzed by the UNMC flow cytometry research core facilities. The
resulting cell cycle data was represented as stacked bar graphs of the geometric mean ±
SEM of percentage of cells in each phase of the cell cycle and significance was
calculated using a two-way ANOVA using GraphPad Prism software. The number of
replicates is reported in in the tables corresponding to the figure.
3.2.9. FISH
3.2.9.1. Hybridization Technique
For fluorescence in situ hybridization (FISH) analysis of gene expression in cell
cultures, whole alginate beads containing chondrocytes were fixed in 4%
paraformaldehyde in TBS containing 5mM CaCl2 overnight at 4°C, infiltrated and
embedded in 37.5:1 40% acrylamide (JT Baker, Center Valley, PA) overnight at 4ºC to
ensure structural integrity of the sample, bathed overnight at 4°C in 30% sucrose (Sigma
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Aldrich) and embedded for cryosectioning using Tissue-Tek Optimum Cutting
Temperature embedding medium (OCT; Thermo Fisher). FISH was performed according
to product instructions (TSA Plus, Perkin Elmer, Waltham Massachusetts) with ColII and
ColX RNA probes using DNA templates cloned from mouse and generated using
fluorescein label as described [143]. Slides were mounted using Prolong Gold antifade
reagent with DAPI (Life Technologies, Eugene, OR). Images were captured with
fluorescence on a Leica DMI6000B inverted microscope to visualize hypertrophic and
non-hypertrophic chondrocytes, as well as nuclei using DAPI. For each image, a tiled,
stitched, z-stacked image (5-µm slices, 3 total slices, 15 total width of the z-stack) was
produced to show the entire section of the bead for downstream quantification, described
next.
3.2.9.2. Statistical Analysis for FISH
Resulting FISH images were subjected to batch processing analysis using a macro
programmed in FIJI software (http://fiji.sc/) to count total number of cells labeled for
ColX, and DAPI using particle analysis. The macro performed the following functions:
The name of each image was stored, and z-stacks and channels were split into separate
images. Each image was automatically set to binary, such that cells appeared black on a
white background, and the software ran a particle analysis including particles only within
size range 50-1000, as determined optimal by analyzing the size distribution of cells from
our images. The particle analysis determined counts for each image, which were summed
across images of similar conditions. Typically, each image yielded cell counts of
approximately 1000, and each condition resulted in approximately 10,000 cell counts in
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total. Summed cell counts for each gene were divided by DAPI counts to produce the
values of fraction of total cells. To calculate the ColX/Col2 ratio, the geometric mean of
the Col2/DAPI ratio for each replicate (n=3 or 4 sections for each replicate) was divided
by the geometric mean of the ColX/DAPI ratio for each replicate (n=3 or 4 sections for
each replicate) to control for total cell number. The ratio is reported as the geometric
mean of the ColX/Col2 ratio for each replicate ± SEM. The number of replicates for each
treatment group is reported in the table corresponding to the figure. For regional/spatial
gene expression analysis of FISH images, bead diameter was measured in ImageJ using a
circular region of interest (ROI). The bisection of each bead radius was used to demarcate
inner and outer regions of each bead. Each image was duplicated and cropped to include
only the inner or outer regions. The resulting images were analyzed by particle counting
as described above to determine the amount of cells expressing the target gene within the
ROI. The distribution of gene expression was examined for spatial differences.

3.3. Results
3.3.1. RGD Conjugation Confirmation
One of the objectives of this paper was to explore the effect of cell adhesion and
specifically the effect of integrin activation via RGD; chondrocytes were cultured in vitro
in either ALG or RGD-modified ALG beads (Fig. 3-2). The successful conjugation of
RGD to ALG was confirmed via 1H-NMR, which is shown in Chapter 2 (Fig. 2-2).
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3.3.2. The effect of scaffold on chondrocyte behavior
The first objective of this study was to explore the difference in chondrocyte
behavior when exposed to different encapsulating scaffolds: ALG and RGD.
Chondrocytes encapsulated in ALG or RGD-modified ALG were cultured for up to 7
days and FACS, ddPCR and FISH were all utilized to investigate changes in chondrocyte
cell cycle distribution and gene expression.
3.3.2.1. Encapsulation and Viability
To culture primary growth plate chondrocytes in 3-D, a homogenous
encapsulation method was used. Fig. 3-2 is a schematic showing the method of
encapsulation. In order to ensure the bead fabrication process did not cause harm to the

Fig. 3-2. Schematic of the “drop” method to produce homogenous chondrocyte-alginate beads.
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primary growth plate chondrocytes and to ensure a homogenous distribution of cells
throughout the bead, Live/Dead stain was used to visualize the viability of the
chondrocytes, with live cells fluorescing green and dead cells fluorescing red. Fig. 3-3
shows an even distribution of cells throughout the bead, as well as many cells stained
green, while very few cells stained red. The distribution of live cells and low amounts of
dead cells remained consistent throughout a 7-day culture period.

Day 4

Day 1

Day 0

Day 7

B

C

D

E

F

G

H

RGD

ALG

A

Fig. 3-3. Representative images of Live/Dead stain of chondrocytes encapsulated in beads. A-D)
Chondrocytes are encapsulated in alginate and are stained A) immediately after encapsulation, or are
cultured and stained after B) 1 day, C) 4 days or D) 7 days in culture. E-H) Chondrocytes are
encapsulated in RGD-alginate and are stained E) immediately after encapsulation, or are cultured and
stained after F) 1 day, G) 4 days or H) 7 days in culture. Scale bar = 50-µm. (n=3)

3.3.2.2. IF Visualization of Matrix Deposition
In order to ensure the encapsulation and culture processes did not impede the
ability of chondrocytes to deposit an ECM, visualization of the matrix deposition within

78
the alginate bead was accomplished through IF imaging of both Collagen type VI (Col6)
and Collagen type 4 (Col4), as well as with staining for DAPI and F-actin. As shown in

Day 1

Day 4

DAPI Actin
Col4

RGD

DAPI Actin
Col6

DAPI Actin
Col4

ALG

DAPI Actin
Co16

Day 0

Fig. 3-4. Representative images of immunofluorescence visualization of ECM deposition. Neither ALG nor
RGD encapsulation cause any disruptions of either Col4 or Col 6 matrix deposition over time in culture.
However, a slight difference in actin organization between ALG and RGD is observed, and is highlighted by
the white arrows. Scale bar = 5 µm.
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Fig. 3-4, the deposition of both Col4 and Col6 was observed and maintained throughout a
4-day culture period. However, a slight difference was observed in the structure of the
actin fillaments between chondrocytes encapsulated within ALG and RGD: Arrows in
Fig. 3-4 point to F-actin within the chondrocyte lacune, and a qualitative assessment of
the F-actin seen in cells encapsualted within ALG appear to be disrupted and less intense
than the F-actin highlighted in the image of chondrocytes encapsulated within RGD,
which appear to have greater organization and prominance of F-actin.
3.3.2.3. FACS Analysis
To ensure that the
Cell Cycle Distribution
ALG

encapsulation of chondrocytes in

RGD

100

100

80

80

60

60

hydrogels did not cause dramatic
changes in the cell cycle

Percent (%)

distribution, FACS analysis was
G2M
S
G0G1

used to measure the overall

40

40

20

20

0

0

distribution of cell cycle status.
Fig. 3-5 shows the cell cycle

Time Point

7
D

4
D

1
D

0
D

7
D

4
D

1
D

D

0

distribution of chondrocytes
Time Point

Fig. 3-5. FACS analysis of cell cycle of chondrocytes
encapsulated in ALG and RGD. D0 is representative of

encapsulated in either ALG or
RGD and cultured for up to 7 days.
As outlined Table 3-2, the cell

chondrocytes that were encapsulated ALG and were briefly
held in culture media before being harvested for analysis. D1,
D4 and D7 are representative of chondrocytes cultured for 1, 4
or 7 days, respectively, in their respective scaffold: Right:

cycle distribution at D0 was mostly
in G0G1 (85%), with small
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amounts of cells in either S or G2M (9% and 7%, respectively). On D1, chondrocytes
encapsulated in ALG showed a decrease in the percentage of cells in G0G1 to 79% when
compared to D0, with a corresponding increase seen in the proliferative phases: the
amount of cells in G2M phase accounted for 13% of cells, and S for 8%, or 21%
collectively. On D4 and D7, the percentage of cells encapsulated in ALG in G0G1 phase
remained around that of D1 (76% and 78%, respectively) and the percentage of cells in
the proliferative phases also remained collectively similar to D1 (23% and 22%,
respectively). However, no differences in cell cycle distribution of chondrocytes
encapsulated in ALG were statistically significant over time.
Table 3-2. Cell cycle distribution by FACS analysis. Reported in this table are the geometric means with SEM
for each phase of the cell cycle and replicate number for each treatment group.

Phase

G0G1

S

G2M

Mean

SEM

n

Mean

SEM

n

Mean

SEM

n

D0
D1 ALG
D1 RGD
D4 ALG
D4 RGD
D7 ALG

84.579
78.840
75.629
76.205
70.790
77.892

0.813
1.930
2.769
3.510
4.101
2.143

3
3
3
3
3
3

6.652
7.742
9.954
10.342
8.634
15.127

0.184
0.577
2.419
0.689
0.939
0.909

3
3
3
3
3
3

8.697
13.120
13.699
12.590
19.164
6.613

0.692
1.598
1.260
2.842
4.901
1.239

3
3
3
3
3
3

D7 RGD

66.981

1.598

3

16.836

1.135

3

16.057

0.468

3

Cells encapsulated within RGD showed a similar cell cycle distribution as those
encapsulated in ALG on D1, with the percentage of cells in G0G1 at 76% and a
combination of G2M and S phases at 24%. However, by D4, cells encapsulated in RGD
showed less cells in G0G1 (71%) and significantly more cells (P< 0.01) in the
combination of G2M and S phases (28%), when compared to D0. By D7, cells
encapsulated in RGD showed a decrease in G0G1 phase when compared to previous time
points (68%) and a corresponding and significant increase (P< 0.001) in the amount of
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cells in the combination of G2M and S phases (33%). Overall, a trend in the decrease in
the percent of cells encapsulated in RGD in G0G1 phase with a significant increase in the
combination of G2M and S phases was observed over time. This trend was not observed
in ALG after D1.
3.3.2.4. Transcript Expression
ddPCR was utilized to explore the effect of scaffolding and the addition of cell
adhesion ligands on the gene expression of chondrocytes encapsulated in alginate
hydrogels. Table 3-3 shows the geometric means along with SEM and replicate number
(n) for all gene expression data. First, the ratio of the fold change in transcript counts for
Col2 to the fold change in transcript counts for Col1 was determined to ensure significant
dedifferentiation did not occur within the culture system. Fig. 3-6 shows the results for
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Col2/Col1
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RGD

Ratio

2.0

this dedifferentiation ratio. For culture
in ALG, the ratio only slightly
decreased from D1 to D4 from 1 to 0.9
and by D7, the ratio decreased again,

1.5

with an average ratio of 0.9 over all 7

1.0

days of culture in ALG. There were no
significant differences (P> 0.05)

0.5

observed across days in ALG. The
0.0

D1

D4

D7

D1

D4

D7

Time Point
Fig. 3-6. Ratio of Col2 to Col1 to explore the
differentiation status of chondrocytes. Cells were
encapsulated in either ALG or RGD. (n=2)

Col2/Col1 ratio for cells encapsulated
in RGD on D1 was higher than the
ratio measured for cells in ALG
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Fig. 3-7. Gene expression of chondrocytes cultured in ALG or RGD over time. Data are reported as fold
changes over the control of that gene (D1 ALG). Fold changes are shown for A) ColX, B) PTHrP, C) PTH1r
and D) IHH. (n=2)

(average value of 1.7). The average ratio was 1.6 over all 7 days of culture in RGD and
there were no significant differences observed over time. Additionally, the difference in
Col2/Col1 ratios between ALG and RGD was not significant over time, indicating
dedifferentiation was not observed in either scaffold system.
To observe changes in the expression of chondrocyte and zonal specific genes,
ColX, PTHrP, PTH1r and IHH expression was observed over time in both scaffold
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systems. Table 3-3 outlines all data for gene expression analysis and Fig. 3-7 shows the
fold change in transcript expression for the genes of interest. The most dramatic of the
four genes, ColX (Fig. 3-7A) showed both significant differences between scaffolds
overall when compared to each other (P< 0.01) and significant differences within the
individual treatments (i.e. ALG and RGD) between days (P< 0.0001). In ALG, ColX
expression decreased significantly on both D4 and D7 when compared to chondrocytes
encapsulated in ALG on D1. However, no other significant changes in gene expression
were quantifiable for PTHrP, PTH1r or IHH in ALG. The ColX expression of
chondrocytes encapsulated in RGD decreased significantly (P< 0.001) from D1 to D4
and decreased again on D7 when compared to D1. In both IHH and PTH1r, a noticeable
decrease in expression was observed in cells encapsulated in RGD when compared to D1,
although these changes were not significant. Overall, cells encapsulated in both ALG and
RGD show a statistically significant decrease in ColX expression over time, and the
decrease in ColX expression in of cells within ALG was statistically higher (P< 0.01)
than the decrease expression of cells in RGD. However, no other day or scaffold effects
were significant in the expression of PTHrP, PTH1r or IHH in either scaffold system over
time.
Table 3-3. Fold change in transcripts of genes of interest as compared to the D1 ALG of each column.
Reported in this table are the geometric means with SEM and replicate number for each treatment group.

Target Gene

Col1

Col2

ColX

PTHrP

PTH1r

IHH

Mean

SEM

n

Mean

SEM

n

Mean

SEM

n

Mean

SEM

n

Mean

SEM

n

Mean

SEM

n

D1 ALG
D1 RGD
D4 ALG
D4 RGD
D7 ALG

1
0.512
0.59
0.639
0.913

0
0.098
0.238
0.041
0.104

2
2
2
2
2

1
0.683
0.525
0.748
0.574

0
0.187
0.202
0.11
0.239

2
2
2
2
2

1
0.556
0.085
0.073
0.043

0
0.052
0.031
0.014
0.014

2
2
2
2
2

1
1.46
1.296
1.698
1.534

0
0.36
0.686
0.74
1.187

2
2
2
2
2

1
1.163
0.788
0.5
0.751

0
0.23
0.165
0.198
0.63

2
2
2
2
2

1
0.881
0.586
0.584
0.933

0
0.17
0.332
0.193
0.584

2
2
2
2
2

D7 RGD

0.496

0.212

2

0.684

0.187

2

0.036

0.019

2

1.544

1.284

2

0.357

0.351

2

0.363

0.352

2
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3.3.2.5. FISH Analysis
FISH was used to visualize the distribution of gene expression of chondrocytes
cultured in ALG or RGD hydrogels. Representative images of FISH are shown in Fig.
3-8A and B. In Fig. 3-8A DAPI and ColX are visualized in one section of an ALG bead,
and in Fig. 3-8B, DAPI and Col2 are visualized.
To better understand the rate of hypertrophy within the system, the ratio of ColX
to Col2 expression was analyzed through image analysis across 9 images of cells
encapsulated in ALG or cells encapsulated in RGD in three separate experiments (Fig.
3-9C). On D1, the ColX/Col2 ratio for cells cultured in ALG was 0.463 ± 0.058, but by
D4 the ratio decreased to 0.251 ± 0.148; however, this was not significant due to large
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Hypertrophic Ratio
ColX/Col2

C

ALG

1.25

RGD

Ratio

1.00
0.75
0.50
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B
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Col2

0.00

D1

D4

D1

D4

Time Point
Fig. 3-8. FISH analysis to visualize distribution of A)
ColX gene expression and B) Col2 gene expression
within the ALG bead on D0. C) Ratio of the count of
Col2 positive cells to the count of ColX positive cells.
Scale bar is 500 µm.
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error on D4. Conversely, on D1 the ColX/Col2 ratio for cells cultured in RGD was 0.321
± 0.167, and the ratio increased by D4 to 0.603 ± 0.389. However, no statistically
significant differences (P> 0.05) were observed due to error in ratios observed in cells
encapsulated in RGD. Overall, no sidgnificance in the ColX/Col2 ratio was observed
over time or between the scaffold types.
3.3.3. The effect of soluble factors on chondrocyte behavior
The next objective of this study was to examine the effect of the addition of
soluble factors known to play a role in chondrocyte maturation. The effects of both PTH
and IHH on chondrocytes
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nM PTH. An additional condition was evaluated with 1000 nM PTH and the addition of
10 µM H89, a known inhibitor of PTH. FACS analysis was used to measure the overall
distribution of cell cycle status. Fig. 3-9 shows the cell cycle distribution of chondrocytes
with no added PTH (NT) or added PTH treatments, and Table 3-4 outlines the specific
values for each cell cycle state, the associated errors with the replicates, and the number
of replicates.
On D0, the overall distribution of cell cycle was about 84%:7%:8%
(G0G0:S:G2M) and all treatment groups were compared to D0 or to cells cultured with
NT on the corresponding day. On D1 there were significant treatment effects observed
(P< 0.0001), and when compared to D0, cells in G0G1 phase that were cultured with 10,
100, 1000 nM PTH as well as with 1000 nM PTH + 10 µM H89 were all significantly
decreased (0.01 with H89 and P< 0.0001 for all others). However, when comparing cells
cultured with NT on D1 with 1000 nM PTH + H89, the amount of cells in G0G1 was not
significantly different. There were significant differences observed between treatments in
the percentage of cells in the combination of S-phase and G2M on D1: cells harvested on
D0 and cells cultured with NT on D1 were significantly different from each other (P<
0.0001) and cells cultured with 10, 100 and 1000 nM PTH as well as with 1000 nM PTH
+ 10 µM H89 treatments had significantly increased percentage of cells in the
combination of S and G2M phase over the D0 (P< 0.0001for all) for each treatment.
Overall on D1, the percentage of cells in G0G1 phase decreased significantly over D0
with increasing PTH treatment and when compared to D1, H89 treatment included with
the highest PTH dose showed no significant increase over D1. Conversely, the percentage
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of cells that were in the S and G2M phases on D1 increased significantly with increasing
PTH treatment.
Table 3-4. Cell cycle distribution by FACS analysis. Reported in this table are the geometric means with SEM
and replicate number for each treatment group

Phase

G0/G1

S

G2/M

Mean

SEM

n

Mean

SEM

n

Mean

SEM

n

D0
D1

83.61

0.245

4

8.145

0.284

4

8.219

0.214

4

NT
10
100
1000
1000 + H89
D4
NT
10
100
1000

75.42
36.55
63.88
62.04
70.65

1.81
1.789
0.866
0.494
1.968

4
3
4
3
4

9.49
18.07
18.09
17.82
13.21

1.183
1.852
1.273
1.74
0.873

4
3
4
3
4

14.68
18.04
17.73
19.79
15.6

1.135
1.225
1.308
1.863
1.996

4
3
4
3
4

45.26
30.79
26.94
29.99

1.93
3.99
3.38
6.53

3
2
2
2

22.89
19.59
20.08
21.38

1.65
1.345
3.815
1.745

3
2
2
2

31.44
49.03
51.83
47.13

5.547
5.335
7.095
8.275

3
2
2
2

1000 + H89

41.15

6.161

3

21.7

0.642

3

34.93

6.607

3

By D4, significant (P< 0.0001) dose effects were evident. When compared to D0,
the percentage of cells in G0G1-phase on D4 that were cultured with NT and with 10,
100, 1000 nM PTH, as well as 1000 PTH with H89, were all significantly decreased (P<
0.01 for NT, 0.0001 for all others). When observing changes in the percentage of cells in
the combination of S-phase and G2M, the percentage of cells cultured with NT was
significantly increased (P< 0.01) when compared to D0. Cells cultured in all treatment
groups on D4 showed significant increases in S and G2M phases over cells on both D0
(P< 0.0001 for all treatments) and on D4 with NT (P< 0.001 for all treatments except
with H89 with P< 0.05). Overall on D4, the percentage of cells in G0G1-phase decreased
significantly and cells in the proliferative phases (i.e. S and G2M phases) increased
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significantly with increasing PTH treatment, which were more pronounced than the trend
seen on D1. The most prominent shift in cell cycle from the D0 distribution was seen
with the 100 nM PTH treatment on D4.
3.3.3.1.2. Transcript Expression
ddPCR was utilized to measure the effect of treatment with varying PTH
concentrations on the gene expression of chondrocytes encapsulated in ALG at two time
points (D1 and D4). Table 3-5 shows the geometric means along with SEM and replicate
number (n) for all gene expression data. First, the ratio of the fold change in transcript
counts for Col2 to the fold change in transcript counts for Col1 was determined to ensure
significant dedifferentiation did not occur within the culture system. Fig. 3-10 shows the
results for this dedifferentiation
ratio. There were no statistical
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To observe changes in the expression of chondrocyte and zonal specific genes,
ColX, PTHrP, PTH1r and IHH expression was observed on D1 and D4 in ALG with the
aforementioned treatments. Table 3-5 outlines all data for gene expression analysis and
Fig. 3-11 shows the fold change in transcript expression for the genes of interest. The
expression of ColX (Fig. 3-11A) on D1 and D4 showed a significant (P< 0.001)
treatment effect of PTH and PTH with H89. When compared to NT on D1, cells cultured
with 10, 100 and 1000 nM PTH treatments showed a significant decrease (P< 0.05, 0.01
and 0.05, respectively) in ColX expression. However, while the treatment with 1000 nM
PTH + 10 µM H89 on D1 showed a slight decrease in ColX expression, the decrease was
not statistically different than NT on D1. Additionally, there were no statistical
differences within PTH or PTH + H89 treatments on D1. When compared to NT on D4,
10, treatment with 100 and 1000 nM PTH caused a significant decrease (P< 0.05 for all)
in ColX expression. Unlike on D1, the treatment with 1000 nM PTH + 10 µM H89 on D4
showed a significant decrease when compared to NT (P< 0.01) in ColX. Additionally,
there were no statistical differences within PTH or PTH + H89 treatments on D4 or
overall between D1 and D4.
Next, when observing the change in expression of PTHrP (Fig. 3-11B) on D1 and
D4, a significant (P< 0.01) treatment effect of PTH and PTH + H89, as well as a
significant (P< 0.001) day effect between D1 and D4 emerged. When compared to NT on
D1, treatment with 10, 100 and 1000 nM PTH caused a significant decrease (P< 0.05 for
all) in PTHrP expression. Likewise, 1000 nM PTH + 10 µM H89 treatment showed a
significant decrease (P< 0.05) in PTHrP expression on D1. Furthermore, there were no
statistical differences within PTH or PTH + H89 treatments on D1. When compared to
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Fig. 3-11. Gene expression of chondrocytes cultured in ALG with or without PTH treatments over time. Data
are reported as fold changes over the control of that gene (D1 ALG). Fold changes are shown for A) ColX, B)
PTHrP, C) PTH1r and D) IHH. (n=2)

NT on D4, treatment with 10 nM PTH did not cause any change in PTHrP expression,
while treatment with 100 nM PTH caused a significant decrease (P< 0.05) in expression.
Treatment with 1000 nM PTH on D4 caused a significant decrease when compared to
culturing with NT (P< 0.05) in PTHrP expression. Likewise, treatment with 1000 nM
PTH + 10 µM H89 on D4 showed a significant decrease when compared to culturing
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with NT (P< 0.05) in PTHrP expression. Furthermore, there were no statistical
differences within PTH or PTH + H89 treatments on D4. The expression of PTHrP was
significantly higher overall for all conditions taken together (P< 0.001) on D4 than it was
on D1.
Next, when observing the change in expression of PTH1r (Fig. 3-11C) on D1 and
D4, a significant (P< 0.05) treatment effect of PTH and PTH + H89 as well as a
significant (P< 0.01) day effect between D1 and D4 emerged. When compared to NT on
D1, treatment with 10, 100 and 1000 nM PTH caused a decrease in PTH1r expression,
although the decrease was not significant. While treating encapsulated cells with 1000
nM PTH + 10 µM H89 caused a slight decrease in expression when compared to NT on
D4, the decrease was not significantly different than NT on D1. On D1, there were no
statistical differences between any treated or untreated groups. When compared to NT on
D4, treatment with 10 nM PTH caused a slight increase in PTH1r expression, while
treatment with 100 nM PTH did not cause any changes in PTH1r expression. The 1000
nM PTH treatment on D4 caused a slight decrease in PTH1r expression. Additionally,
treatment with 1000 nM PTH + 10 µM H89 on D4 showed a significant decrease (P<
0.05) in PTH1r expression when compared to treatment with 10 nM PTH. Furthermore,
there were no other statistical differences within PTH or PTH + H89 treatments on D4.
The expression of PTH1r was significantly higher overall for all treatments together (P<
0.01) on D4 than it was on D1.
Finally, when observing the change in expression of IHH (Fig. 3-11D) on D1 and
D4, a significant (P< 0.01) treatment effect of PTH and PTH + H89 as well as a
significant (P< 0.01) day effect between D1 and D4 emerged. When compared to NT on
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D1, cells encapsulated and cultured with treatments of 10, 100 and 1000 nM PTH caused
a significant decrease in IHH expression (P< 0.01 for 100 nM PTH and P< 0.05 for
others). While treatment with 1000 nM PTH + 10 µM H89 caused a slight decrease in
IHH expression when compared to NT on D1, the decrease was not significantly
different. When compared to NT on D4, treatment with 10 nM PTH caused a decrease in
IHH expression, while 100 and 1000 nM PTH treatment only caused slight changes in
IHH expression. Conversely, treatment with 1000 nM PTH + 10 µM H89 on D4 showed
a significant decrease (P< 0.05) in IHH expression when compared to NT on D4.
Furthermore, there were no other significant differences within PTH or PTH with H89
treatments on D4. The expression of IHH was significantly higher overall for all
treatments taken together (P> 0.01) on D4 than it was on D1.
Table 3-5. Fold change in transcripts of genes of interest as compared to the NT of each column. Reported in
this table are the geometric means with SEM and replicate number for each treatment group.

Target Gene

Col1

Col2

Mean

SEM

n

NT

1

<0.01

10

0.88

0.746

100

0.437

1000

ColX

Mean

SEM

n

2

1

<0.01

2

0.873

0.324

0.156

2

0.967

0.761

0.25

2

0.807

0.34

2

NT

1

<0.01

10

0.73

0.128

100

1.011

1000

PTHrP

Mean

SEM

n

2

0.97

0.029

2

0.494

0.012

0.515

2

0.342

0.873

0.321

2

0.834

0.078

2

2

1

0.017

2

0.534

0.069

0.136

2

0.622

0.79

0.047

2

0.52

0.189

2

PTH1r

Mean

SEM

n

2

1

<0.01

2

0.3

0.199

0.11

2

0.254

0.532

0.103

2

0.686

0.099

2

1

1

<0.01

1

0.565

0.015

0

1

0.605

0.395

0.02

1

0.705

0.024

1

IHH

Mean

SEM

n

Mean

SEM

n

2

1

<0.01

2

0.572

0.06

2

1

<0.01

2

2

0.344

0.046

0.068

2

0.437

2

0.057

2

0.29

0.044

0.272

0.107

2

2

0.502

0.088

2

0.431

0.123

2

0.191

0.081

2

0.651

0.222

2

0.579

0.102

2

2

1

<0.01

2

0.998

0.227

2

1

<0.01

2

1

<0.01

2

2

1.175

0.379

2

0.651

0.032

0.075

2

0.855

2

0.087

2

0.979

0.04

2

0.86

0.233

0.646

0.801

2

2

0.726

0.096

2

0.773

0.057

2

0.778

0.026

0.398

0.019

2

2

0.345

0.101

2

0.461

<0.01

2

0.444

0.041

2

D1 (nM PTH)

1000 +
10 µM H89
D4 (nM PTH)

1000 +
10 µM H89

Overall, ColX, PTHrP and IHH expression decreased with PTH treatment on D1
and ColX and PTHrP expression decreased with PTH treatments on D4. The expression
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of PTH1r showed slight decreases

Hypertrophic Ratio
ColX/Col2

in expression on D1 and D4 with

0.6
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PTH treatments, but changes were
0.4
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not significant.
3.3.3.1.3. FISH Analysis
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Fig. 3-12. FISH analysis to examine hypertrophy over time
with increasing PTH treatment. The fraction of ColX positive

the distribution of gene expression
of chondrocytes cultured with no
PTH treatment (NT) or with 10,
100, or 1000 nM PTH in ALG and

cells compared to the number of nuclei by a DAPI count and
the count of Col2 positive cells to number of nuclei was
calculated and the ratio of the fraction of ColX positive cells
to Col2 positive cells was reported.

to explore the ColX/Col2 ratio that
is indicative of hypertrophy. To
better understand the rate of

hypertrophy within the system, the ratio of ColX to Col2 expression was determined
through image analysis and is reported in Fig. 3-12. On D1, the ColX/Col2 ratio slightly
decreased with increasing PTH treatments, but no changes were significant. On D4, a
trend of decreasing ColX/Col2 ratio with increasing PTH concentration, with the
exception of cells treated with 10 nM PTH, was observed. The lowest ratio of ColX to
Col2 was almost 0.04 for 1000 nM PTH on D4. However, no statistically significant
differences were observed over time or with treatments.
3.3.3.2. IHH
3.3.3.2.1. FACS analysis
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To explore the effect of

Cell Cycle Distribution

IHH on chondrocytes

D1

encapsulated in alginate
hydrogels in culture, media

D4

100

100

80

80

concentration of 0 (NT) or,
0.05, 0.5, or 5.0 nM IHH for

Percent (%)

was supplemented with a
60

G2M
S
G0G1

60

40

40

20

20

0

0

cycle status. Fig. 3-13 shows
the cell cycle distribution of

nM IHH

00
5.

50
0.

T

0

05
0.

N

D

5.
00

0.
50

T

D

0

overall distribution of cell

N

was used to visualize the

0.
05

up to 4 days. FACS analysis

nM IHH

Fig. 3-13. FACS analysis of cell cycle of chondrocytes encapsulated

chondrocytes with treatments

in ALG with IHH treatments on D1 (left) and D4 (right). D0 is

and Table 3-6 outlines the

representative of chondrocytes that were encapsulated in ALG and
immediately processed for FACS, NT is representative of cells that

specific values for each cell

were encapsulated and cultured with no treatment and 0.05, 0.5 and

cycle state, the associated

5.0 represent cells cultured with that concentration of IHH

errors with the replicates and

supplemented in the culture media.

the number of replicates.
On D0, the overall distribution of cell cycle was approximately 84%:8%:8%
(G0G0:S:G2M) and all treatment groups were compared to D0 or to NT on that day. On
D1, there were significant treatment effects observed (P< 0.0001), and when compared to
D0, G0G1-phase for NT and treatment with 0.05, 0.5 and 5.0 nM IHH were all
significantly decreased (P< 0.05, 0.001, 0.01, and 0.01, respectively). When comparing
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the combination of S and G2M phases across treatment groups, the amount of cells in
these proliferative phases was statistically greater with IHH treatments: treatment with
0.05, 0.50 and 5.0 nM IHH demonstrated more cells in S and G2M phases (P< 0.01, 0.01
and 0.05, respectively). Overall on D1, cells desplayed a cell cycle distribution of
increased amounts in G2M and S phaes and decreased amounts in G0G1 phases with
IHH treatment.
Table 3-6. Cell cycle distribution by FACS analysis. Reported in this table are the geometric means with SEM
and replicate number for each treatment group.

Phase

G0/G1

S

G2/M

Mean

SEM

n

Mean

SEM

n

Mean

SEM

n

D0
D1 (nM IHH)
NT
0.05
0.5
5
D4 (nM IHH)
NT
0.05
0.5

83.61

0.245

4

8.145

0.284

4

8.219

0.214

4

75.42
69.42
69.9
73.49

1.81
4.58
4.575
3.986

4
2
2
3

9.49
14.66
14.8
11.49

1.183
3.895
3.665
3.539

4
2
2
3

14.68
15.25
14.68
13.8

1.135
0.68
0.915
0.642

4
2
2
3

75.42
47.05
49.21

1.18
-

4
1
1

9.49
19.93
16.81

1.183
-

4
1
1

14.68
33.03
34.61

1.135
-

4
1
1

5

44.63

3.56

2

29.57

0.435

2

25.46

3.13

2

When compared to D0, the amount of cells in G0G1 phase on D4 for NT and for
treatment with 5.0 nM IHH were significantly decreased (P< 0.01 and 0.001,
respectively). When observing changes in the percent of cells in the combination of S and
G2M phases, significant increases were observed in cells with NT and with cells with 5.0
nM IHH treatment (P< 0.01 and 0.0001, respectively) when compared to D0, and
treatment with 5.0 nM IHH revealed significant increases (P< 0.0001) in cells in these
phases when compared to NT. A trend of increased amount of cells in G2M and S phases
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and a decrease in G0G1 phases were observed with 0.05 and 0.5 nM PTH treatments, but
significance could not be calculated with 1 replicate. Overall on D4, the percent of cells
in G0G1 phase decreased significantly with the highest dose of IHH, and the amount of
cells that were in S or G2M phase on D4 was significantly different from D0 and NT.
3.3.3.2.2. Transcript expression
ddPCR was utilized to explore changes in gene expression with treatment with
IHH. Fold changes in gene expression are tabulated in Table 3-7. All transcript data
reported are only an n of 1, so statistically significant differences could not be calculated.
First, the ratio of the fold change in transcript counts for Col2 to the fold change in
transcript counts for Col1 was determined to ensure significant dedifferentiation did not
occur within the culture system. Fig. 3-14 shows the results for this dedifferentiation
ratio. While some differences in
this ratio were observed, no

3.5

decreases in the ratio were seen
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decreased with increasing IHH treatment, while cells cultured with NT showed similar
gene expression as chondrocytes cultured with treatment with 0.05 nM IHH. On D4,
ColX expression in the NT group decreased dramatically when compared to non-treated
cells on D1, while treatment with 0.05, 0.5 and 5 nM IHH on D4 caused similar decreases
in ColX expression when compared to cells cultured with NT on both D4 and D1.
Studying the fold change in expression of PTHrP (Fig. 3-15B), decreases in
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Fig. 3-15. Gene expression of chondrocytes cultured in ALG over time with no treatment (NT) or treatment
with 0.05, 0.5 or 5.0 nM IHH. Data are reported as fold changes over a D0 (not shown). Fold changes are
shown for A) ColX, B) PTHrP, C) PTH1r and D) IHH.

98
expression relative to NT were observed on D1 in cells cultured with treatment with 0.05,
0.5 and 5.0 nM IHH. On D4, an elevation of expression of PTHrP compared to cells
cultured on D1 in cells encapsulated in ALG and treated with or without IHH. While
observing changes in transcript expression of PTH1r (Fig. 3-15C), it was observed that
transcript expression in cells cultured in ALG with NT on D1 was elevated compared to
cells treated with IHH on D1. As the concentration of IHH increased, the fold change
decreased when compared to NT. On D4, the expression of PTH1r was decreased in all
groups when compared to D1, and was elevated in chondrocytes treated with 0.05, 0.5
and 5.0 nM IHH when compared to the NT D4 control.
Finally, while studying changes in transcript expression of IHH (Fig. 3-15D) in
chondrocytes cultured in ALG with or without exogenous IHH treatments, it was
observed that expression in NT on D1 was elevated compared to treatment with IHH on
D1. As the concentration of IHH increased, the fold change in IHH transcript expression
decreased from the NT on D1. On D4, the expression of IHH was elevated in
chondrocytes cultured with 0.05, 0.5 and 5.0 nM IHH treatments when compared to both
the NT on D4 and IHH treatments on D1. Overall, when compared to NT, the expression
of ColX decreased on D1 with increasing IHH concentration and the same is true on D4.
The expression of PThrP was elevated on D4 when compared to D1 with no dose
dependence. PTH1r expression decreased with increasing IHH treatment on D1 when
compared to NT and was decreased in all groups on D4 when compared to D1. The
expression of IHH on D1 shows lower expression with higher IHH treatment when
compared to NT, and on D4 IHH expression slightly increased with IHH dose.
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Table 3-7. Fold change in transcripts of genes of interest as compared to the D0 NT of each column. Reported
in this table are the geometric means with SEM and replicate number for each treatment group.

Target Gene
D1 (nM PTH)
D0 NT
NT
0.05
0.5
5
D4 (nM PTH)
D0 NT
NT
0.05
0.5
5

Col1

Col2

ColX

PTHrP

PTH1r

IHH

Mean

SEM

n

Mean

SEM

n

Mean

SEM

n

Mean

SEM

n

Mean

SEM

n

Mean

SEM

n

1
0.441
0.434
0.559
0.603

0.011
0.006
0.02
0.022
0.014

1
1
1
1
1

1
0.924
0.748
1.051
0.802

0.05
0.036
0.01
0.064
0.021

1
1
1
1
1

1
0.941
0.998
0.615
0.409

0.019
0.009
0.017
0.01
0.002

1
1
1
1
1

1
4.672
5.018
4.51
3.025

0.01
0.02
0.031
0.031
0.076

1
1
1
1
1

1
2.86
2.613
2.526
1.686

0.015
0.058
0.099
0.046
0.051

1
1
1
1
1

1
1.414
1.056
0.603
0.605

0.04
0.078
0.072
0.014
0.025

1
1
1
1
1

1
0.841
0.947
0.686

0.054
0.077
0.126
0.054

1
1
1
1

1
2.588
1.091
1.089

0.014
0.043
0.033
0.032

1
1
1
1

1
0.288
0.316
0.237

0.019
0.005
0.009
0.003

1
1
1
1

1
10.94
11.84
11.54

0.092
0.274
0.196
0.304

1
1
1
1

1
1.616
2.018
2.054

0.016
0.022
0.057
0.043

1
1
1
1

1
1.168
1.448
1.388

0.033
0.045
0.026
0.031

1
1
1
1

0.991

0.042

1

1.534

0.025

1

0.315

0.007

1

10.62

0.152

1

1.931

0.03

1

1.659

0.036

1

3.3.3.2.3. FISH analysis
FISH was used to visualize the distribution in gene expression of chondrocytes
cultured in 0 (NT), 0.05, 0.5 and 5.0 nM IHH and to explore the ColX/Col2 ratio that is
indicative of hypertrophy (Fig.
3-16). Note that no data are
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Fig. 3-16. FISH analysis to find ratio of the count of Col2
positive cells to the count of ColX positive cells between
D1 and D4 in ALG with varying IHH treatments.

was observed with NT, 0.50 and
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5.0 nM IHH having ratios of 0.22, 0.64 and 0.19, respectively. No statistically significant
differences were observed over time or with treatments since every treatment had an n of
1 besides NT, which was an n of 3.
When determining ratios using FISH, it was noted that encapsulation in ALG with
treatment of 0.5 nM IHH on D4 revealed spatially differential gene expression
throughout the bead (Fig. 3-17). Fluorescent probes show that ColX (Fig. 3-17A)
expression was denser around the outer edge of the ALG bead and Fig. 3-17B shows the
same bead section with nuclei stained for DAPI in order to normalize to an overall cell
count to inform of the proportion of total cells that were expressing ColX. In Fig. 3-17C,
fluorescent probes showed Col2 expression was denser in the center of the ALG bead and
Fig. 3-17D showed the same bead section with nuclei stained for DAPI to inform of the
proportion of total cells that were expressing Col2. Images were annotated for
clarification: the outer white dotted oval indicates the outline of the alginate bead and the
inner white dotted oval indicates where the “inner” and “outer” sections of the beads
were separated when measuring the density of cells positive for the target probe. To
quantify the difference in the amount of cells expressing the target gene in the inner or
outer portion of the bead, image analysis was utilized and Fig. 3-17E shows that the ratio
of ColX positive cells that were situated within the “outer” portion of the bead was higher
than the ratio of ColX positive cells that were situated in the “inner” portion of the bead.
Conversely, Fig. 3-17E shows that the ratio of Col2 positive cells that were situated in the
“inner” portion of the bead was higher than the ratio of Col2 positive cells situated in the
“outer” portion of the bead, suggesting that with IHH treatment and over time ColX was
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more highly expressed on the outer portion of the bead while Col2 was more highly
expressed by chondrocytes encapsulated further inside the alginate bead.
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Fig. 3-17. FISH visualization of A) ColX and corresponding B) DAPI, and of C) Col2 and corresponding D)
DAPI. Scale bar is 200 µm. E) Ratio of ColX and Col 2 positive cells to a nuclei count (DAPI) using image
analysis to show differences in cells positive for ColX or Col2 in radially defined regions.

3.4. Discussion and Conclusion
The overarching goal of this study was to develop a 3-D chondrocyte culture
system using alginate hydrogels that can be used to investigate the mechanisms behind
the formation of distinct zones within the growth plate. The first objective was to explore
the effect of scaffold material on chondrocyte behavior by encapsulating primary growth
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plate chondrocytes in either ALG or RGD-modified ALG hydrogels. The second
objective was to use the unmodified ALG scaffold to culture chondrocytes in treated
media to explore the effect of PTH or IHH on chondrocyte behavior. Live/Dead staining
was applied to ensure that chondrocytes can survive encapsulation, IF was used to
visualize matrix deposition in the scaffolds, FACS was performed to observe any changes
in the cell cycle distribution, ddPCR was utilized to monitor gene expression changes,
and FISH was employed to study the distribution of gene expression throughout the bead
constructs.
Within the field, in vitro culture of growth plate chondrocytes has been a longstanding goal since 1965, when Chesterman et al. explored methods to expand a supply
of primary chondrocytes using monolayer culture conditions [150, 156]. However, since
then it has been well established that two-dimensional (2-D) culture of chondrocytes
leads to a loss of chondrocytic phenotype and dedifferentiation over time [148, 149].
More recently, attempts have been made to avoid this characteristic dedifferentiation by
culturing growth plate chondrocytes in 3-D in vitro by using either suspension cultures,
pellet cultures or by culturing chondrocytes in biomaterial scaffolds [103, 150, 151].
Within this current study, Alginate (ALG) was used to develop a 3-D in vitro
culture model to study growth plate cartilage development, as it has been widely used in
tissue engineering and has also been thoroughly characterized for its use in articular
cartilage engineering [157]. ALG has previously been employed in the culture of growth
plate chondrocytes as well; it has been shown that not only does culturing growth plate
chondrocytes in ALG allow for the maintenance of a chondrogenic phenotype, but also
that dedifferentiated human chondrocytes undergo redifferentiation when cultured in
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ALG beads [158]. The use of ALG as a scaffold for chondrocyte culture has many
advantages that include mild gelation conditions, fluid diffusion of nutrients and wastes
into and out of the construct, non-fouling properties and accessible functional groups for
modifications [35]. In this study, we aimed to use the alginate scaffold to explore the
effects of specific signaling factors known to play a role in zonal arrangement of
chondrocytes. We aimed to use these factors to elicit a quantifiable response in the
chondrocytes, in order to use the forthcoming information to build our culture model. To
begin, we first explored how cell interaction with the hydrogel matrix in vitro affected the
chondrocyte phenotype. To do this, we modified the alginate molecule with the celladhesion ligand, RGD.
One of the main responsibilities of growth plate chondrocytes is to produce an
ECM that is characteristic of each particular zone of the growth [139]. Most of the matrix
proteins secreted throughout development are collagens and sulfated proteoglycans that
act as a substrate for cellular adhesion via integrin binding, resulting in signal
transduction cascades that lead to distinct chondrocyte behaviors [139, 140]. While the
majority of the secretory proteins within the growth plate are collagens, it has also been
shown that the growth plate contains molecules such as fibronectin (FN) and osteopontin
that are involved in cell adhesion via integrin binding with the RGD sequence within
these proteins [159]. In the present study, in order to recapitulate the cell adhesion aspect
of the growth plate and to explore the effect of integrin binding and cell adhesion on
chondrocyte behavior, the RGD peptide was covalently conjugated to the ALG molecule
before encapsulation.
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It has been previously shown that cell adhesion and integrin binding are essential
not only to survival and morphology, but also to the function of chondrocytes specifically
within the resting and proliferative zones of the growth plate [142, 143]. It was shown
that when growth plate chondrocytes were seeded onto substrates coated in Col1, Col2 or
FN, cell spreading occurred, but if the cells were treated with free RGD peptide,
spreading was completely reversed and proliferation decreased suggesting that the
adhesion properties of proteins within the growth plate such as Col1, Col2 and FN which
contain RGD are due to both β-1 integrin interactions and to mechanical stimuli due to
these interactions that may be linked to proliferative capacity [160]. Furthermore, Aszodi
et al. demonstrated that when the beta-1 integrin was knocked out of mice, proliferative
zone chondrocytes did not flatten and were still very large and round and proliferation
was reduced, indicating the necessity of this integrin binding for differentiation from
immature to mature, hypertrophic chondrocytes [142]. It follows then that the lack of
maturation seen in the proliferative chondrocytes of the β -1 knockout mouse towards
hypertrophy could be because of the chondrocyte’s inability to anchor to the surrounding
ECM. Additionally, the lack of maturation could have been caused by of actin
rearrangement that would normally be signaled by an activation of the β -1 integrin. In
the present study, it was shown that both Col4 and Col6 were deposited over time in both
ALG and RGD scaffolds. However, differences were observed in the IF analysis of
chondrocytes cultured in ALG and RGD-modified ALG hydrogels. Chondrocytes
cultured within RGD gels exhibited potential actin filament formation and organization
(Fig. 3-4), while cells in ALG showed less organization of F-actin, resembling disrupted
actin filaments. A lack of organization of actin in a hydrogel with no cell adhesion
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functionality would be consistent with the previous results that demonstrated that without
integrin activation of downstream signaling, rearrangement of actin during proliferation,
hypertrophy, or simply cell spreading was disrupted resulting in punctuated actin
distribution [142]. While this is only qualitative data, a more detailed examination of
integrin binding could be performed using IF by specifically targeting focal adhesions or
even integrin receptors themselves. The extent of actin formation could also be quantified
over many IF images using image analysis software.
In order to explore changes in cell cycle distribution between the two scaffold
types (i.e. ALG and RGD modified alginate), FACS was performed. The cell cycle is
exquisitely regulated and is characterized by several sequential phases. Cells are either in
G0, where they are quiescent or they pass through an initial growth phase (G1) of the cell
cycle before entering into S phase, where DNA is replicated in preparation for another
obligatory round of cell division (G2M) [161]. While there were no statistically
significant differences in cell cycle distribution over time in ALG, a more pronounced
trend of decreasing amount of cells in G0G1 with a compensation and significant
increase in the amount of cells in the S and G2M phases was observed. A decrease in the
percent of cells in G0G1 indicates less of the cells are arrested, while more and more
cells are synthesizing DNA and are going through mitosis, indicating an increase in
proliferation [162]. An increase in proliferation in cells encapsulated in RGD follows
with the previous description that if the β-1 integrin receptor is not activated, proliferation
is halted, but proliferation, differentiation and maturation should continue with RGD
interaction with the β -1 integrin [142]. The proliferative cell cycle distribution along
with the observations noted with the IF images would suggest that culture in RGD gels
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allows for cell-matrix interactions potentially by β-1 integrin binding, which supports
maturation and proliferation of growth plate chondrocytes over time.
Observing changes in gene expression of Col2 with respect to Col1 in
chondrocytes cultured in vitro can elucidate any potential dedifferentiation that is taking
place. Chondrocytes in the resting and proliferative zone of growth plate express Col2
abundantly, providing the framework for the tissue growth and the structural stability to
withstand compression [163]. However, it has been shown that when chondrocytes
dedifferentiate in vitro, a shift from Col2 expression to Col1 expression occurs, causing
the ratio of Col2/Col1 to decrease [164] [165]. One of the main advantages to culturing in
3-D and in ALG hydrogels is the ability to avoid dedifferentiation in culture, but a check
of this ratio ensures proper functioning of the chondrocytes. The ratio of the fold change
of Col2 to the fold change in Col1 (Col2/Col1 ratio) should be 1 if no changes are
observed in differentiation status. In cells encapsulated in ALG, the Col2/Col1 ratio
decreased slightly over time, which could indicate dedifferentiation. On the other hand,
the Col2/Col1 ratio was elevated compared to at all time points in RGD when compared
to all time points of ALG, indicating the chondrocytes encapsulated in RGD did not
dedifferentiate in culture over time. However, it is important to note that there are no
statistical differences between scaffolds or over time in the Col2/Col1 ratio, which
supports studies that show no dedifferentiation when culturing chondrocytes in ALG
hydrogels [142].
When examining differences in the expression of other gene transcripts, similar
trends were observed between alginate and RGD. Typical gene expression patterns of
different zones of the growth plate as described by Kozhemyakina et al. show that ColX,
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PTH1r and IHH are expressed primarily in the pre-hypertrophic and hypertrophic zones.
The decrease observed in the expression of these in this current study over time suggests
the behavior of growth plate chondrocytes encapsulated in either ALG or RGD is less
hypertrophic, or more immature and proliferative [89]. Additionally, since PTHrP is only
expressed in the immature resting zone chondrocytes and its expression signals a block of
maturation (Fig. 1-5B), the slight increase in its expression of PTHrP over time suggests
that culture in ALG or RGD promotes a more immature and less hypertrophic phenotype
supporting the conclusion drawn from ColX, PTHrP and IHH downregulation [14, 166].
Gene expression data was also analyzed by FISH analysis, which demonstrated a
difference between ALG and RGD cultures. Previously, most FISH analyses were
performed on intact tissue, and Bengtsson et al demonstrated in 2005 that probes for Col2
and for ColX could be used to visualize hypertrophic and proliferative and resting zones,
respectively [167]. However, a protocol for FISH in ALG hydrogel beads had to be
optimized utilizing acrylamide infiltration for stability through processing. As previously
stated, a decrease in ColX expression suggests the suppression of hypertrophy, but Col2
is expressed everywhere in the growth plate until hypertrophy begins [89]. Therefore, if
ColX decreases and Col2 increases, the ratio of ColX to Col2 the two would decrease,
indicating an increase in hypertrophy, with the converse being true as well. The data
gathered from FISH image analysis demonstrated a slight decrease in the ColX/Col2 ratio
over time in ALG, suggesting a slight increase in hypertrophy in ALG, while a slight
increase is shown in RGD over time, suggesting a slight decrease in hypertrophy in RGD
over time.
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Culturing chondrocytes in ALG scaffolds provided a feasible method to maintain
a 3-D architecture for long-term culture while avoiding excessive, if any
dedifferentiation. FACS analysis showed no significant change in cell cycle distribution,
and gene expression indicated a more resting zone phenotype with increased PTHrP
expression and decreased ColX, PTH1r and IHH expression over time and a slight, nonsignificant decrease in the ColX/Col2 ratio. When presenting the RGD ligand to 3-D
cultured chondrocytes, differences in actin morphology were observed, cell cycle
distribution indicated an increased amount of cells in a proliferative state over time, and
transcription expression and distribution showed low ColX, decreased PTH1r and IHH
expression with slightly increased PTHrP expression, and a ColX/Col2 ratio that is not
significantly different over time all add to the conclusion that RGD guided chondrocytes
toward a less hypertrophic, more proliferative phenotype that resembled the proliferative
zone more than the resting zone [142, 160, 165].
In order to continue to explore the ability of this system to be used as a tool to
explore the mechanisms behind zonal arrangement, signaling molecules were introduced
to the culture media. To begin, the effect the addition of PTH as well as the effect of the
combination of PTH with the PTH inhibitor H89 to the culture media was explored. As
previously stated, periarticular resting zone cells secrete PTHrP, which diffuses through
the growth plate to produce a gradient of signaling activity, and it has previously been
shown that PTHrP/PTH signaling suppresses the rate of hypertrophy, keeping immature
chondrocytes in a more proliferative or resting zone state [144, 145]. Additionally, it has
been shown that the loss of PTHrP expression in the mouse growth plate lead to
shortened limbs and the loss of the proliferative zone, with most cells becoming
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prematurely hypertrophic [144]. The converse is also true: it has been shown that
treatment of chondrocytes with PTH leads to the delay in hypertrophy along with an
increase in proliferation, while Col2 expression remains unchanged [168]. In our culture
system, when encapsulated chondrocyte were treated with PTH, significant differences in
cell cycle distribution were observed both between PTH doses and between days. An
overall decrease in the percent of cells in G0G1 phase suggests more cells are
synthesizing DNA and moving on to mitosis or are exiting the cell cycle, which is
indicative of an increase in the percentage of cells that are proliferating, supporting
previous in vitro data [169]. Additionally, slightly less of a decrease in the percent of
cells in G0G1 was seen when the H89 inhibitor was included with PTH treatment, which
indicates that the effect of PTH can be negated using a known PTH inhibitor, further
suggesting the specificity of PTH. Again, to be sure chondrocytes were not
dedifferentiating in culture with PTH treatment, the Col2/Col1 ratio was measured. There
were no significant differences between treatments or days and these results follow
closely with studies that showed that PTH treatment in 3-D culture did not disrupt
chondrogenesis [168].
When examining gene expression, as predicted and described in studies of
growth plate chondrocytes cultured in the presence of increased PTH concentrations, the
expression of ColX was significantly lower in cells within ALG treated with PTH than
the non-treated control, suggesting a suppression of hypertrophy, which was observed on
both days of culture. It then follows that because the chondrocytes were being treated
with PTH, the endogenous expression of PTHrP was significantly less than the untreated
control on both D1 and D4.
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Similarly, the expression of transcripts for the receptor for PTHrP decreased with
PTH treatment, which could be explained by the receptor sites being utilized at full
capacity due to the increased PTH molecules present leading to the downregulation of the
PTH receptor. Additionally, PTHrP is an inhibitor of IHH, and it has been shown that the
activity of PTH is comparable to that of PTHrP [166]. In this study, a significant decrease
in IHH expression was observed by D1; both ColX and IHH are mostly found in the
prehypertrophic and hypertrophic zones of the growth plate, and it was to be expected
that if chondrocytes were treated in culture with PTH, a decrease in in the gene
expression for both ColX and IHH would be observed, which is true of our culture
system. Additionally, the distribution of gene expression throughout the ALG construct
was studied using FISH, which showed that treatment with a high dose of PTH had a
slight effect on the attenuation of maturation of chondrocytes on D1 and on D4, Other
factors besides PTH are involved in the growth plate and to further explore the role of the
PTHrP/IHH feedback loop in vitro, the addition of IHH to the culture system was
explored.
IHH is expressed in the prehypertrophic zone of the growth plate and it has been
suggested that IHH in conjunction with PTHrP provide the necessary cues to induce
zonal arrangement. To explore the specific role of IHH in chondrocytes cultured in vitro
in ALG, IHH was added to the culture media and changes in cell cycle and gene
expression were observed. On D1, no significant differences were seen in cell cycle
distribution with IHH treatments, but by D4, a more proliferative gene expression
distribution was seen suggesting the effects of IHH treatment become evident after longer
culture periods, and the proliferative cell cycle distribution could be explained by IHH
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stimulating PTHrP, leading to more proliferation. The addition of IHH to the culture
media resulted in increased PTHrP expression on both D1 and D4, which follows with
the current PTHrP/IHH feedback loop model, and as depicted in Fig. 3-1, PTHrP blocks
further IHH expression, but IHH signaling pathways stimulates PTHrP expression [170].
Therefore, it follows that the introduction of exogenous IHH to the culture constructs
would increase the expression of PTHrP since any inhibitory effect of PTH on IHH is not
relevant when the IHH in the media [92]. Finally, using FISH to visualize the entire
chondrocyte bead, preliminary studies have shown the ability to induce differential gene
expression in chondrocytes encapsulated in ALG and treated with IHH. Two theories to
explain why differential gene expression was observed are possible. First, the IHH
molecule is larger than the other factors mentioned in this study, as the MW of PTH is 4
kD and IHH is around 20 kD. It has been described that in ALG beads, molecules smaller
than 70 kD but greater than 10 kD diffuse through ALG more slowly than smaller
molecules, so it then follows that the diffusional characteristics of IHH could be slower
and more hindered through ALG than molecules like PTH [154]. The encapsulated
chondrocytes on the periphery of the bead would then encounter more IHH molecules
than those in the inner bead, resulting in differential gene expression within the scaffold.
However, over many hours in culture, it is likely that IHH had diffused throughout the
bead construct [154]. Therefore, if the entire construct is exposed to IHH, then the
chondrocytes must be upregulating the production of PTHrP endogenously [136]. The
PTHrP produced by the cells on the periphery of the bead can readily diffuse away, while
in the center of the bead, PTHrP can diffuse to interact with surrounding chondrocytes,
creating a zone of PTHrP inhibition of IHH, which may lead to the increase of Col2 and
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the decrease of ColX in the center of the bead and the opposite in the outer part of the
bead. The next step to understanding more about this system is to utilize an IHH inhibitor
to probe for specific pathways that can elucidate the specific mechanisms at work in this
condition.
In conclusion, in this study we have defined a system that allows for the
modulation of biomaterial scaffold and culture conditions in order to modulate the cell
cycle distribution, maturation and differentiation, and activate the PTHrP/IHH signal loop
by using soluble factors to control hypertrophy with growth plate chondrocytes in vitro.
The ability of ALG and RGD-modified ALG to provide a suitable supporting scaffold for
chondrocyte culture in vitro was confirmed by the lack of dedifferentiation in either
culture system. Additionally, it was suggested that RGD tended to promote a proliferative
phenotype while ALG also promoted an immature, resting zone phenotype. The inclusion
of PTH into the culture media also resulted in a proliferative, less hypertrophic phenotype
of encapsulated chondrocytes indicated by characteristic gene expression and cell cycle
distributions. By utilizing ALG hydrogels and the addition of IHH to the culture media,
we have observed differential areas of highly hypertrophic chondrocytes surrounding an
area of less mature chondrocytes- a promising first step to designing a multi-zonal,
functioning culture model to elucidate mechanisms behind growth plate development.
Future studies will include the testing of other factors such as Thyroxine [102, 136] and
Nogin [171] to explore the effect that culture in ALG has on the receptiveness to factor
manipulations. The overall success in building an in vitro culture model of the growth
plate will give developmental biologists and engineers another tool to probe more
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information about the mechanisms of zonal arrangement and columnar architecture and
for future therapies.
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CHAPTER 4- Future Directions and Conclusions

4.1. Introduction
In this thesis, alginate hydrogels were explored and optimized as scaffolds used
for in vitro culture models of tissue development. Because of the demonstrated ability of
alginate hydrogels to be manipulated to control shape, mechanical properties and
biological activity, alginate hydrogels were specifically utilized as a scaffold for an in
vitro culture model to study porcine embryo elongation and for the study of growth plate
cartilage development. First, the ability of alginate hydrogels to facilitate the process of
pig embryo elongation was validated by this study, but furthermore these hydrogels were
used to explore the effects of known uterine factors on elongation via integration of those
factors into the culture system by the incorporation of SPP1 into the hydrogel, as well as
the chemical modification of the alginate with RGD. Next, alginate hydrogels were
employed for the encapsulation of growth plate chondrocytes with the goal of designing
an in vitro culture model of growth plate cartilage development. We demonstrated the
ability to characterize the response of chondrocytes both to unmodified and RGDmodified alginate encapsulation and were able to use the alginate culture system to
present the soluble factors PTH and IHH in order to observe and visualize changes in
gene expression to compare to zones found in native growth plate cartilage.
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4.2. Future directions for the in vitro porcine embryo elongation model
An alginate in vitro culture system was developed and utilized in Chapter 2 to
mimic the native uterine environment and to allow for specific factors to signal to
developing porcine embryos, facilitating survivability and morphological changes in base
media. Not only did these studies validate previous studies using alginate hydrogels [9] in
their effectiveness of facilitating survival and morphological changes, but also the
modifications to the scaffold system outlined Chapter 2 (i.e. RGD conjugation to the
alginate molecule) enabled a significant increase in survivability when compared to
CONT embryos, which had not yet been reported. Additionally, RGD encapsulation
continued to support elongation, allowing for significant increases in the percentage of
embryos that underwent morphological changes when compared to both ALG and SPP1
encapsulation. Furthermore, characteristic behaviors of elongation such as an increase in
E2 production and steroidogenic transcript expression consistent with trends seen in
elongating in vivo produced embryos [9]. This improvement demonstrated the ability to
incorporate factors into the scaffold design, providing a tool to elucidate mechanisms
involved in the promotion of elongation. Further improvements upon and usage of this
model by both investigating molecular changes initiated by the interaction with these
factors and by the combination of modified alginate scaffolds with soluble factors should
be made moving forward. The following approaches are recommended as the next steps:
1) investigate the effect of the addition of factors to the culture media on survivability,
rate of occurrence of elongation and corresponding changes in gene expression and
protein production in vitro, as well as the effect of the combination of these soluble media
factors with the RGD-modified scaffold; 2) evaluate the differential effect of culture
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within alginate and SPP1 or RGD on the metabolomic or proteomic profile elongating
embryos produced both in vivo and in vitro; 3) investigate the effect of the group culture
of encapsulated embryos within the same culture dish on survivability, elongation and
corresponding metabolic changes. Each of these approaches is described in greater detail
below.
First, the addition of factors to the basal culture media known to be upregulated
within the uterine environment during early pregnancy such as transforming growth
factor β (TGFβs) or fibroblast growth factor 7 (FGF7) should be evaluated to explore
their individual effect on elongation, [172]. TGFβs are synthesized in the endometrial and
conceptus tissues and levels increase with the progression through elongation and
transplantation [172]. TGFβ can positively regulate molecules associated with cell
adhesion, like SPP1, which can in turn direct cell attachment and therefore cross talk
between the conceptus and the uterine lining [173]. It has been shown that alterations in
the expression of TGFβs can affect the interaction between the conceptus and the uterus.
For example, Caniggia et al. used antibody inhibition of TGFβ to study trophoblast
differentiation toward an invasive phenotype, which is critical to the preparation for
implantation of embryos [174]. It was reported that embryos exposed to elevated levels of
TGFβ maintained an immature state of differentiation, delaying trophoblast implantation
and placental invasion of the uterus [174]. Other studies have shown that
supplementation with TGFβ or similar factors such as EGF during in vitro maturation
might improve maturation of oocytes, thus resulting in an increased developmental
competence of fertilized eggs in sheep, and pigs [175, 176]. Others have shown that in
normal trophoblast cells, TGFβ inhibits proliferation [177]. Conversely, by inhibiting the
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Fig. 4-1. Representative images of embryos cultured with or without encapsulation or TGFβ
from 0 h to 96 h. C-0) Image of control embryo cultured without encapsulation in alginate or
TGFβ is represtative of all surving control embryos with or without TGFβ. 0-10) Images
represent embryos encapsulated in alginate without TGFβ, with 0.1, 1.0 or 10 ng TGFβ/mL
media respectively.

reception of TGFβ in embryos, a switch to the differentiative/invasive phenotype was
observed via in situ hybridization and transcript expression, indicating that without
TGFβ, embryos begin to differentiate prematurely, potentially suppressing elongation or
promoting implantation before sufficient elongation can occur [174]. These studies
suggest that a specific level of TGFβ is crucial during the pre- and peri-implantation
period of gestation, and exploring the effect this particular factor has on the elongation of
porcine embryos in vitro using our alginate system can provide useful knowledge on the
mechanisms behind the success or failure of elongation.
Preliminary studies have been performed to evaluate the effect of TGFβ on
embryo survivability and elongation within the in vitro alginate hydrogel culture system.
Using the same method described in Chapter 2, D9 porcine embryos were either
encapsulated in ALG (ALG) or were not encapsulated (C) and were cultured for 96h with
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the addition of the following concentrations of TGFβ in the culture media: 0, 0.1, 1.0 or
10 ng TGFβ/ mL media. Representative images of embryos from all encapsulated
treatment groups and from a non-encapsulated control group are shown in Fig. 4-1.
Results from these studies indicated that not treating with TGFβ promoted the greatest
survival in both the encapsulated and the non-encapsulated embryo groups (75%, 66%
respectively), but with positive survival rates (> 40%) in all treatments as shown in Fig.
4-2A and Table 4-1. In our previous studies, we have seen increases in survivability by
encapsulating in ALG while culturing in basal media, and it might have been expected to
see increases in survivability with growth factors such as TGFβ added to the basal culture
media, as previous studies in mice have shown that in vitro culture with the addition of
growth factors partially reduced apoptosis leading to greater survival [178]. However, in
our system we see a decrease in survivability in encapsulated embryos with the addition
of TGFβ. The mechanisms behind the negative effect of TGFβ should be explored further
by studying apoptosis via propidium iodide and Hoechst to visualize fragmented DNA as
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explained by Brison et al [178]. As seen previously in the literature and in Chapter 2, no
morphological changes were observed in non-encapsulated embryos, but encapsulation in
alginate hydrogels allowed for elongation to take place with details tabulated in Table
2-1. When treated with TGFβ, the concentration in the media of 1.0 ng/mL induced the
greatest percentage of embryo morphological changes from all embryos (50%; Fig. 4-2B)
and from surviving embryos (100%; Fig. 4-2C), while as shown in Chapter 2, the greatest
percentage of embryos undergoing morphological changes was 24% of all embryos and
56% of the surviving embryos that were encapsulated in RGD-modified ALG hydrogels.
The increase in the percentage of embryos that undergo elongation with TGFβ
supplementation in these early preliminary studies suggest that TGFβ plays a significant
and opposing role in the rate of survival of the embryo and the rate of elongation of the
embryo in culture, perhaps even greater than that of SPP1 or RGD explored in Chapter 2.
Table 4-1. Summary of embryo survival and morphological changes observed after 96 hours of culture of
alginate encapsulated embryos and non-encapsulated control (C) embryos with TGFβ incorporated in the
culture media.
TGFβ
Treatment

Total Embryos

Embryo
Survival (n)

Embryo
Survival (%)

(ng/mL)

M orph Change M orph change M orph change
from all
from surviving
embryos
(%)
embryos (%)
(n)

C-0

3

2

66.67%

0

-

-

C-0.1

2

1

50.00%

0

-

-

C-1.0

2

1

50.00%

0

-

-

C-10

2

1

50.00%

0

-

-

0

8

6

75.00%

3

37.50%

50.00%

0.1

8

5

62.50%

2

25.00%

40.00%

1

8

4

50.00%

4

50.00%

100.00%

10

8

3

37.50%

1

12.50%

33.30%

These results support the results of other studies that show that mouse embryos
without smad2, a receptor of TGFβ, fail to produce normal extraembryonic membranes
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leading to disruptions in development, suggesting a role in pre-implantation development
and perhaps in elongation for TGFβ [179]. The present study with TGFβ has only been
performed once, and additional replicates are necessary for validating this response.
Additionally, the effects of combining successful treatment groups (e.g. RGD
encapsulation with TGFβ in the media) should be explored to investigate if the
combination of more than one treatment can lead to even greater success in rate of
elongation and survivability.
In addition to adding known factors to the culture media to induce elongation in
vitro, a more detailed investigation of the differences between embryos that successfully
undergo elongation and those that do not should be done. In order to fully understand the
behavior of a complex system, the response of an organism to a perturbation of that
system must also be fully understood, on the transcriptome, proteome, and metabolome
levels [180]. The transcriptome is a complete set of transcripts in the cell at a particular
developmental stage or condition, and understanding it completely is essential for
interpreting the functional elements of the genome and understanding the developmental
process [181]. RNA-seq catalogues all species of transcripts to quantify changes in
expression levels of each transcript of interest under different conditions. In the context
of this study, the differences in the profile of embryos that have shown morphological
changes and those that have not could be quantified to elucidate which genes or sets of
genes in particular are important to the initiation and maintenance of elongation.
Transcriptomic studies in mice have shown success in elucidating novel gene transcripts
involved in the segregating of the inner cell mass of preimplantation embryos, leading to
a better description of the timing of upregulation of these genes [182]. The same
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transcriptomic approach could be applied to either in vitro or in vivo produced porcine
embryos to expand upon what is already known about the transcriptome and to identify
novel transcripts or the novel timing of the expression of these transcripts to further
understand elongation. By evaluating the transcriptome of in vivo embryos, new ways to
evaluate in vitro produced elongating embryos could emerge.
Furthermore, metabolomics is the holistic study and/or quantification of the
metabolites, or small molecules that function as fuel, structure, signaling, stimulatory,
inhibitory or developmental entities related to metabolism, found within a functioning
organism [183]. Metabolites are the downstream result of transcripts, coupling the two
endpoints. Currently, metabolomics are being used to identify the most viable embryos
for use in in vitro fertilization in humans. Seli et al. studied the capacity of embryos to
survive in humans by analyzing the culture media of embryos that did and did not survive
after implantation from IVF using metabolomic approaches. It was reported that by using
Ramen spectroscopy and near-infrared spectroscopy, differences were observed in the
metabolites produced by the embryo in vitro between embryos that survived and those
that did not [184], which demonstrates that a metabolomic approach to understanding
what determines whether or not a porcine embryo elongates in our system could be used
[184]. By using two separate populations of in vitro-produced embryos, elongated and
not elongated, both RNA-seq and non-targeted metabolomic readouts could provide a
comprehensive and global picture of differences found between the two populations and
elucidate genes and metabolites both within the embryo and the uterine/culture
environment that are critical for the success of elongation. Once differences emerge, that
knowledge can be used to suggest soluble factors and proteins to incorporate into our
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culture model to confirm their role in elongation and provide the gene transcripts to target
to provide an endpoint to determine the authentication of true physiological elongation to
ultimately improve upon our current in vitro culture model.
In the uterine horns, embryos develop in close proximity to each other. Studies
have shown that the distance between each embryo in the uterus ranges from 5-50 cm.
Chen et al. aimed to correlate the spacing of pig embryos in the uterus to survival by
measuring the distance between embryos en utero and evaluating whether or not that
embryo survived after a certain amount of days [185]. It was reported that as the distance
between embryos increases, so does survivability up to about 25 cm where the correlation
was no longer seen [185]. As previously stated, the embryo secretes many factors during
gestation including estrogen that not only signal to the uterus for the acceptance of
pregnancy, but also to signal to embryos in close proximity to ensure proper spacing
within the horns [186]. In vitro studies have shown in bovine models that culturing
embryos within the same culture well improves the overall survivability of the embryos
due to their proximity to embryotrophic factors secreted by neighboring embryos [187,
188]. However, culturing embryos in the same well can lead to losing track of the
specific embryo to be observed. In preliminary studies, a method to culture encapsulated
embryos in the same well, but also to keep them stationary to track each embryo over
time has been developed. Using a polyethylene mesh, 6 50-µL droplets of alginate were
pipetted onto the mesh in a line, and the entire mesh was lowered into a petri dish of
CaCl2/NaCl crosslinking solution described in Chapters 2 and 3. The droplets were
crosslinked on top of the mesh with portions of the droplets crosslinking around the
individual threads of the mesh, allowing the alginate to become immobilized on the
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mesh. Fig. 4-3 shows an
image of the apparatus. By
placing double-layered
alginate beads onto alginate
Fig. 4-3. Device for the immobilization of double encapsulated beads

droplets on this mesh, a final

for culture. Alginate droplets on polyethylene mesh were

crosslinking step would

immobilized after crosslinking.

immobilize the already

constructed beads to the mesh, allowing for the culture of the embryos within the same
culture media while defining the distance between the individual embryos.
In addition to the aforementioned steps to continue the development and
utilization of alginate hydrogels to study embryo elongation, a more detailed study of the
timing and extent of morphological changes could be performed to better understand the
process. For example, images of the embryos are taken every 24h and are assessed by
96h, but some embryos may reach their peak of elongation prior to 96h. If each image
were analyzed, the rate of elongation could be mapped over time, giving us a more
accurate timeline in which to assess metabolomic and transcriptomic changes within our
system.

4.3. Future directions for the in vitro culture system of growth plate cartilage
development
In order to develop alginate hydrogel scaffolds to culture growth plate
chondrocytes to study the mechanisms behind the PTHrP/IHH feedback loop, both
unmodified and RGD-modified alginate were used to encapsulate chondrocytes to
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explore the effects of cell adhesion on behavior, and the addition of factors like PTH,
IHH and inhibitors of either molecules within the culture system and their effect on
behavior were explored. When comparing unmodified and modified alginate hydrogels,
outputs such as the cell cycle distribution indicated that encapsulation within ALG and
RGD gels did not cause any adverse changes to the cell cycle, supporting their use as
scaffold materials for chondrocyte culture. Furthermore, it was shown that cells
encapsulated in RGD gels demonstrated a significantly greater percentage of cells in the
proliferative phases over time, suggesting RGD encapsulation promotes a more
proliferative phenotype than ALG encapsulation over time. Additionally, no change was
observed in the Col2/Col1 ratio in either scaffold over time, indicating the lack of
dedifferentiation within both ALG and RGD scaffolds. A decrease in the expression of
ColX, PTH1r and IHH and the increase in expression of PTHrP in chondrocytes
encapsulated within both ALG and RGD scaffolds indicated that both scaffold systems
suppress hypertrophy over time. Conversely, the utilization of FISH to observe changes
in the ColX/Col2 ratio demonstrated that in ALG, chondrocytes remained less
hypertrophic over time, while RGD facilitated a slight increase in the ratio; however, the
increase was not significant. Furthermore, when chondrocytes were encapsulated in ALG
and PTH was included in the culture media, significant changes were observed in the cell
cycle distribution with treatment over time, suggesting that chondrocytes became more
proliferative with increasing PTH doses over time. The Col2/Col1 ratio resulted in no
changes with treatment or over time, indicating no dedifferentiation was observed with
PTH, while significant decreases in ColX, PTHrP, PTH1r and IHH expression levels with
PTH treatment suggested PTH aided in the suppression of hypertrophy in ALG, both on
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D1 and D4, as expected [189]. This conclusion was further supported by the decrease in
the ColX/Col2 ratio on D4 with the highest dose of PTH, demonstrating our ability to
present soluble factors to the encapsulated chondrocytes and measure subsequent changes
in behavior, and that PTH may help to suppress hypertrophy. Finally, with the addition of
IHH, a significant change in cell cycle was observed on D4 with increasing dose of IHH
that suggested IHH induced a more immature phenotype later in culture. While more
replicates are needed for statistical significance in all outputs, we also observed no
significant changes to the Col2/Col1 ratio, suggesting dedifferentiating was not occurring
with treatment with IHH over time. The expression of ColX and IHH demonstrated a
dose dependent decrease in expression on D1, indicating a decrease in hypertrophic
markers, but the dose-dependence and decreasing trend was not observed on D4.
Additionally the expression of PTHrP and PTH1r were slightly elevated over the control
on D1 and D4, which was to be expected. Furthermore, the decrease in the ColX/Col2
ratio on D1 with increasing IHH treatment further supports the conclusion that IHH
suppresses hypertrophy, as expected. Most interestingly, by FISH we observed a
differential pattern of the expression of ColX and Col2: ColX expression was mostly
concentrated on the outer diameter of the alginate bead, while Col2 expression was
concentrated mostly in the inner portion of the bead, suggesting our ability to induce
spatial gradients in gene expression that resemble the expression of these gene transcripts
in vivo. Taken together, the results described in Chapter 3 of this thesis demonstrate that
modified and unmodified alginate hydrogels maintain cell cycle and aid in suppressing
hypertrophy and promoting proliferation, while also allowing soluble factors to signal to
the chondrocytes in vitro. While we confirmed the validity of using alginate to study
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chondrocyte behavior in vitro, future studies are necessary to further develop this model
in order to elucidate more mechanisms involved in the development of these tissues. The
recommendations for moving forward are as follows: 1) Evaluate the effect of the
addition of inhibitors of IHH to the culture media with the concentration of IHH that
produced the differential gene expression in Chapter 3 to prove our response is because
of the mechanistic action of IHH; 2) incorporate other factors known to play a role in the
PTHrP/IHH feedback loop into the culture media to show the utility of our scaffold
system in presenting factors in order to study the specific response of chondrocyte to
those factors; 3) utilize a multi-layered alginate bead and HEK293T cells to present PTH
to chondrocytes in a gradient manner to better recapitulate the PTHrP/IHH feedback loop
in vitro. All of these approaches are detailed below.
In Chapter 3, an alginate scaffold system was utilized to encapsulate chondrocytes
and IHH was presented via the culture media, which resulted in evidence of differential
expression of Col2 and ColX within the alginate bead. In order to confirm the hypothesis
that IHH and the related downstream pathways that IHH activates are responsible for the
differential gene expression seen in beads treated with IHH, the initial results must first
be replicated and then the inhibition of IHH must be explored. IHH plays a critical role in
coordinating endochondral ossification, which is evident by the severity of IHH knockout
mice [146]. It has been shown that IHH upregulates PTHrP expression (although the
mechanism remains unclear) and acts on its own to drive proliferation and IHH may also
be necessary to drive differential growth across the longitudinal axis of the long bone
[146]. As described throughout this thesis, PTH/PTHrP act as inhibitors of IHH [190].
The mechanism as understood today is depicted in Fig. 1-5 and as follows: PTHrP
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activates the PTH receptor, PTH1r, which in turn activates protein kinase A (PKA) [166,
189, 191]. PKA blocks Gli2/3, effectively blocking the downstream response cascade of
IHH activation of patched (PTC) [136, 191]. Therefore, it follows that PTH could be
utilized in conjunction with IHH treatment to effectively block IHH signal transduction.
If the gradient in gene expression is no longer seen with co-treatment within the ALG
bead on D4, it may be concluded that IHH played a role in the differential gene
expression, potentially through the Gli2/3 pathway. However, it is known that PTH acts
in other ways on chondrocytes, so this method may not be sufficient to implicate the IHH
signal cascade as solely responsible for the results seen in Chapter 3. Therefore, another
factor should be employed to effectively block IHH mechanisms: cyclopamine.
Oji et al. demonstrated that the addition of cyclopamine to cultures of growth
plate chondrocytes significantly decreased the proliferation rate of the cells, which was
expected since IHH causes an increase in proliferation, indicating the inhibition of IHH
signaling [147, 192]. On the cell surface, two transmembrane proteins smoothened (Smo)
and PTC control the cellular responses to hedgehog (HH) signaling (Fig. 1-3) [193]. It
has been shown that PTC suppresses Smo and that the binding of IHH to the PTC protein
releases the inhibition, activating Smo, which in turn produces downstream products such
as Gli [193]. While molecules such as IHH interact with PTC to remove the inhibition of
Smo, cyclopamine acts to suppress Smo regardless of the status of PTC and IHH, leading
to the successful inhibition of any effect IHH would have on the system [194]. In order to
prove that HH signaling is in fact responsible for the radial gradient in gene expression
described in Chapter 3, cyclopamine is one inhibitor that should be incorporated into the
culture media. It is hypothesized that a homogenous distribution of cells expressing Col2
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and ColX will be observed using FISH when chondrocytes are encapsulated in ALG and
are treated both with IHH and cyclopamine, similar to the example shown in the
beginning of the results section of Chapter 3.
In this thesis, it was demonstrated that our culture system could be used to prevent
hypertrophy of chondrocytes by utilizing ALG or RGD hydrogels, or by utilizing PTH or
IHH in the culture media. In order to demonstrate the utility of the alginate culture system
to present factors and induce directed responses in chondrocytes, the next step in this
project should be to aim to induce hypertrophy in our culture system. Soluble factors that
should be used to induce hypertrophy include thyroxine (THX), permorphamine (PMP)
or bone morphogenic protein (BMP). First, THX is a hormone produced in the thyroid
gland, and its use in vitro has been proven to induce hypertrophy in chondrocytes [195,
196]. For example, Alini et al cultured bovine growth plate chondrocytes in serum-free
media with the addition of THX or thyroid hormone into the culture media and observed
that at higher concentrations, the expression of ColX increased along with the production
of alkaline phosphatase, another indicator of chondrocyte maturation, while Col2
decreased [197]. These endpoints demonstrate the ability of THX to induce hypertrophy
in growth plate chondrocytes, and the use of THX in our system is hypothesized to
induce similar chondrocyte behaviors. Preliminary experiments (Fig. 4-4) were
performed using the bead fabrication method and culture method outlined in Chapter 3
with the addition of THX in the culture media at concentrations of 1, 5 and 20 µM THX
for up to four days to explore the use of THX in inducing hypertrophy within our culture
system. FACS was utilized and the preliminary results indicate that on D1, THX had little
effect on chondrocyte cell cycle distribution when compared to the untreated D1 control,
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while on D4, an increase in THX concentration lead to a slight decrease in the percentage
of cells in G0G1 phase and the percentage of cells in the S and G2M phases slightly
increased with increasing THX dose. An increase in cells in the proliferative phases (i.e.
G2M and S) could actually indicate elevation of proliferation in the system, opposite of
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Fig. 4-4. Preliminary results of cell cycle distribution and Col2/ColX ratio for encapsulated
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what was expected with the addition of THX. However, when examining the ColX/Col2
ratio determined by image analysis using FISH with treatments with THX, a increase in
the ColX/Col2 ratio on D4 with increasing THX treatment indicates hypertrophy may
still have been induced since either ColX had to increase or Col2 had to decrease in order
to see an increase in the ColX/Col2 ratio. These preliminary results support the further
exploration of THX in the culture media to induce hypertrophy.
Moving forward, PMP is a small molecule that acts as a Smo agonist and is
regularly used to guide stem cells to osteogenic differentiation [198]. Many studies
demonstrate PMP as an IHH pathway activator due to its upregulation of pathway
mediators such as Smo, Ptc and Gli 1 and 2 [199]. Additionally, and the utilization of
PMP specifically in limb bud cell cultures resulted in the upregulation of such genes,
inducing hypertrophy [199-201]. Preliminary studies using PMP in our culture system
were performed by culturing growth plate chondrocytes in ALG using the method
outlined in Chapter 3. PMP was added to the culture media at concentrations of 1, 5 and
20 µM and encapsulated chondrocytes were cultured for up to 4 days (Fig. 4-4). FACS
was performed to observe changes in the cell cycle distribution with PMP treatment over
time. On D1, the cell cycle distribution remained constant with increasing dose; however,
by D4, a reduction of cells in G0G1 phase was observed and the overall percentage of
cells in G2M and S phases increased overall with PMP treatment, but decreased relative
to 1.0 µM PMP with increasing PMP dose. These results indicate that increasing PMP
treatment decreases the number of cells synthesizing DNA and proliferating over time,
suggesting a decrease in proliferation and potentially an increase in hypertrophy [16].
Additionally, image analysis using FISH was performed to determine the ColX/Col2
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ratio, and while data have not yet been gathered for D1, on D4 a dose dependent increase
in the ratio with increasing PMP concentration was observed with the highest ratio seen
with 20 µM PMP, which suggests that increasing PNP concentrations direct encapsulated
chondrocytes toward a more hypertrophic phenotype. The use of PMP to drive
hypertrophy should be explored further in order to drive chondrocytes toward a more
hypertrophic phenotype within our culture system.
Finally, BMPs have been shown to transduce signals through heteromeric
transmembrane receptors, but relatively little is known about the downstream signal
transduction activated by BMP, which leads to transcriptional activation of target genes
[202]. It was demonstrated by Volk et al. that the addition of BMP to the media in which
explants were cultured caused a significant increase in ColX expression and ALP, along
with a decrease in Col2 expression, all of which are markers for chondrocyte
differentiation and hypertrophy [203]. Additionally, the highest values ColX and ALP,
along with the lowest value for Col2 expression, were observed with the use of BMP-4,
which should be explored in future studies [203]. In preliminary studies chondrocytes
were again encapsulated and cultured according to the protocol detailed in Chapter 3. In
addition to the basal cartilage culture media, the media was supplemented with 1 or 5
ng/mL BMP-4 and hypertrophic markers such as the decrease in proliferation via FACS
were evaluated. On D1, a slight increase in the percentage of cells in S and G2M phases
was observed when compared to the NT control, but on D4, a dose dependent response
was observed in the percentage of cells in the proliferative phases; the percentage of cells
in the combination of G2M and S phases increased with increasing BMP treatment,
suggesting that chondrocytes treated with BMP exhibit a decrease in the percentage of
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Fig. 4-5. Schematic of the calcium leaching method. Steps 1-3a, or 4a, are the methods to make the
homogenous inner bead specific to the calcium leaching method. The resulting construct is either a
homogenous bead with encapsulated cells or a heterogeneous bead with encapsulated cells in the outer layer.

cells in the proliferative phases, indicating hypertrophy. Additionally, image analysis
using FISH demonstrated a lower ColX/Col2 ratio on D1 with increasing BMP dose, but
by D4, the chondrocytes encapsulated and cultured in this system show a dose dependent
increase in the ColX/Col2 ratio, further supporting the hypothesis that the incorporation
of BMP induces hypertrophy in vitro.
Finally, the last recommendation for this project is the utilization and optimization
of a multilayer alginate construct for the presentation of factors like PTH in order to
recapitulate the PTHrP/IHH feedback loop with factors in vitro. Multilayered alginate
hydrogels have been used in the past to modulate the release of soluble factors. For
example, Khanna et al. found that by first coating alginate microspheres with PLL and
then coating the ALG-PLL microsphere again with ALG, the release profile of FGF from
the alginate construct could be modulated by changing alginate percentage or by utilizing
heparin sulfate to sequester the growth factor [204]. In the case of this thesis, it is our aim
to recapitulate the PTHrP/IHH feedback loop in vitro by utilizing the alginate pore sizes
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and diffusional properties to present factors in a differential pattern, within concentric
beads, both from the inside out and outside in. However, it has been shown that alginate
has a pore size of up to 20 nm, so the diffusional characteristics of small molecules are
similar to the diffusion in a liquid without the scaffold [154]. Additionally, due to the
mass transport and fluid mechanics, the thickness of the substrate in which we aim to
diffuse factors through makes a difference in the diffusional profile of any factor.
Therefore, it is recommended that a method to create and modulate a multilayered
alginate beads for encapsulation, culture and factor presentation be developed for future
studies, and preliminary experiments have been performed.
To begin, the original 10-µL alginate beads were fabricated according to methods
described in Chapter 2 and Chapter 3 for further use in double encapsulation (Fig. 4-5).
Once the initial homogenous bead was formed, all crosslinking solution was removed.
The bead was placed onto a 10-µL droplet of alginate containing either growth plate

Fig. 4-6. Representative phase and fluorescent images of layered beads using the calcium leeching method
overlaid and measured using ImageJ. Beads fabricated by both A) keeping the alginate percentage of the
inner bead and the outer layer identical and B) keeping the inner bead at 1.5% and changing the outer layer
percentage. Both images are of the 1.0% data points discussed below. The scale bar is 100 µm.
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chondrocytes or human embryonic kidney cells (HEK293T) cells. Then, 30-µL of the
same alginate-cell solution was slowly pipetted over the top of the bead, ensuring
complete submersion. The bead incubated in this cell-solution as the calcium leached out
of the inner bead, crosslinking the surrounding alginate-cell solution for 2 minutes before
the entire construct was picked up with forceps and dropped into crosslinking for 30
seconds to seal the outer layer. A representative image of the multilayer bead can be
found in Fig. 4-6. First, the effect of changing the alginate percentage used for inner bead
and outer layer was explored (Fig. 4-6A and Fig. 4-7A and B), followed by keeping the
inner bead alginate percentage at 1.5% as is used in Chapter 3, but varying the percentage
of alginate used for the outer bead (Fig. 4-6B and Fig. 4-7C and D). The thickness of the
outer layer is defined as the diameter between the inner bead and the edge of the entire
construct. Three images were taken of every construct with 3-4 measurements of
thickness for every image, and 3 beads of every condition were made, totaling 27-35 total
images per condition. The thickness was measured using ImageJ. The effect of the
percentage of alginate in solution on the thickness of this outer layer was explored first.
For the visualization of the secondary layer of the bead, HEK cells were mixed with the
alginate designated for outer layer formation. A shows that there is little effect of alginate
percentage on the outer layer thickness, however as the alginate percentage increases, the
average diameter slightly decreases. This is opposite of what others show. Others have
shown that an increase in alginate percentage leads to greater layer thicknesses; however,
other studies utilized low molecular weight alginate as well as the incorporation of other
hydrogel materials, which may affect layer thickness [204]. There are no statistical
differences in layer thickness between the alginate percentages. The deviation in the
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measured thicknesses is shown in Fig. 4-7B to illustrate the consistency of the calcium
leeching method with respect to layer thickness. As the alginate percentage increases, the
deviation in the diameter decreases, indicating that the consistency of the formation of the
outer layer is greater as the percentage is increased. Next, the percentage of alginate used
to make the inner homogenous bead was held constant while the percentage of the

Fig. 4-7. Changing alginate percentage to modulate layer thickness. All figures show results of using the
calcium leaching method. A) and B) keep the inner and outer alginates at the same percentage while C) and
D) keep the inner bead at 1.5% while modulating the outer layer percentage. B) and D) are the deviations in
the thickness of the layers of the results shown in A) and B) respectively.
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alginate-cell solution (i.e. outer layer) was modulated. There is no appreciable effect on
outer layer diameter by only changing the outer layer percentage as shown in Fig. 4-7C,
with the deviation shown in Fig. 4-7D.
Next, the effect of calcium concentration in the crosslinking solution was
explored to modulate the thickness of the outer layer of the construct (Fig. 4-8). It was
hypothesized that a greater concentration of calcium ions used to crosslink the inner bead
could lead to the availability of more ions to leach out, resulting in a difference in layer
thickness. However, Fig. 4-8 illustrates that the calcium concentration does not affect the
thickness of the outer layer in our developed system. Overall, no statistical differences
were observed by modulating alginate percentage or by changing calcium concentration.
Further tests should be done moving forward in order to begin to modulate the thickness
of the outer layer of the construct, in order to tailor the scaffold system to present factors
appropriately. However, the average thickness of a mouse growth plate is around 300

Fig. 4-8. The role of calcium concentration on the layer thickness. There is no
effect seen in our system.
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µm, which is close to the average thickness of the outer layer of our constructs, so
moving forward with the method described above, a method of presenting the small
molecule PTH has been explored.
Because PTH is only 4 kD, and the pore size of alginate hydrogels allow for the
immediate diffusion in and out of the construct for substrates smaller than 10 kD, a
method for presenting PTH to chondrocytes in a diffuse way must be designed [154].
Preliminarily, HEK293T cells have been employed for their ability to be transfected
easily. Briefly, transfection is the delivery of exogenous DNA to a cell using non-viral
vectors. By transfecting HEK293T cells with Lipofectamine 2000 and a plasmid that
codes for the PTH molecule and then encapsulating the cells in alginate, the transient
transfection and subsequent steady protein production will allow for the slow diffusion of
PTH out of the bead. Then, the double layer method should be used to encapsulate
chondrocytes around the inner bead containing transfected HEK293T cells, recapitulating
the resting zone with PTH-producing HEK cells and even mimicking the prehypertrophic
zone by adding the high molecular weight molecule IHH to the culture media [189]. The
high molecular weight of IHH is important because the diffusion of this molecule may
take place differentially because of its size relative to the pore size of alginate, which
could be between 5 and 25 nm [154].
A plasmid coding for the PTH molecule fused with a DDK flag tag (Fig. 4-9) was
purchased and expanded using a Qiagen Mega Prep Kit according to the manufacturer’s
instructions. Using Lipofectamine 2000 at a ratio of 1.5:1 to DNA, and a plasmid
concentration of either 0.6 or 1.0 µg DNA/well, HEK293T cells were transfected 18
hours after initially seeding a 24-well plate with 30,000 cells/well. Four hours later and
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every 12 hours after that, media samples were taken and stored for further processing to
assess secretion of the PTH produced by transfection of the plasmid. Once media was
collected for up to 48 hours, the amount of PTH in the culture media was assessed using a
Ray Biotech PTH (1-34) ELISA kit according to the manufacturer’s instructions.
Representative results are shown in Fig. 4-9. As expected, the production of PTH
by HEK293T cells increased over time. While the results reported above are
representative of the trends shown, is important to note that consistent results using the
ELISA method have been difficult to obtain, and new methods of quantifying PTH
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Fig. 4-9. ELISA results of PTH plasmid transfection with varying concentrations of plasmid per well
over 48 hours of HEK 293T cells.

production should be explored.
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4.4. Conclusions
This thesis describes the establishment of in vitro culture systems for preimplantation pig embryos and growth plate chondrocytes using alginate hydrogels as a
scaffold for development. Embryos double encapsulated in alginate hydrogels continued
to show elongation whereas control, non-encapsulated embryos did not. However, by
encapsulating embryos in RGD-modified alginate hydrogels, a significant difference in
survivability was seen over control (not encapsulated) embryos. RGD-alginate
demonstrated a greater ability to facilitate elongation in encapsulated embryos than
unmodified alginate hydrogels, which suggest that providing a specific interaction
between the surrounding environment and the embryo is important to the elongation
process and further verifies the RGD ligand, and by extension cell adhesion capabilities,
is an important part of signaling molecules such as SPP1. By continuing to improve the
scaffold and thereby the culture system, more information can be gathered to elucidate
the mechanisms and most important molecules in regards to embryo elongation. In
addition, alginate hydrogels were used for the encapsulation of growth plate chondrocytes
in vitro to construct a growth plate model to study the developmental mechanisms behind
zonal arrangement and columnar formation. It was demonstrated that encapsulation and
culture in ALG and RGD promoted a more proliferative chondrocyte phenotype and the
presentation of the RGD ligand in culture may further induce proliferation as well as
suppress hypertrophy when compared to ALG. Additionally, encapsulating chondrocytes
in ALG and supplementing the culture media with PTH or IHH resulted in a more
proliferative and less hypertrophic chondrocyte phenotype over time.
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Overall, the information gained through in vitro culture models of development
can be used to advance the fields of embryology and cartilage developmental biology.
The use of the developed in vitro culture model of porcine embryo elongation can lead to
potential improvements in pregnancy outcomes in pigs, resulting in increases in food
production and the utilization of the in vitro culture model of growth plate cartilage could
afford greater insight into cartilage development and maturation in order to provide better
therapies for growth plate injuries and diseases.
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